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Summary 
The fonnation of the kidney in vertebrates proceeds through a succession of up to three 
structures. the pronephros. metanephros and mesonephros. This project aimed to 
identify a suitable target gene involved in the development of the pronephros and study 
its role in development. By analysing the functional role of a target gene. this thesis 
ultimately aims to further elucidate the developmental regulation of pronephric 
organogenesis. 
The candidate target genes were identified from 3 sources. Firstly. a Xenopus laevis 
stage 13 cDNA library was screened using a probe made from retinoic acid and activin 
A treated animal caps. Secondly. four UniGene cluster genes were investigated. after 
initial analysis indicated they were highly pronephros specific (Personal correspondence 
Pollet. N). Finally, data mining identified Xenopus homologues of important kidney 
development genes identified in higher vertebrates or newly identified genes expressed 
in the pronephros. On the basis of preliminary data. Darmin r and Pod J were taken 
forward for functional studies. 
Pod J, a basic-helix-Ioop-helix transcription factor. was found to be expressed from 
pronephric initiation with enhanced expression in the pronephros. The expression 
patterns of Pod J strongly matched that of the mouse homologue. implying a conserved 
evolutionary role. Pronephros targeted over-expression resulted in the reduction of 
glomus tissue, with no alteration in pronephric tubule or duct morphology. In addition. 
targeted knock-down resulted in the absence of cells in the glomus region. 
Preliminary analysis of Darmin r. a cytosolic non-specific dipeptidase. indicated a role 
later in pronephric tubule development. Targeted over-expression experiments 
disrupted tubule morphology and reduced the size of the pronephric anlagen. 
Initial promising data clearly placed Pod J and Darmin r as important pronephric 
development genes. 
Xli 
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Chapter 1 
Introduction 
1.1 The pronephros; the simplest of the 3 kidney forms 
Kidney organogenesis in vertebrates follows a succession of kidney structures, which 
are formed, degraded, and reformed with increasing structural complexity (Saxen, 
1987). Induction of each successive kidney structure requires the previous temporal 
form for its own induction from the intermediate mesoderm (Brandli, 1999: Vize, et al., 
1997). The 3 kidney structures are the pronephros, mesonephros and metanephros (Fig. 
1.1, reproduced from Vize, et al., 1997). When functional, the kidney structures all 
have the same principle role of osmoregulation and waste disposal. This role is 
achieved by their basic functional unit, the nephron. The pronephros, comprising only 
one nephron, is the simplest and also the earliest in evolutionary terms. The 
mesonephros is next, consisting of 10-50 nephron-like structures and finally, the 
metanephros, with approximately I million nephrons is the most sophisticated. The 
final structural complexity of the kidney is correlated to the complexity of organism. In 
lower vertebrates, amphibia and fish, the progression is from the pronephros to the 
mesonephros only, where the mesonephros is the functioning kidney of the adult. In 
higher vertebrates, mammals and birds, all three kidney stages are created, with the 
metanephros being the functioning kidney of the adult and the pronephros being 
vestigial. This thesis will focus on the simplest kidney structure, the pronephros, and its 
development in Xenopus laevis. 
1.1.1 Xenopus Pronephros: Overview of Structure and Function 
The Xenopus pronephros, comprising one nephron, has 3 distinct structures: a glomus, 
the blood capillary network responsible for filtration of the blood: pronephric tubules, 
used for the selective reabsorption of water and nutrients from the filtrate; and the 
pronephric duct, which channels waste to the exterior. 
The Glomus 
The Xenopus pronephros is described as a non-integrated nephron, where the 
vascularised filtration unit, the glomus, is not directly integrated with the tubules. 
E 
o 
"8 
(.) 
pronephros: 
1 nephron 
degenerating pronephros 
V.·, 
•.. ~: ....... . 
:>-\; __ ;i ) 
glomus 
mesonephros: 
10 to SO nephrons 
degenerating mesonephric duct (females) or 
incorporation into reproductive organs (males) 
eruli 
:/ 
• 
metanephros: 
one million nephrons 
(not 10 seQ/,) 
Fig. 1.1 The pronephros, mesonephros and the metanephros. Reproduced from Vize, et al., 
1997. The pronephros is the first kidney tissue to form in all vertebrates, consisting of 
one nephron. With a few exceptions, the nephron comprises a glomus/glomerulus, 
tubule, and duct. The pronephros is the simplest and also the earliest kidney in 
evolutionary terms. The pronephros is required for the induction of the mesonephros 
which consists of 10-50 nephron-like structures. Although not forming a fully 
functioning kidney in mammals, the mesonephros is an important source of 
hematopoietic stems cells, and in males some mesonephric tubules persist forming 
sperm carrying tubes. The metanephros is the final and most complex of the kidney 
structures and is the final kidney structure in higher vertebrates, comprising 
approximately one million nephrons. 
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Instead, the glomus and tubules are separated by the coelom and the nephrostomes (Fig. 
1.2). Integrated nephrons can be found in the mesonephros and the metanephros. 
The glomus is composed of a high pressured capillary network, derived from the dorsal 
aorta, which projects into the nephrocoel space within the pronephric capsule (Fig. 1.3). 
Filtration from the high pressured capillary network of the glomus through to the 
nephrocoel is both passive, through the slit diaphragms, and active, through the 
podocyte foot processes. The surface of the glomus vasculature 'bulb' is covered by 
podocytes with foot processed protruding into the basement membrane of the 
capillaries. The foot processes of metanephric kidneys have been found to have 
characteristics consistent with high levels of endocytosis (Mundel and Kriz, 1995). 
Between the podocytes are slit diaphragms which are the dominant size selection 
element during filtration (Abrahamson, 1986). The matrix of the glomus vasculature 
'bulb' is high in podocalyxin and nephrin. Podocalyxin helps maintain foot process 
structure and function (Schnabel, et al., 1989 and Horvat, et al., 1986) and nephrin is a 
major component of slit diaphragms (Tryggvason, 1999). 
The Pronephric Tubules 
The pronephric tubules are joined to the nephrocoel through nephrostomes (Fig. 1.3). 
Nephrostomes are thin epithelial tubes lined with cilia along their length. The epithelial 
cells of the nephrostomes are distinct from the pronephric tubule cells by their lack of 
brush borders and convoluted membranes. The cilia draw fluid from the nephrocoel 
into the pronephric tubules by ciliary action. The pronephric tubules possess two 
morphologically distinct segments called the proximal tubules and the distal tubule. 
The proximal tubules are connected to the nephrostomes and are consistently arranged 
(Vize, et aI., 1997). The epithelial cells forming the proximal tubules have a dense mat 
of short microvilli on the apical surface (M~bjerg, et al., 2000). This is known as the 
brush border and serves to increase cell surface area, enhancing water, salt and nutrient 
uptake. The lateral and basal membranes of the epithelial proximal tubule cells are 
convoluted and have gap junctions. This morphology may permit the regulation of ion 
gradients between the epithelial proximal tubules cells and the filtrate. The distal tubule 
connects the proximal tubules to the pronephric duct. The epithelial cells of the distal 
tubule do not have a brush border, but have extensive basal membrane convolutions. As 
with the brush border, these basal membrane convolutions may augment water, salt and 
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," 
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Fig. 1.2 Integrated and non-integrated nephrons. (A) Integrated nephron organisation. A 
blood vessel (red) enters the Bowman's capsule where wastes are filtered into the 
Bowman's space. The blood vessel then exits the capsule and surrounds the distal (near 
the capsule) and proximal tubules. Resorbed nutrients, salts, and water are then returned 
to the blood stream via the venous system ( ) JrIJ1l ). (B) Organisation of a non-
integrated nephron. Wastes filtered into the coelom are collected by tubules. Resorbed 
materials are returned to the bloodstream via blood sinus ( L11 JI ) derived from the 
posterio cardinal vein that surrounds the tubules. (C) Mammalian glomerulu . (D) 
Amphibian glomus (reproduced from Vize, et at., 1997). 
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Fig. 1.3 Structure of the Pronephros. The glomus is a high pressured capillary network 
derived from the dorsal aorta. The glomus projects into the nephrocoel space within the 
pronephric capsule. It is covered by a 'bulb' within the nephrocoel space. This 'bulb' 
consists of podocytes, an extracellular matrix that contains podocalyxin and nephrin, 
basement membrane and endothelial cells of the glomus capillary. Filtration from the 
high pressured capillary network of the glomus through to the nephrocoel is both 
passive, through the slit diaphragms, and active, through the podocyte foot processes. 
Once within the nephrocoel, the filtrate is drawn through to the proximal tubules 
through ciliary action by the nephrostomes. The epithelial cells of the proximal tubules 
are lined with a brush border which serves to increase cell surface area, enhancing 
water, salt and nutrient uptake. The proximal tubules are connected to the distal tubules 
which have extensive basal membrane convolutions, also designed to augment water, 
salt and nutrient uptake. The pronephric tubules are surrounded by a capillary bed 
called the blood sinus. The blood sinus returns the reabsorbed water, salt and nutrients, 
to the blood stream. The resulting filtrate after filtration through the glomus and 
reabsorbtion through the pronephric tubules is channelled out of the organism though 
the pro nephric duct and cloaca. 
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nutrient uptake. The pronephric tubules are surrounded by a capillary bed called the 
blood sinus. The blood sinus returns the reabsorbed water, salt and nutrients, to the 
blood stream (Brandli, 1999). 
The Duct 
The epithelial cells of the pronephric duct resemble those of the distal tubule, but have a 
smooth basal membrane (M~bjerg, et al., 2000). The pronephric duct is fused with a 
cloacal horn, which extends the structure to the cloaca (Fig. 1.3). The resulting waste 
after the filtration through the glomus and reabsorbtion through the pronephric tubules 
is channelled out of the organism though the pronephric duct and cloaca. 
1.1.2 Xenopus Pronephric Development 
The pronephros is derived from the intermediate mesoderm, located between the 
somites and the lateral plate. The developing pronephros is therefore exposed to signals 
from the somites, lateral plate and ectoderm. However, the complete picture of the 
molecular control of pronephros formation is still unclear, although, certain factors have 
been identified to playa role. The genes actively involved in pronephric development 
have been reviewed, although this does not include genes expressed by terminally 
differentiated tissues. 
1.1.2.1 The Pronephric anlagen 
Morphological development of the pronephric anlagen 
Analysis of presumptive pronephric tissues cultured in animal caps revealed the 
specification of the Xenopus pronephros to be between stages 12.5-14 (Brennan, et al., 
1998 and Brennan, et aI., 1999). However, the first physical sign of pronephric 
development is not until stage 21, where a slight thickening (condensation) of the 
somatic lateral mesoderm is observed below somites 3 to 5 (Nieuwkoop and Faber, 
1994). This structure will form the body of the pronephros (Fig. 1.4). A second 
thickening (condensation) of the somatic lateral mesoderm forms below somites 5 to 7 
and will give rise to the pronephric duct. The condensation is caused by alterations in 
cell shape, making the cells elongate along the anterior-posterior axis. The primordia of 
these two structures fuse at stage 24 and are known as the pronephric anlagen or the 
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Fig. 1.4 Segregation of the Xenopus pronephric anlagen from the intermediate mesoderm. At 
stage 2 J slight thickning of the somatic portion 0 f the lateral mesodenn is caused by 
pronephric precursor cells becoming more columnar. By stage 24 this fonns a compact 
aggregate, referred to a the pronephric swelling. At stage 27 the pronephric anlage is a 
distinct mass, lying distal to the lateral plate. The tubule, duct and glomus anlagen can be 
distinguished at this stage. Cells are arranged radially, which leads to a tiny lumen forming 
at stage 28. (J.p. lateral plate) (adapted from Vize, et al., J 997). 
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pronephric swelling. Cells from the pronephric anlagen then become radial and 
gradually form a lumen at stages 27 through to 32 (Vize, et al., 1997). 
Gene expression and regulation in the pronephric anlagen 
Xliml, a LIM family transcription factor, is one of the earliest markers of pronephric 
specification and is visible at stage 12.5 by wholemount in situ hybridisation (Taira, et 
aI., 1994). Expression, however, is not restricted to the pronephric anlagen and can be 
seen in the prechordal mesoderm and forming notochord before the pronephric 
expression. Pronephric expression is seen in the lateral mesoderm and continues 
throughout condensation of the somatic lateral mesoderm, labelling the entire 
pronephric anlagen. This expression ceases in the glomus primordium around the time 
that it divides from the pronephric tubule and duct primordium. Xliml expression then 
continues in the pronephric tubule and duct primordium until late tail bud stages. This 
loss of expression is concurrent with the initiation of xWTI. Wilms' Tumour I, 
expression in the extreme anterior of the pronephric anlagen. which may indicate an 
exclusion of Xliml expression by xWTI (Carroll. et al., 1999). Indeed, targeted xWTI 
over-expression reduces Xliml expression in the pronephric anlagen (Wallingford, et 
al., 1998). However, this exclusion is not complete and a small proportion of cells in 
the extreme anterior of the pronephric tubule and duct primordium do express both 
transcription factors. 
Targeted injection of an inactivated mutant of Xliml does not only result in the loss of 
the pronephros, but also the anterior somites (Chan, et al., 20(0). It is suggested that 
somites, muscle precursors. appear to have a crucial role in pronephric specitication. 
possibly in supplying inducing factors. Pronephric structures are lost when embryos are 
extremely UV -ventralised or lithium-dorsalized, removing the anterior somites (Seufert, 
et al., 1999). To investigate this phenomenon, half of a UV -ventralised blastula and a 
quarter of a Iithium-dorsalized blastula were combined and incubated. The resulting 
tissue gave pronephric structures in the UV -ventralised tissue, indicating that pronephric 
inducing signals came from the lithium-dorsalized tissue. Other evidence came from 
animal cap sandwiches containing lateral mesoderm, somite tissue, notochord tissue and 
neural tissue alone and in combinations. Only those sandwiches containing lateral 
mesoderm and somite tissue in combination were able to produce pronephric structures 
(Tetelin and Jones, unpublished). 
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xPax 8, paired box transcription factor, is another early marker of pronephric 
specification, and like Xliml, is observed by wholemount in situ hybridisation during 
late gastula (Carroll and Vize, 1999). The expression pattern of xPax 8 in the 
developing gastula, differs from that of Xliml. xPax 8 expression appears more diffuse 
over the lateral mesoderm and initially, is only expressed in the presumptive glomus and 
pronephric tubule tissues. Later, between stages 20 to 25, the elongating neurula, Xliml 
and xPax 8 expression co-localise to the pronephric anlagen. Over-expression of either 
Xliml or xPax 8 in Xenopus laevis leads to an enlargement of the pronephros or ectopic 
pronephroi, indicated by antibody staining for the pronephric tubules. Furthermore, co-
injection of the transcription factors has a synergistic effect on this phenotype (Carroll 
and Vize, 1999). Retinoic acid and activin treatment of dissected animal caps can 
produce pronephric tissues (Reviewed Chapter in 3). Interestingly, this treatment of 
dissected animal caps also induces expression of Xliml and xPax 8 (Heller and Brandli, 
1999 and Chan, et al., 2000). In fact, Xliml expression was found to be required for the 
induction of pronephric tissues in treated animal caps. These data suggests that Xliml 
and xPax 8 are involved in pronephric specification and patterning, possibly in 
collaboration, although, observation of their early expression patterns suggest that they 
may be regulated by different mechanisms. 
X/db-I, a LIM domain binding protein, has been shown to bind to Xliml and synergize 
with it to activate the Spemann organizer and neural markers when co-injected (Breen, 
et al., 1998). Expression is observed in the pronephros and central nervous system in 
the elongating neural a, stages 23 to 28 (Chan, et al., 2(00). However, there is no 
evidence of their co-activity in the pronephros. 
In Xenopus, two homologs of the cold-inducible RNA binding protein have been 
identified, XCIRP and XCIRP-l (Uochi and Asashima, 1998 and Peng, et al., 2(00). 
XCIRP is expressed in the pronephric anlagen at stage 28 through to stage 35 (Uochi 
and Asashima, 1998). The other homolog, XC1RP-I, differs from XCIRP by four 
additional amino acids at the C terminus and has been shown to have a role in kidney 
morphogenesis (Peng, et al., 2(00). Targeting full length XCIRP-I antisense mRNA to 
the C3 blastomere changed the morphogenetic lineage migration of C3 blastomeres and 
led to defects in the pronephric anlagen at stage 22. XCIRP-l, an RNA binding factor, 
was also found to be required for the induction of pronephric tissues in retinoic acid and 
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activin treated animal caps. The role of XCIRP-l is proposed to be required for 
marking genes or gene transcripts for future activation. where it might change the 
conformation of the DNA or RNA to establish competence for differentiation programs. 
Xwnt-4 and xPax 2. another paired box transcription factor. have similar expression 
patterns to Xliml. although they are observed later in the elongating neurula (Heller and 
Brandli. 1997 and Carroll, et al., 1999). Xliml. Xwnt-4 and xPax 2 expression in the 
developing pronephric anlagen is entirely co-localised. even as expression is restricted 
to the pronephric tubule and duct primordium. with a slight over-lap with xWT I. The 
co-expression of Xliml, Xwnt-4 and xPax 2 with xWT 1 in the extreme anterior portion 
of the pronephric tubule and duct primordium is transient and by stage 30. xWTl 
expression is exclusive to the glomus primordium. 
NDRG 1, N-myc downstream-regulated gene I, expression is initiated between stages 12 
and 15 and is observed in the pronephric anlagen at stage 26 by wholemount in situ 
hybridisation (Kyuno, et al., 2003). Over-expression of NDRGI resulted in a reduction 
and disorganisation of pronephric structures and somites. Morpholino oligonucleotide 
knock-down of NDRG 1 caused a complete oblation of pronephric structures. NDRG 1 is 
therefore involved in pronephric development. possibly. pronephric anlagen 
specification events due to the timing of pronephric expression and mis-expression 
effects on the whole pronephros. 
Bone morphogenetic proteins, BMP. are secreted TGF-p superfamily members and 
have been implicated in a diverse range of biological processes. BMP inhibitors are 
associated with axis patterning and are believed to be one of the dorsal ising factors 
diffused from the organizer of the blastula (Dale and Wardle. 1999). BM P4 is 
expressed in the lateral mesoderm and in the pronephros, although detailed analysis of 
pronephric expression has not been published (Fainsod. et al .• 1994). BMP4 acts as a 
morphogen in the specification of ventral tissues, such as blood and epidermis with high 
concentrations and lateral tissues, such as pronephros and muscle with lower 
concentrations, in a gradient across the embryo (Dale. et al., 1992 and Dale. 2000). 
BMP7 is also expressed widely in the entire marginal zone of early Xenopus embryos. 
including in the mesoderm fated to form the pronephros (Hawley. et al .• 1995). 
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Xwnt-ll, expressed in pro nephric tubules at stage 28 (Ku and Melton, 1993), has been 
suggested to provide an important signal during the earliest stages of pronephric 
development, from preliminary experiments from our laboratory (Tetelin and Jones, 
unpublished). 
Notch- 1. Serrate- 1. and Delta-1 are believed to be involved in a feedback loop within 
the pronephric anlagen that controls the division of glomus. tubule and duct primordia 
(McLaughlin, ef al .• 2000). Notch- 1 and Delta-1 expression is visible at stage 21/22 in 
the anterior region of the pronephric anlagen. Serrate-l expression is observed in a 
similar area. a stage later at 23124. From this similar origin of expression the expression 
patterns dynamically change, so that at stage 30. Notch- 1 is expressed in the duct. 
Serrate-l is expressed in the pronephric tubules. and Delfa-l is expressed in the glomus 
to pronephric tubule border. The role of Notch- 1 in pronephric development was 
investigated using targeted injection of activated or dominant negative forms of the 
transcription factor SuCH) to mimic or inhibit Notch signaling. Activation of Notch 
signaling inhibited Delta-l and enhanced Serrate-l expression and inhibition of Notch 
signaling inhibited Serrate-land enhanced Delta-1 expression at stage 30. 
Surprisingly. activation of Notch leads to an enlargement in tubule and glomus 
structures and a reduction of duct structures. In addition. inhibition of Notch signaling 
enhanced duct formation. In fact, activation of Notch promoted Xliml expression in the 
anterior pronephric anlagen. the area of the presumptive glomus and pronephric tubules. 
and completely reduced expression in the presumptive duct region at stage 30. Notch- 1 
signaling is therefore believed to partition the fates of the pronephric anlagen by a 
feedback loop with Delta-1 and Serrate- 1. 
There are three members of the Hepatocyte Nuclear Factor (HNF) transcription factor 
family that are expressed in the Xenopus pronephros. HNF-la, HNF-IP and HNF-4. 
HNF-l P transcripts are detected in the somatic layer of the intermediate mesoderm at 
stage 15 and in the pronephric anlage at stage 23. where it is expressed in both the 
tubules and duct later in development (Demartis. et al .• 1994). HNF1-aand HNF-4 are 
expressed from stage 20 onwards and later in development are detected in the 
pronephric tubules (Holewa, et al., 1996, Weber, et al., 1996a and Weber. et al., 
I 996b ). It has been proposed that HN F-4 is at the top of a transcriptional cascade that 
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leads to the activation of HNF-J a via an activin A response element in the promoter to 
establish tissue-specific gene expression (Weber, et al., 1996a). Expression of a human 
gain-of-function HNF-J P mutant in Xenopus, leads to defective development and 
agenesis of the pronephros. This phenotype is similar to HNF-IP mRNA over-
expression and demonstrates a conserved role in renal development (Wild, et al., 2000). 
1.1.2.2 The Glomus anlagen and development of the nephrocoel 
Morphological development of the glomus and nephrocoel 
The capillary network of the glomus is derived from the dorsal aorta and is visible at 
stage 29-30 (Nieuwkoop and Faber, 1994). Although the blood supply to the glomus 
does not commence until stage 35/36. The nephrocoel and the glomus 'bulb' are 
formed from the pronephric anlagen containing condensing intermediate mesoderm. 
During the early tail bud stages, the nephrocoel and the glomus 'bulb' primordium 
segregate from the pronephric anlagen (Jones, 2005). The area of intermediate 
mesoderm (within the nephrocoel and the glomus 'bulb' primordium) lying adjacent to 
the developing glomus capillary network forms a visceral epidermal layer which 
protrudes into the nephrocoel and forms the glomus 'bulb' (Nieuwkoop and Faber, 
1994). The area not lying adjacent to the glomus capillary network is the parietal 
epidermal layer which forms the lining of the nephrocoel. 
Gene expression and regulation in the glomus and nephrocoel 
WIl, a zinc-finger transcription factor, is the earliest glomus-specific gene expression 
in the pronephric anlagen (described in 1.1.2.1 Gene expression and regulation in the 
pronephric anlagen, Carroll, et al., 1999). Expression is observed in the lining of the 
nephrocoel and glomus of late tail bud stage embryos and at stage 38 is also detected in 
the heart (Carroll and Vize, 1996 and Semba. et al., 1996). xWII over-expression 
disrupts glomus formation and inhibits pronephric tubule development (Wallingford, et 
al., 1998). It is hypothesised that the function of xWIJ may be to reserve the fate of 
pronephric competent cells for the formation of the glomus, possibly by preventing 
xPax 2, Xliml or xWnt-4 expression, and thus tubule specification, in the glomus 
primordium. This could account for the difference in timing between initiation of xWfJ 
expression and glomus differentiation and the exclusion of the pronephric tubule 
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development genes from the glomus primordium shortly after the onset of xWfl 
expression. 
The other early glomus marker is the LIM domain binding protein xlmx I b, which is 
expressed from stage 10.5 in neural and presumptive pronephric regions (Haldin, et al., 
2(03). It is expressed in the glomus primordium at stage 27 and expression continues 
throughout development. Xlmxl b morpholino oligonucleotide knock-down reduces the 
size of the glomus and disrupts tubule morphology (Haldin and Jones, unpublished). 
Like xWT1, xlmxlb has been implicated in early glomus specification, although has yet 
been shown to inhibit the expression of pronephric tubule development genes. 
Nephrin is a trans-membrane protein, expressed in the developing podocytes in the 
glomus from stage 25 (Gerth, et al., 2005). A component of slit diaphragms, nephrin 
has been used to study the 3 dimensional structure of the glomus. 
VEGF, Vascular Endothelial Growth Factor, and its tyrosine kinase receptor, flk-l 
expression are observed in juxtaposed tissues through-out the Xenopus vasculature 
(Cleaver, et al., 1997). Expression of VEGF is seen in the glomus from stage 32. Over-
expression analysis reveals an alteration in the vasculature morphogenesis. Ectopic 
expression in embryos revealed VEGF acts as a chemoattractant for angioblasts, 
indicating a role in vertebrate vascular development (Cleaver and Krieg, 1998). 
1.1.2.3 The Pronephric Tubules 
The positioning of the 3 nephrostomes is indicated by the formation of 3 protuberances 
in the dorsal region of the pronephric anlagen at stage 28 (Fig. 1.5). This is after the 
segregation of the nephrocoel and the glomus 'bulb' primordium from the pronephric 
anlagen, leaving the pronephric tubule and duct primordium (Jones, 2005). The 
nephrostomes are formed before the pronephric tubules and are structurally complete at 
stage 33 (Nieuwkoop and Faber, 1994). The pronephric tubules begin to form a lumen 
at stage 30. The first anterior branch of the proximal tubules is formed joined to the two 
anterior nephrostomes (Fig. 1.5). The final second branch of the proximal tubules is 
formed joined the more dorsal nephrostome and links the distal tubule. The proximal 
tubule ultimately joins the pronephric duct. At stage 34, this arrangement is clearly 
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Fig. 1.5 Formation of the pronephric tubules in Xenopus as observed by 
immunohistochemistry using the tubule specific monoclonal antibody 3G8 and 
Darmin r wholemount in situ hybridisation. (A) Cartoon depiction of the pronephric 
tubule and duct primordium at stage 30 (adapted from Vize, et al., 2003). The 3 
protuberances in the dorsal region of the primordium indicate position of developing 
nephrostomes. (B) Wholemount 3G8 and 4A6 antibody staining in a stage 34 embryos. 
3G8 staining is ob erved in the pronephric tubules in purple and 4A6 staining in the 
pronephric duct in red. At this stage the three nephrostomes can be clearly identified. 
(C) Tubules at stage 36 are more coiled although nephrostomes are still distinguishable. 
(D) Tubule become extended and tightly coiled by stage 42 as indicated by 
wholemount in situ hybridisation using Darmin r DIG-labelled antisense RNA probe 
(Chapter 5). 
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visible by 3G8 (pronephric tubules) and 4A6 (pronephric duct) immunohistchemistry. 
As the tadpole develops, the distal tubule extends and coils, forming a convoluted mass 
by feeding stages (Vize, et al., 2003). 
Gene expression and regulation in the pronephric tubules 
As the pronephric tubule and duct primordium develops, Xliml pronephric expression is 
dramatically restricted to the tubules, before becoming exclusive to the nephrostomes, 
the regions of increased extension and growth (Carroll, et al., 1999). This is similar to 
the later expression patterning of xPax 2 but not xPax 8 (Carroll, et al., 1999 and Heller 
and Brandli, 1997). As described previously, co-injection of Xliml and xPax 8 leads to 
an enlargement of the pronephros or ectopic pronephroi, indicated by antibody staining 
for the pronephric tubules (Carroll and Vize, 1999). Interestingly, xPax 2 can also form 
an enlargement of the pronephros or ectopic pronephroi when co-injected with X/iml. 
Comparison of xPax 2 and xPax 8 with Xliml expression patterns during pronephric 
tubule morphogenesis shows a much closer relationship of Xliml with xPax 2. It has 
been suggested, therefore, that xPax 8 is involved with early pronephric patterning 
events, and xPax 2 is involved with later pronephric tubule patterning events. 
In the developing pronephric tubule and duct primordium, XWnt-4, Xliml and xPax 2 
expression coincides with the anterior-dorsal most region of wn expression (Carroll 
and Vize, 1999). It is not clear whether this environment contributes to the formation of 
the nephrostomes, or is a result of unspecified cells yet to be determined as glomus or 
tubule tissue. In zebrafish, nephrostomes are formed transiently, and are derived from 
the coelom before the tubules develop (Drummond, et al., 1998). In Xenopus, however, 
the nephrostomes are formed from the tubule primordium, but are again formed before 
tubule morphogenesis (Jones, 2005). 
As previously mentioned, Xwnt-4 is expressed initially in the whole pronephric anlagen 
and then focuses to the tubules before terminal differentiation. At stage 32, Xwnt-4 is 
detected in the nephrostomes (Saulnier, et al., 2(02). Embryos injected with Xwnt-4 
morpholino oligonucleotide fail to develop tubules, whilst Xwnt-4 mRNA over-
expression appears to perturb morphogenesis of the pronephric tubules with the 
nephrostomes often fused to form a single structure. 
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XTRAP-y is one of four subunits that make up the translocon-associated protein 
complex which is involved in intracellular protein transport (Li, et al., 2005). 
Expression was observed in the pronephros from stage 25 in the pronephric tubules. 
Morpholino oligonucleotide knock-down of XTRAP-y disrupted the pronephric tubule 
formation and expression of xPax 2 and xWnt-4 at stage 30. Conversely for a 
pronephric tubule promoting gene, Xliml pronephric expression increased in targeted 
XTRAP-y knock-down embryos. XTRAP-y expression was also found to be required for 
the induction of pronephric tissues in treated animal caps, which suggests an earlier role 
in pronephric induction. 
Annexin IV is expressed in the pronephric primordium from stage 26 and later on the 
luminal surface of the pronephric tubules (Seville, et al., 2002). Over-expression 
experiments resulted in a disruption of WTI expression in the glomus, although no 
effect on Xliml or xPax 8 expression was observed. Morpholino oligonucleotide 
knock-down analysis gave a single shortened, enlarged tubule, rather than the branching 
tubules seen in control embryos. 
PKDI forms part of an ion channel complex with PKD2 and has been implicated in the 
activation of intracellular signalling pathways (Burtley, et al., 2005). Expression is 
observed by dissected pronephric RT-PCR from pronephric initiation, stage 14, and 
continues until stage 40, the last stage tested. xPKDI expression is induced by the 
treatment of animal caps with retinoic acid and activin to produce pronephric tubules. 
Inactivation of xPKDJ ion channel properties by blocking calcium flux where xPKDI is 
expressed, suppresses tubulogenesis. 
1.1.2.4 The Duct 
The posterior region of the pronephric tubule and duct primordium forms the majority 
of duct tissue. The pronephric tubule and duct primordium extends posteriorly, forming 
a lumen at stages 33 to 34. The progressing duct structure fuses with the cloacal horns 
at stage 37. The cloacal horn originates as a small slit in the cloacal wall at stage 32, 
which extends anteriorly from the cloaca (Vize, et al., 2003). During metamorphosis, 
the pronephros degenerates and the mesonephros is formed. The pronephric duct 
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induces the surrounding mesonephric mesenchyme to form the mesonephros, before 
gradually regressing to form part of the genital system in males. 
Gene expression and regulation in the pronephric duct 
A detailed previously, Xliml pronephric expression is initiated at stage 12.5 continues to 
late tail bud stages (Carroll, et al., 1999). Later expression includes a reducing 
expression in the anterior duct which is maintained in the portion extending towards the 
cloacal horns, although not in the cloacal horns themselves. Interestingly, similar to the 
expression in the pronephric tubules, this is also a region of extension and growth. This 
expression pattern differs from xPax 2 in the pronephric duct, which has been 
comparable in the other pronephric tissues. xPax 2 expression is ubiquitous over the 
pronephric duct and includes the cloacal horns. 
Xfz8 is detected in the pronephric anlagen at stage 22 and becomes restricted to the 
pronephric duct by stage 28. Depletion of Xfz8 results in reduced pronephric tubule 
branching and a reduction in 4A6 duct staining. XJz8 is hypothesised to be involved in 
epithelium formation in the developing pronephric tubule and duct after specification 
(Satow, et ai., 2004). 
At stage 27, gremlin, a BMP antagonist, is expressed anteriorly in the early developing 
duct and proceeds posteriorly as the duct develops (Hsu, et al., 1998). Xenopus c-ret 
has been detected at stage 28 in the caudal tip of the migrating duct primordium and in 
the tubules (Carroll, et al., 1999). 
1.2 Developmental Congenital Kidney Disease 
Investigating the development of the pronephros in Xenopus laevis can lead to advances 
in the understanding of vertebrate kidney development and so may impact human 
developmental congenital kidney disease. The sequential nature of kidney development 
suggests that there may be a degree of repetition and similarity in the induction of the 
three kidney structures. Indeed, some critical kidney development genes have been 
shown to have similar roles in human metanephric and Xenopus pronephric 
development (discussed below). Furthermore, the successive kidney structures develop 
in a precise spatial and temporal pattern, each requiring the formation of the previous 
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form for its own induction (Brandli, 1999 and Vize, et al., 1997). Structural defects in 
the development of the earlier structures may therefore effect the formation of later 
kidney structures. 
Xenopus laevis was the model organism used in this study. The pronephros in Xenopus 
forms just below the epidermal surface, allowing for effortless accessibility. In 
addition, the morphological development of the pronephros in Xenopus has been well 
documented. Xenopus, itself is an ideal organism to use due to its external 
development, large egg and embryo sizes, ease of embryo culture and adult husbandry. 
The external development and detailed fate mapping of early division allows for 
targeted micro-injection of mRNA in over-expression experiments, or morpholino 
oligonucleotides in knock down experiments. The other common model organism to 
use in kidney development research is the mouse. However, the metanephric kidneys of 
the mice are complex and their internal development means embryo manipulation is 
more difficult. Also the knock-out phenotypes of many kidney development genes are 
embryo lethal, restricting developmental analysis. 
To impress the importance of studying kidney development, four important human and 
Xenopus development genes will be highlighted. WTl, Pax 2, Nephrin and PKDl have 
been previously shown to have critical roles in pronephric development (1.1.2 Xenopus 
Pronephric Development). The roles of these genes in human developmental congenital 
kidney diseases will now be discussed. 
1.2.1 Wilms' Tumour 1 
Wilms' tumour is a cancer of the kidney that affects I in 10,000 children (Discenza and 
Pelletier, 2(04). It is believed to arise when the developing metanephric mesenchyme 
fails to properly differentiate, forming nephrogenic rests. These rests degenerate, 
remain dormant, or in the case of Wilms' tumour, proliferate. Human WT 1, a four zinc-
fingered transcription factor, was identified from positional cloning identifying genes on 
the Wilms' tumor locus human chromosome II (p 13) (Call, et al., 1990 and Gressler, et 
al., 1990). However, WTJ mutations were only found in 10-15% of Wilms' tumours 
(Gressler, et al., 1994 and Varanasi, et al., 1994), although, wr J mutations have been 
found in nephrogenic rests (Discenza and Pelletier, 2004). 
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The earliest observation of human wn expression in the kidney is in the developing 
podocytes of the mesonephros and the metanephros, the condensing metanephric 
mesenchyme and the tip of the ureteric bud (Discenza and Pelletier, 2004). Expression 
is also observed in the sex cord region of the urogenital ridge, spleen, epicardium and 
other epithelial tissues. 
Denys-Drash syndrome 
W[J mutations were found at a higher incidence, 90%, with Denys-Drash Syndrome 
sufferers (Little and Wells, 1997). Denys-Drash syndrome is associated with 
nephropathy due to diffuse mesangial sclerosis and intersex (Denys, et al., 1967 and 
Drash, et al., 1970). Denys-Drash syndrome kidneys typically show glomerular lesions, 
enlarged immature podocytes, thickening of glomerular membranes, reduced capillary 
lumens and severely damaged tubules. Hypertension is often a symptom, as fibrotic 
material is produced in the cells lying adjacent to the glomerular, causing the collapse of 
the arteries (Scharnhorst, et al., 2001). Patients also suffer from a high incidence of 
Wilms' Tumours (Little and Wells, 1997). 8 out of 10 unrelated Denys-Drash 
syndrome patients were found to be heterozygous for point mutations in exon 9 of wn 
(Pelletier, et ai., 1991). These point mutations are believed to alter the structure of the 
third zinc-finger and so hinder the binding of WTI to the target DNA binding site 
(Pelletier, et ai., 1991, Little, et ai., 1993 and Scharnhorst, et at., 200 I). Indeed, WTI 
DNA binding has been shown to be interrupted in vitro by point mutations in exon 9 of 
the WI'1 gene. Chimeric and heterozygous mice for a mutation that truncates the third 
zinc finger, coded by exon 9, have been created. Interestingly, the phenotypes observed 
in the mutant mice were similar to those of Denys-Drash syndrome patients (Patek, et 
ai., 1999). Also co-incident with the human syndrome, >75% of Denys-Drash 
syndrome mutant mice developed Wilms' Tumours, further implying a link. 
WI'1 has been shown to repress the Pax 2 promoter and inhibit its expression (Ryan, et 
at., 1995). In fact, Pax 2 down regulation was found to be required for podocyte 
maturation, (Quaggin, 2002). Unsurprisingly, abnormal Pax 2 podocyte expression is 
observed in patients with Denys-Drash syndrome (Yang, et ai., 1999). However, it is 
unclear whether Pax 2 expression is a cause. or an effect of Denys-Drash syndrome. 
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Frasier's syndrome 
Related to Denys-Drash syndrome, but less severe, Frasier's syndrome was also found 
to be associated with wn mutations (Barbaux, et al., 1997). Like Denys-Drash 
syndrome, Frasier's syndrome is characterized by intersex and nephropathy, although, 
no Wilms' tumours have been detected. The nephropathy, however, is due to focal 
segmental glomerulosclerosis, where kidneys have fused podocyte foot processes and 
scar tissue in the glomerulus. The condition is termed focal, as not all nephrons are 
affected, and segmental due to the localised effect on the filtration barrier of the 
glomerulus. Frasier's syndrome patients are missing one of the alternatively spliced 
WTI isoforms, known as the +KTS isoform (Barbaux, et al., 1997). This loss is caused 
by mutations in the donor splice site in intron 9 of Wf J, loosing the addition of three 
amino acids (KTS) between WTl zinc-fingers 3 and 4. The 3 additional amino acids 
are believed to be involved with subnuclear localisation of the WTl protein 
(Scharnhorst, et al., 200 1). 
WAGR syndrome QYilms' tumour, Aniridia, Genitourinary defects and Mental 
Retardation) 
WAGR syndrome is characterized by development of Wilms' tumours, iris 
abnormalities (Aniridia), genital defects and mental retardation. W AGR syndrome has 
been linked with the deletion of part of the short arm of chromosome II, the region of 
the Wf I and Pax 6 genes (Riccardi, et al., 1978). The reduction of Wf I expression, 
due to gene deletion, has been implicated in the unexpected or late-occurring renal 
failure in some W AGR syndrome patients (Breslow, et al., 2000). The condition of 
Aniridia has been linked to the deletion of Pax 6 (Discenza and Pelletier, 2004). 
The null Wfl mouse does not produce any kidney structures, and heterozygous null 
Wfl mice have a normal kidney phenotype at birth (Kreidberg, et al., 1993). However, 
glomerular sclerosis (scar tissue growth in the glomerulus) and albuminuria (thickening 
of the glomerular basement membrane and fusion of the podocyte foot processes) 
develops later in heterozygous null WfJ adult mice (Menke, et al., 2003). This late 
onset is also associated with loss of WfJ and nephrin expression in the kidneys. 
Interestingly, the reduced expression of WfJ appears to have a less severe effect on the 
kidney than the point mutations described with Denys-Drash syndrome. 
21 
Chapter 1 
WTl and other vertebrates 
Analysis of wn expression in developing quail chick embryos revealed similar 
expression observed in mouse kidneys, that the mesonephric glomerulus and duct 
(ureteric bud) and the condensing metanephric mesenchyme (Carmona, et al., 2001). 
Although no mis-expression experiments have yet been performed, quail expression 
patterns suggest a link with Slug, which is also expressed in podocytes and is involved 
in their mesenchymal-epithelial transition (Carmona, et al., 2001 and Davidson, et al., 
2(02). 
The null wn mouse lacks kidneys, gonads and adrenal glands (Kreidberg, et al., 1993). 
Morpholino oligonucleotide knock-down experiments in zebrafish have shown similar 
phenotypes, with disrupted pronephric and interrenal (adrenal gland) organogenesis. 
Ff] b is a functional homologue of SF], which is a sex determining gene in mammals. 
wn knock-down in zebrafish was also found to reduce ff] b expression, also effecting 
gonad development (Hsu, et ai., 2003). 
1.2.2 Paired bo;! £ 
Pax 2 is part of the paired box transcription factor family. The highly conserved paired 
box encodes a bipartite helix-loop-helix DNA-binding domain that enables Pax 2 to 
bind directly to gene promoters (Sanyanusin, et al., 1996). Pax 2 is positioned at the 
boundary band of q24 and q25 of chromosome 10 (Gough, et al., 2(03). Comparable 
with mouse expression, Pax 2 is believed to be expressed in the pronephric tubule, duct 
and mesonephric tubules of early human developing kidneys (Eccles, 2(02). During 
induction of the metanephros, expression is observed in the epithelium of the branching 
ureteric bud and in the condensing mesenchyme. Later expression is observed in the 
differentiating renal vesicle and the developing nephron, and excluded from the 
glomerulus. Interestingly, in adulthood, expression has also been observed in 
regenerating proximal tubule cells following treatment with nephrotoxins. This 
indicates that Pax 2 may also be involved in regenerative processes (Eccles, 1998). 
Other areas of mouse expression include the central nervous system, eye and ear (Favor, 
et ai., 1996). 
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Papillorenal syndrome I Renal-coloboma syndrome 
Papillorenal syndrome is generally associated with a reduced kidney, resulting from 
reduced ureteric bud branching and a reduced number of nephrons. Other symptoms 
include vesicoureteral reflux, optic nerve and disc defects, and a high-frequency of 
hearing loss. Papillorenal syndrome is caused by a single nucleotide deletion in exon 2 
or 5 of Pax 2, creating a frame-shift of the Pax 2 coding region creating a premature 
stop codon which results in a truncated protein (Sanyanusin, et af., 1995 and 
Sanyanusin, et af., 1999). Symptoms vary in extremity and are increased with 
homozygous mutations, leading to the hypothesis of haploinsufficiency, where 
phenotypes are produced from a reduction of healthy protein to inadequate levels 
(Eccles, 2002). 
A spontaneous mutation, typical of the Papillorenal syndrome mutation in humans, has 
been studied in mice (Favor, et al., 1996). The mutation creates a frame-shift in the 
helix-loop-helix DNA-binding domain of the Pax 2 protein, resulting in 27 mis-matched 
amino acids in the DNA-binding domain and a truncated protein. The truncated mutant 
protein is therefore unable to recognize its normal target genes and so is ineffectual. 
The Pax i Neu heterozygous mice were reported to have unaffected, reduced or absent 
kidneys and eye defects, including severe abnormalities of the optic disc region. The 
developing homozygous Pax i Ncu mouse had a reduced metanephric anlagen and a 
deficiency in tubule formation. Other homozygous phenotypes observed in the 
developing mouse include defects in the mid-hindbrain region, lack of inner ear 
structures and severely disrupted eye structures. Not only are these phenotypes largely 
analogous to the symptoms observed in Papillorenal syndrome, but also they display the 
same variation in intensity. This is again suggestive of haploinsufficiency and 
collaborates with the inadequacy of the truncated protein. 
In mouse metanephric development, the ureteric bud branches into the condensing 
metanephric mesenchyme, forming a nephron at each ureteric bud tip outgrowth. The 
number of ureteric bud branches therefore sets the number of nephrons formed for life. 
Pax 2 is believed to protect the ureteric bud against apoptosis. Indeed, increased 
apoptosis was observed in the kidneys of heterozygous Pax l'Neu mice (Porteous, et al .• 
2(00). Analysis using Pax 2 promoter targeted apoptosis in mice resulted in increased 
ureteric bud apoptosis and retinal defects similar to Papillorenal syndrome (Dziarmaga, 
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et al., 2003). In addition, the inhibition of apoptosis in heterozygous Pax i Neu mice, 
led to a partial rescue of the decreased ureteric bud branching and nephron number. 
Pax 2 and adult carcinoma 
The role of Pax 2 in the protection against apoptosis is not restricted to developmental 
events. Renal cell carcinoma accounts for 3% of all adult aggressive tumours and is the 
most common malignancy in the adult kidney, 90-95% (Gnarra and Dressler, 1995). 
Renal cell carcinoma cells lines were found to express Pax 2. Inhibition of Pax 2 by 
antisense oligonucleotide resulted in the inhibition of cell proliferation. Pax 2 is 
therefore a potential anti-apoptotic carcinoma gene. Pax 2 expression was also 
observed in Kaposi Sarcoma cells (Buttiglieri, et al., 2004). Kaposi Sarcoma is a cancer 
of the blood vessels associated with immunodepressive conditions, such as HIV-l 
infection and long term post-transplantation therapy. Again, Pax 2 inhibition, this time 
by transfection with an antisense Pax 2 gene, resulted in the reduction of cell 
proliferation and an enhanced sensitivity to apoptosis. 
Pax 2 and other vertebrates 
Similar to the mouse and human expression, chick Pax 2 expression is found in the 
early developing pronephros and mesonephros, the developing ear and brain (James and 
Schultheiss, 2003 and Hutson, et al., 1999). Also, chick Pax 2 has been shown to have 
a role in early kidney induction, where exogenous mesodermal expression was 
sufficient to produce ectopic kidney structures (Bouchard, et al., 2(02). The chick 
homologue of Pax 2 has even been shown to have a role in protection against apoptosis, 
although in the development of the ear, not the kidney (Li, et al., 2(04). These common 
characteristics suggest conserved evolutionary properties of Pax 2 in development. 
Two Pax 2 zebrafish homologues have been identified, Pax 2.1 and Pax 2.2, however 
Pax 2.1 more closely resembles the mammalian Pax 2 based on its expression pattern 
(Majumdar, et ai., 2000). Pax 2.1 expression is observed in the central nervous system, 
ear, optic tracts and pronephros, analogous to the mouse (Majumdar, et al., 2000 and 
Favor, et al., 1996). The zebrafish no isthmus mutant has a truncated form of the Pax 
2.1 gene. Detailed expression analysis of the developing pronephros did not reveal an 
increase in cell apoptosis, but did show presumptive tubule cells and anterior duct cells 
ectopically expressing podocyte-specific markers (Majumdar, et al., 2000). This does 
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not match the increase in apoptosis observed in the kidneys of "Papillorenal syndrome" 
mice (Porteous, et ai., 2000). 
1.2.3 Nephrin 
Nephrin is a major component of the slit-diaphragm of podocytes (Fig. 1.3) 
(Tryggvason, 1999 and Ruotsalainen, et ai., 1999). Without slit-diaphragms, the 
nephrons are unable to stop large proteins, such as albumin, from entering the tubules 
and resulting in proteinuria. Nephrin was identified using positional cloning to identify 
the gene responsible for Congenital Nephrotic Syndrome of the Finnish type (See 
below) (Kestila, et ai., 1998). Nephrin was found to be located on chromosome 
19q13.1. 
Congenital Nephrotic Syndrome of the Finnish type 
Congenital Nephrotic Syndrome is associated with massive proteinuria at, or shortly 
after birth (Kestila, et ai., 1998). Congenital Nephrotic Syndrome of the Finnish type is 
autosomal-recessive disorder with an frequency of I in 10,000 births in Finland, 
although significantly less in other European countries. Symptoms of proteinuria and 
glomerula lesions are observed during embryo development. Structurally, Congenital 
Nephrotic Syndrome of the Finnish type kidneys have podocytes lacking in foot 
processes and slit-diaphragms (Fig.I.3), dilated proximal tubules and an increased 
number of nephrons, resulting in enlarged kidneys. The most frequent cause of 
Congenital Nephrotic Syndrome of the Finnish type is two nucleotide deletions in exon 
2, which result in a frame-shift and a truncated protein. However, many different 
Nephrin mutations have been identified (Koziell, et ai., 2002). 
Experiments were performed using a human embryonic cell line and 21 mis-sense 
disease causing Nephrin mutations (Liu, et ai., 200 I). Analysis revealed a localisation 
of mutant Nephrin to the endoplasmic reticulum, not the cell surface of the podocyte. 
This could explain the lack of slit-diaphragms in Congenital Nephrotic Syndrome of the 
Finnish type kidneys, and the associated proteinuria. 
The homozygous null Nephrin mouse dies within the first 24 hours of birth (Putaala, et 
ai., 2001). Consistent with Congenital Nephrotic Syndrome of the Finnish type, the 
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homozygous and the null Nephrin mouse has enlarged kidneys, dilated tubules, massive 
proteinuria, edema and the absence of slit-diaphragms. Heterozygous null Nephrin 
mice also have similar phenotypes, but these are less severe and proteinuria and edema 
do not develop until a week after birth. 
Nephrin and other vertebrates 
In zebrafish, nephrin expression is localised to the podocytes (Kramer-Zucker, et af., 
2(05). Morpholino oligonucleotide mis-translation results in a general edema that 
spreads throughout the larval body. Embryos die aged I week, with pronephric tubule 
cysts and aberrant glomerulus morphology. The majority of podocytes lack foot 
processes and no slit-diaphragms are present. The disrupted morphology of the 
glomerulus reduces the size discrimination of filtration, and large protein deposits are 
found in the tubules. These phenotypes exactly match the symptoms of Congenital 
Nephrotic Syndrome of the Finnish type, showing a conserved evolutionary role of 
nephrin in kidney development and a correlation between pronephric and metanephric 
development. 
1.2.4 PKDJ 
PKDl encodes Polycystin I, a trans-membrane protein with potential adhesion and 
protein to protein interactions (Kim, et af., 2000). Polycystin I has been found to be 
expressed in epithelial tissues, endothelial and vascular smooth muscle cells and at cell 
to cell junctions. In mice kidneys, expression is observed in mature collecting ducts 
(Gallagher, et af., 2(02). PKDl has been located chromosome 16 and was identified by 
its link with Adult polycystic kidney disease. 
Autosomal Dominant Polycystic Kidney Disease 
Adult polycystic kidney disease is the most common monogenic disease in humans with 
a frequency of I in 400 to 1 in 1000 (Kim, et af., 2000). It is characterised by the 
formation of cysts in both kidneys, and the progressive destruction of normal renal 
tissue (Gallagher, et af., 2(02). Cyst development in the kidneys normally arises from 
the tubule or duct tissues. Other symptoms include the formation of cysts in other 
organs and blood vessel abnormalities (Kim, et af., 20(0). In 85-95% of Adult 
polycystic kidney disease patients, the disease has been linked to a heterozygous 
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mutation in the PKDJ gene. In other cases, mutations in related PKD2 and PKD3 genes 
have been implicated (Deltas, 2001 and Paterson, and Pei, 1998). 
Mutant PKDJUL mice were created carrying a mutation similar to that observed in 
humans (Kim, et al., 2000). The mutation caused a frame-shift in the coding sequence 
which resulted in a truncated protein. Homozygous PKDJUL mice died at embryonic 
day 15.5 from critical vascular defects. Cyst formations were observed in the kidney, 
although, early metanephric kidney induction did not appear to be affected. Mutant 
PKDrl - mice were also created that lacked exon 32, also observed in human Adult 
polycystic kidney disease (Lu, et al., 1997). Homozygous PKDrl - mice die during birth 
from under developed lungs, and have enlarged kidneys with cysts. Renal cyst 
development was found to originate in the tubules during elongation and maturation. 
PKDl and other vertebrates 
Similar to homozygous PKDrl - mice, polycystic kidney disease medaka fish have 
enlarged mesonephric kidneys with multiple renal cysts (Mochizuki, et al., 2005). The 
mesonephric tubule cells have reduced characteristics such as endocytic vesicles, tight 
junctions and membrane invaginations. Interestingly, cysts were also observed at the 
microscopic level in the pronephros, suggesting the mutation effects all stages of kidney 
development. 
Studies in zebrafish had indicated that polycystic kidney disease is linked to defects in 
primary cilia function in the tubules (Low, et al., 2006). It is suggested that a 
PKDJISTAT61PJOO pathway is involved in the transduction of a mechanical stimulus 
into cilia movement. During stimulus, the C-terminal region of polycystin I is believed 
to be cleaved and translocated to the nucleus, where it inhibits the transcriptional 
activity of STAT6. STAT6 may be under default conditions, reducing cilia activity. The 
mis-translation of this region due to a frame-shift mutation in autosomal dominant 
polycystic kidney disease could disrupt this process and inhibit the ability of the cilia to 
respond to mechanical stimulus. 
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1.5 Aims of Thesis 
This project had two mam aims, to identify a suitable target gene involved in the 
development of the pronephros and then to study its role in development. The 
identification of a suitable target gene was approached using three different sources of 
candidate genes. The first source of target genes was the screening of a Xenopus laevis 
stage 13 cDNA library with a subtractive hybridisation probe made from retinoic acid 
and activin treated animal caps (Chapter 3). This potentially highlighted the genes 
involved pronephric initiation. The second was the preliminary analysis of a set of 
UniGene cluster genes that were previously found to be pronephros specific (Personnal 
correspondence Pollet, N) (Chapter 4). Thirdly, data mining identified Xenopus 
homologues of important kidney development genes identified in higher vertebrates or 
newly identified genes expressed in the pronephros (Chapter 5). 
Subsequent characterisation of the target gene involved mis-expression analysis and 
regulatory gene network analysis. Over-expression experiments were performed using 
targeted micro-injection of mRNA into the developing embryo and knock-down 
analysis was performed using targeted micro-injection of designed morpholino 
oligonucleotides (Chapters 6 and 8). Investigation into the regulatory gene network was 
achieved using the animal cap assay system and RT-PCR (Chapter 7). 
By analysing the functional role of a target gene, this thesis ultimately aims to further 
elucidate the developmental regulation of pronephric organogenesis. It is hoped that 
studies in such a developmental model organism might provide information on human 
congenital disorders. 
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Materials and Methods 
2.1 Materials 
Materials were sourced accordingly: 
MateriallReagent 
32p_GTP 
15S h" I . .. -met IOn me cysteme 
Activin A 
Calf intestinal alkaline phosphatase 
Chemicals 
DIG RNA labelling kits 
DNA ladder 
DNase I 
dNTP 
Gel extraction kits 
Gentamycin 
Goat-anti-mouse-AP 
Hybond nylon membrane 
Miniprep plasmid DNA isolation kits 
mMESSAGE mMACHINE™ kits 
Pre-stained protein ladder 
Proteinase K 
Restriction enzymes 
Retinoic acid 
RNase Inhibitor 
RNase A 
T4 DNA ligase 
TaqlPfu 
X-ray film 
2.2 Media and stock solutions 
Supplier 
GE healthcare 
GE healthcare 
Invitrogen Life Technologies (Gibco BRL). 
Roche 
Becton, Dickinson and Co., Helena 
Biosciences, Fisher Scientific, Merck, and 
Sigma. 
Roche 
MBI Fermentas 
Roche 
MBI Fermentas 
Qiagen 
Sigma 
Sigma 
GE healthcare 
Qiagen and Sigma. 
Ambion®. 
New England BioLabs 
Boehringer-Mannheim 
Invitrogen 
Sigma 
GE healthcare 
Sigma 
MBI Fermentas 
Invitrogen 
Fuji 
The solutions were made by in house facilities, according to Sambrook, et al .. 1989. 
2.3 Plasmids 
The following plasm ids were used in this study and are detailed in the Appendix. 
pBLUESCRIPT SK - x 1.1 2848 (IMAGE clone), xl.l6795 (IMAGE clone), X/im-/ (In 
situ hybridisation probe), RA + AlRA and RA + AlA clones. 
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pCMV SPORT6 
pGEM Teasy 
pGEMT7 
PCS2+ 
pCS3+MT 
- Pod J (IMAGE clone), Darmin r (IMAGE clone), xl. 5110 
(IMAGE clone), x1.5983 (IMAGE clone). 
- (Promega) initial work on x1.511O, x1.5983, x1.l2848, x1.4624, 
xl. 16795, xl.I 1205, Pod J and Darmin r before ordering the 
selected IMAGE clones. 
- xWT (In situ hybridisation probe). 
- Pod J (mRNA production), Darmin r (mRNA production). 
- Pod J (c-myc tagged mRNA production). 
2.4 Bacterial strains (E. coli) 
DH5a 
XLI Blue MRF' 
SOLR 
2.5 DNA Techniques 
F supE44 b.lacUI69(080IacZb.MI5) hsdRI7 recAI gyrA96 thi-I 
reLAI. 
tl(mcrA)l83 b.(mcrCB-hsdSMR-mrr)/73 endAI suppE44 thi-I 
recAI gyrA96 relAllac [F' proAB lacf'lZb.M 15 Tn/O (Td)]. 
e14-(Mcrk) tl(mcrCB-hsdSMR-mrr)171 sbcC recB reel uvrC 
umuC::Tn5(Kanr) lac gyrA96 reLAI thi-I endAJ X [F' proAB 
lacf'l Zb.M 15] Su- (nonsuppressing). 
2.5.1 Agarose gel electrophoresis 
Agarose gels of 0.5 - 1.5 % were prepared using TBE (x I) with 0.51lg/ml ethidium 
bromide. DNA/RNA was separated using electrophoresis in I x TBE at 30 - 175 V and 
then photographed under ultra-violet light (using the GENE DOC). When appropriate, 
DNA was extracted from the gel using a Qiagen gel extraction kit according to the 
manufacturer's instructions. 
2.5.2 Restriction digests 
Restriction digests were carried out following the manufacturer's (Invitrogen) 
recommendations. Where the digest was for sequence analysis, the reaction mix was 
20JlI, whereas for other experiments, a larger digest of 50JlI was performed. Following 
digestion of plasmids for ligation, treatment with phosphatase prevented plasmid re-
ligation. I III of calf intestinal alkaline phosphatase was added per IOIlI of reaction, and 
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the reaction was incubated at 37°C for a further 20 minutes. When necessary, DNA was 
purified using the Qiagen gel extraction kit according to the manufacturer's instructions. 
2.5.3 Ligation of DNA into plasmid vectors 
10 - 15ng of vector was mixed with insert digested with appropriate restriction enzymes 
(molar ratio 1 :3) to make a final volume of 20Jll with T4 DNA ligase (MBI Fermentas) 
and ligation buffer. The ligation mix incubated for either 6 hours or over night at room 
temperature. Where appropriate, PCR products were sub-cloned into pGEM-T Easy® 
according to the manufacturer's instructions using the Hailed overhangs. 
2.5.4 peR 
PCR reactions were set up as follows: 
PCR buffer (lOx) 
MgCh (50mM) 
dNTP (IOmM) 
Primer mix (25,..M) (Table 2.1) 
Taq polymerase (Invitrogen) 
Water (autoclaved MQ) 
Sample 
PCR cycle programme: 
Denature 
Anneal 
Elongate 
Hold 
(94°C) 
(55°C) 
(nOc) 
(4°C) 
First cycle 
3 
,..1 per sample 
2.5 
1.5 
0.5 
0.1 
18.4 
Next (x) cycles Last cycle 
3 3 
I 
5 
Details of all primers used can be seen in table 2.1. After the PCR program had run, 
15,..1 of the products were then run on a 1% agarose gel (O.05,..lIml Ethidium Bromide), 
at 150V for roughly 45 minutes. A digital image of the gel was then taken under UV 
light, using the GENE DOC. For Southern blotting and hybridisation (2.9.3 Southern 
Blotting, 2.9.4 Southern hybridisation), a ruler was placed next to the gel to show the 
distance travelled of the bands and the gel was kept for further analysis. 
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Name "Sequence" Annealing Soune temperatun re) 
EFiaU CAG ATI GGT GCT GGA TAT GC 55 (Mohun ", al .. 1989) 
EFlaD CAC TGC CTT GAT GAC TCC T A 55 (Mohun <'Ial .. 1989) 
OOCU GGA GCT GCA AGT TGG AGA 55 (Bassel 1'1 III •• 1990) 
OOCD TCA GTI GCC AGT GTG TGG TC 55 (Bassez .. , al .• 1990) 
n AATTAA CCC TCA CTA AAG GG 55 Standard 
n GTA ATACGACTC ACT ATAGGGC 55 Standard 
SP6 ATITAGGTG ACATATAG 55 Standard 
Pod A TCT CAG TGA TGT GGA GGA CTT 51 CF210481 
Pod B TGA CGC AGG TGA GCT ATG TAA 51 CF270487 
Darmin rA TI A TGG TCT CCG TGG CAT CTG CT A 51 BC056069 
Darmin r B ATC AGG CAC CAG CCT TAT GGA GAA 51 BC056069 
A4229 GAC ACT TGG ATC GTC TGC AAC TTC 55 CA914 150 
B4229 TIA CAT ACA GGTTCG GCG ACA AGG 55 CA914150 
4229C AAC CGC TGG CAA GTC TAT TC 55 CA974150 
A4624 GGA T AC AGG AAG TGA CTC TGG CT A TG 55 AF358 \33 
B4624 CAC ACC AAT GCA GTG ACA AGG ATA GG 55 AF358133 
4624C CTG GAG TCA TAG CTC AGA GT 55 AF358 \33 
A5110 AAA GCT GGG T AC GCG T AA GCT 55 BE508541 
B5110 TAG CAC CCA TCT GAT TCT CC 55 BE508547 
5110 E GCT GGT AAG GTA CAG ACA GAG A 53 BE508541 
5110 F GTA AGTGGTGTGCAGCAGTGA A 53 BE508541 
A5983 CTCGCACTI ATGATCCTACCAC 55 8C043955 
B5983 GTA ATG GAG AGGCGCTIC ATIG 55 BC043955 
5983C TGA AGC GCC TCT CCA TI ACT 55 BC043955 
AI120S CCA TCC AGC ACC ACA GAA T 55 AW782622 
BI1205 CGG CCA GTG CCT AGC TIA T 55 AW182622 
11205E CAA CTG GTC AGG CAG GTA TG 55 AW182622 
12&48 A GAC AGG TIG ACA CGC TGC AGA A 55 CA914 150 
AI6195 ATA TCT GCG CTA CTG C 55 CA98 1992 
BI6195 T AC CTG CTT CAC TGG TGA C 55 CA98 1992 
16795 C GCC TAT GAG CTC CAA CTG TIG T 55 CA981992 
A22053 CCAGGTGGTGGCAATAGTT 55 BC043955 
B22053 TCA TGA TGG CAT CTC CTC 55 BC043955 
6C5A CAC CAG CTC CAG TGT AGG CT A A 55 In hoose sequencing 
6C5B TCC TAA CAT TCC ACG CAG TGA C 55 In hoose sequencing 
\8BI A GAA TCT GAA CCG CTG CAT TGC T 55 In house sequencing 
18BI B GCT GAT CTC TGC AAC TCC TGT A 55 In hoose sequencing 
Rho A FI TGC GAC CTC TGT CCT ATC CA 55 In hoose sequencing 
Rho I RI TIC TIC TIG CCA CGC CTA CG 55 In hoose sequencing 
5f6(A) GCT GGT TGC TGT TGG TGA AG 55 In hoose sequencing 
5f6(B) TGT ACA CCA CTG CGA TGA CT 55 In hoose sequencing 
6a4(A) GAA TIC GGC ACC AGA 55 In hoose sequencing 
6a4(B) CGA AGA GTI GCC TAG A 55 In hoose sequencinR 
12a1(A) TGCTGCTCACTCGGAATCTG 55 In hoose sequencing 
12al(B) TGC CAA GTC ATC TCC ACT GC 55 In hoose sequencing 
15b2(A) TGG TCG CTC TGC TAA CAG T 55 In hoose sequencing 
15b2(B) GCT AGC AGT GCA AGA TCT C 55 In house sequencinll: 
15c7(A) TCT TCT GGT TCC ACG CTG CTT A 55 In hoose sequencing 
15c1(B) GCCTGGACTTGAAGATGGTATG 55 In house sequencing 
xE l2ft!:.'47 F2 GGC TIl CCT GCT GCT GTG CTC T 55 X669591 BC044064 
xEI2 CTC CTT CTC ACG CTC TGC TIT TG 55 X66959 
xE47 TCT CGT ACT CGC ACT CTT TCT CGT 55 BC044064 
Xlim I U GAA GGA TGA GAC CAC TGG TGG 55 (Willa and Sato. 1(97) 
Xlim I D CAC TGC CGT TIC GTI CAT TTC 55 (Willa and Sato. 1(91) 
xPax 2 U TCG GAA GAA GAG TGG TCT AC 55 Haldin. C. E. (thesis) 
xPax 2 D GGT ATICAT ATICCG CAT TC 55 Haldin. C.E. (thesis) 
xPax8 U CCA ACA GCA GCA TCA GAT C 53 Haldin. C.E. (thesis) 
xPlu8D CAA TGA CAC CTG GCC GGA TA 53 Haldin. C.E. (thesis) 
xWTI U CAC ACG CAC GGG GTC T 6() (Carroll and Vize. 1996) 
xWTID TGC ATG TIG TGA TGA CG 60 (Carroll and Vize. 1996) 
xfTF2b F3 AGC CAG CCG CCA GCA CTT TIC 55 DN059210 
xlTF2b R3 GGC GCG AGG GAG AC A AAC AGT 55 DN059210 
Xlmxfb U GGA GAG TGG CAT GGA TATTG 6() ( Haldin • .. , al.. 2(03) 
XlmdbD AGT AGC AGC TGG TGG TGA GG 6() (Haldin. t'lal .. 2(XJ3) 
xPodocal\'Xin f U CCA GAG ATG CAG GAG AAA AA 55 BG233342 
xPodoca/l'Xin f D GTI TGG TCT GCA TAG TIT TCT T 55 BG233342 
Table 2.1 Primers used in this study. Primers were either standard primers used in the 
laboratory, or were designed using Primer designer (Scientific and Educational 
Software version 3.0) using in house sequencing of clones or EST sequences obtained 
from NCBI (www.ncbi.nlm.nih.gov) website as indicated. 
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2.5.5 Primer Design 
All novel primers were designed using Primer Designer (Scientific and Educational 
Software version 3.0). Standard laboratory primers and novel primers can be found in 
table 2.1. 
2.5.6 DNA probe labelling 
The screening probe (Chapter 3) was made by Dr Karine Masse according to the 
protocols of the CLONTECH PCR-Select eDNA Subtraction kit. To label the probe, 
4J.lI probe was added to 31 J.ll of autoclaved MQ water and denatured by heating at 95°C 
for 3 minutes, then rapidly cooling on ice. Once cool, the denatured probe was 
centrifuged at 13,000 rpm and cooled again. Under radioactive procedure control. toJ.ll 
OLB (200mM Tris.HCI pH 8, 200mM HEPES buffer, dATP, dTTP, dCTP, random 
hexamer), 2J.lI BSA tomg/ml, 5J.l1 32p dGTP (50J.lCi), and 2J.lI Klenow (Invitrogen) was 
added and the mixture incubated for over 30 minutes at room temperature. After 
incubation (approximately 3 hours), 23J.ll T.E. (Tris pH8 and EDTA), I J.ll salmon sperm 
DNA (Invitrogen), I J.ll EDT A (50mM), 5J.lI NaCI 5M and 21 OJ.lI ethanol was added and 
the probe mixture immediately centrifuged for 10 minutes at 13,000 rpm. The 
supernatant was then removed and 500J.lI T.E. and 50J.lI NaOH 4M was added. The 
labelled probe was incubated for 5 minutes at room temperature before adding to the 
hybridisation buffer (0.5M NaPi, 7% SDS, 5mM EDT A). 
2.6 RNA Techniques 
2.6.1 RNA extraction from embryos and animal caps 
The volumes given below are for to animal caps or 2 whole embryos. Where different 
numbers of animal caps or whole embryos were used, the volumes were adjusted 
accordingly. 
Two whole embryos were homogenized in 300J.l.I extraction buffer (300mM NaCI, 
20mM Tris pH 7.5, ImM EDTA pH8, 1% SDS) with 6J.l.I of proteinase K (I5mg/ml) 
and incubated for 15 minutes at 37°C. Samples were then extracted with an equal 
volume of phenol and 10J.l.g of glycogen was added to the upper phase. RNA was 
precipitated with two volumes of ethanol at -20°C for at least 30 minutes and 
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centrifuged for 20 minutes at 13 000 rpm. The peIlet was resuspended in 60~1 of DNase 
I buffer (20mM Tris pH8.3, 30mM NaCl, 2.5mM MgCh) containing 80u of DNase I 
and 80u of RNase inhibitor, and incubated for 20 minutes at 37°e. The samples were 
then extracted with an equal volume of phenol foIlowed by phenol/chloroform, with 
the aqueous layer being precipitated by adding 2 volumes of ethanol at room 
temperature for no longer than 30 minutes. This was centrifuged at 13 000 rpm for 20 
minutes, the peIlet washed with 70% ethanol before being dried and resuspended in 
20~1 H20. I ~I of RNA was analysed on a 1% agarose gel to check the integrity and 
yield. 
Adult tissue RNA was extracted using TRIzol® reagent according to the manufacturer's 
instructions by Dr Karine Masse. RNA was analysed as above before being stored at -
70°e. 
2.6.2 Reverse Transcription peR 
RT-PCR was performed according to Barnett, et al., (1998). 0.5~g of RNA extracted 
from animal caps, embryo dissections or whole embryos was made up to a total volume 
of 21.1~1 with H20, heated at 75°C for 5 minutes before placing on ice. 7.9~1 of 
reaction mix (3.3~M random hexamers, 1 x PCR buffer, 3mM MgCI2, 500~M dNTPs, 
1 U/~I RNase inhibitor) was added to each tube and incubated at 37°C for 5 minutes 
before addition of 2~1 MMLV reverse transcriptase (2oou/~I) and further incubation at 
37°C for 1 hour. Reactions were denatured at 95°C for 5 minutes and stored at - 20°e. 
Samples lacking RNA and RT were added as negative controls. The prepared eDNA 
was subjected to PCR analysis (2.5.4 PCR). A sample lacking cDNA was checked for 
contamination in any of the components used and a linearity series (0.2~I, 0.4~I. 0.8~I, 
1.6~1) of control cDNA was added to verify that the PCR was in the linear range and 
semi-quantitative. EF 1 a and ODe were used as loading controls, with the amount of 
eDNA being added equalized with respect to these markers. 
2.6.3 Preparation of in vitro transcription of mRNA 
Plasmid template DNA was Iinearised with the appropriate restriction enzyme 
(Appendix) and purified using a gel extraction kit. Capped mRNA was prepared using 
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the mMESSAGE mMACHINE® kits, T3, T7 or Sp6 (Appendix), according to the 
manufacturer's instructions (Ambion®). 
2.6.4 Whole mount in situ hybridisation 
Plasmid templates were Iinearised with the appropriate restriction enzyme (Appendix) 
and purified using a gel extraction kit. Sense/antisense RNA probes were prepared using 
digoxygenin (DIG) labelling kit (Boehringer-Mannheim), and single labelled 
wholemount in situ hybridisation was carried out using a standard protocol adapted 
from Hemmati-Brivanlou, et al., 1990 and Harland, 1991. Where pigmented embryos 
were used, they were bleached (l % H20 2, 5% formamide, 0.5 x SSC in H20) on a 
fluorescent light source following hybridisation for approximately I - 4 hours. Internal 
staining was visualised by clearing the embryos using Murray's solution (benzyl 
benzoate / benzyl alcohol, 2: I). 
2.7 Protein Techniques 
2.7.1 In vivo translation 
Oocytes were injected with 50nl of mRNA at a concentration of 0.5mg/ml and 
incubated at 18°C for 2 hours. Radio-labelling of proteins was carried out by selecting 
the best 7 oocytes and incubating them overnight at 18°C in 100JlI Barth X containing 
10JlCi 35S-methionine and cysteine. 
Oocytes were washed twice in Barth X before being homogenised in cell lysis buffer 
(150mM NaCl, 1% NP40, 50 mM Tris-CI pH8) and I mM PMSF. Samples were 
recovered by centrifugation at 13 000 rpm for 5 minutes to remove cell debris and 
recover the middle layer. 5111 of this layer was mixed with 5111 of protein loading buffer 
and heated for 3 minutes at 95°C before being loaded onto an SDS-PAGE gel. Samples 
were stacked on a 4% acrylamide stacking gel at IOOV, followed by separation through 
a 10% acrylamide resolving gel in a tris-glycine running buffer using the BioRad Mini 
Protean II system. For autoradiography, the gel was dried on for 20 minutes at 80°C. 
2.7.2 In vitro translation 
In vitro translation of 1 Ilg of in vitro transcribed mRNA was carried out using the 
nuclease treated rabbit reticulocyte lysate according to the manufacturer's instructions 
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(Promega). Reaction products were radiolabelled using 35S-methionine/cysteine. 5~1 of 
product was mixed with 5~1 protein loading buffer and heated to 95°C for 3 minutes 
before being separated on a 10% acrylamide gel as performed for oocyte protein 
extraction (2.7.1 In vivo translation). 
2.7.3 Immunostaining 
The embryos previously dehydrated in methanol were re-hydrated gradually in PBS. 
The embryos were then bleached by incubating for I hour in bleach solution (I %-
Hydrogen peroxide, 5% formaldehyde, 2x SSC) in PBS on a light box. Once the 
embryos had been bleached, the bleaching solution was removed and the embryos 
washed three times in PBT (2mg/ml BSA, 0.1 o/c Triton X-IOO in PBS) for 5 minutes. 
The embryos were blocked in fresh PBT for 2 hours at 4°C on a nutator before adding 
350~1 of 308 antibody (1/40 dilution in PBT) and incubating overnight at 4°C on a 
nutator. The excess antibody was washed off by five I hour PBT washes at 4°C whilst 
rotating. The embryos were then incubated overnight in anti-mouse IgG alkaline 
phosphatase conjugate (1/500 dilution in PBT) overnight at 4°C on a nutator. The 
excess antibody was washed off by four 1 hour PBT washes at 4°C whilst rotating. The 
embryos were incubated in colour buffer (0.1 M Tris HCI pH 9, 25mM MgCh, 100mM 
NaCl, 0.1 % Tween-20) for 1 hour before transferring to 350~1 of 1/100 dilution of 
BCIPINBT in colour buffer. The colour reaction was performed in the dark (plate 
wrapped in foil) and after 15-20 minutes the colour reaction was stopped by washing 
with PBS. The embryos were then fixed in MEMFA (2.10.4 Fixing) for I hour at 4°C 
before repeating the process post bleaching with the 4A6 antibody (no dilution) and 
using FAST RED as the colour reaction substrate. 
2.7.4 Western blotting 
The 10% SDS PAGE gel (2.7.1 In vivo translation) was blotted using a Semi dry blotter 
according to manufacturers instructions, for I hour 30 minutes at 150V. The PVDF 
(Amersham Biosciences) membrane was blocked in 5% Marvel (premier International 
Foods) in PTw (0.1 % Tween 20, PBS) for I hour whilst rocking. The membrane was 
then incubated in primary antibody (1/1000 dilution in 5% Marvel in PTw) for I hour 
30 minutes on a rocker. The membrane was washed five times in PTw, 3 immediate 
washes, one 5 minutes wash and one 10 minutes wash. The secondary antibody 
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(1110000 dilution in 5% Marvel in PTw) was then added and incubated for I hour on a 
rocker. The five washes were then repeated. The membrane was then placed face down 
on a plastic sheet drizzled with nRNP substrate for I a minutes before analysing using a 
Phospho Imager. 
2.8 Microbiological Techniques 
2.8.1 DNA minipreps and glycerol stock formation 
DNA was extracted from overnight cultures set up in 5ml liquid broth, containing 
antibiotic where desired, in accordance to the QIAprep Spin Miniprep Kit Protocol 
(QIAGEN). A glycerol stock was made using 0.5ml of the overnight culture containing 
the plasmid of interest mixed with a.5ml glycerol solution and stored at -70°C. 
2.8.2 Transformation 
Where the transformation was to be performed following ligation, lOO1l1 of competent 
cells (2.8.3 Competent cells) was added to the ligation mix (2.5.3 Ligation). This 
mixture was left on ice for 15-30 minutes before heat shock at 42°C for 2 minutes, then 
2 minutes back on ice. To allow the cells to recover, 90alll of LB (2.2 Stock Solutions) 
was added and the mix incubated for I hour at 37°C. After incubation, the cells were 
centrifuged for 5 minutes at 3000rpm and 9OOf..LI of supernatant removed. The cells 
were resuspended and plated out onto agar plates containing the relevant antibiotic. For 
a straight transformation 50f..LI of competent cells and I f..L1 of the plasmid miniprep (2.8.1 
DNA Minipreps) was used. The bacteria were plated out in 10% and 90% bacterial 
dilutions. The plates were incubated overnight at 37°C. 
2.8.3 Competent cells 
An over-night culture of DHL5a (2.3 Bacterial strains) was grown up in LB broth (2.1 
Solutions) at 37°C whilst shaking. 500f..L1 of this culture was then grown up in 50ml of 
Medium A (I0mM MgS04 and 0.2% glucose in LB broth) to OD6()() 0.5-0.7. This 
culture was put on ice for 1 a minutes before centrifuging at 3000rpm for 10 minutes at 
4°C. The pellet was resuspended in 500f..LI of pre chilled Medium A and 2.5ml of pre 
chilled Medium B (36% glycerol, 12% PEG, 12mM MgS04 in LB broth), aliquoted and 
stored at -80°C. 
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2.9 Phage Library Screening 
2.9.1 Infection of XLI-Blue MRF' with phage 
The infection of the XLI-Blue MRF' (2.4 Bacterial strains) bacteria with phage and the 
plaque lifts were done in accordance to the ZAP-cDNA Gigapack III Gold Cloning Kit 
instruction manual (STRATAGENE). The N-Hybond (Amersham Biosciences) 
membranes were then analysed using Southern hybridisation (2.9.4 Southern 
Hybridisation). 
2.9.2 In vivo excision 
The ;n vivo excisions were done in accordance to the ZAP-cDNA Gigapack III Gold 
Cloning kit instruction manual (STRA T AGENE). The resulting colonies (SOLR, 2.4 
Bacterial strains) were checked by PCR using the T3 and T7 primers (Table 2.1). 
2.9.3 Southern blotting 
The dsDNA PCR products in the 1% agarose gel were denatured by incubating the gel 
in 0.45M NaCl, O.5M NaOH at room temperature, for 30 minutes, whilst gently 
shaking. After denaturation, the gel was washed using MQ water and then neutralised 
in 0.45M NaCI, 0.5M Tris HCI pH8 at room temperature, for 30 minutes, whilst gently 
shaking. 
The DNA was transferred to N-Hybond (Amersham Biosciences) membrane. This was 
done by arranging the following materials as in fig. 2.1. The N-Hybond membrane, 2 
sheets of Whatmann paper and the tissues were cut to the size of the gel. Care was 
taken when framing the 1% agarose gel with film strips. The purpose of this was to 
stop displacement of the ssDNA by the lOx SSC not moving directly vertically. When 
the materials had been arranged, lOx SSC was poured into the tray, and the edges of the 
third piece of What mann paper was dipped into the liquid. This was then left overnight 
to allow the ssDNA to transfer onto the N-Hybond membrane. 
After the overnight incubation, position of the wells were marked on the N-Hybond 
membrane, using a pencil. The membrane was then baked for two hours at 80°C, fixing 
the ssDNA onto the membrane. 
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p"". Glass plate 
What mann paper 
sse (lOx) pH7 
Weight 
! ! ! 
Tissue 
Top view of film and I ~ agarose gel. 
,......, ,......, 
I ---------------- I 
I ~ agarose gel 
I ----------------4 I 
Film and 1% agarose gel (See above) 
N-Hybond 
L-J 
Film strips 
Fig. 2.1 Arrangement of Southern blotting apparatus. DNA from a PCR reaction was 
transferred from an agarose gel to N-Hybond (Amersham Biosciences) membrane using 
the setup shown. The N-Hybond membrane, 2 sheets of Whatmann paper and the 
tissues were cut to the size of the gel. Care was taken to frame the 1 % agarose gel with 
film strips to stop displacement of the ssDNA by the lOx SSC not moving directly 
vertically. When the materials had been arranged, lOx SSC was poured into the tray. 
and the edges of the third piece of Whatmann paper was dipped into the liquid. This 
was then left overnight to allow the ssDNA to transfer onto the N-Hybond membrane. 
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2.9.4 Southern hybridisation 
After Southern blotting and baking (2.9.3 Southern blotting), the N-Hybond membranes 
(Amersham Biosciences) were placed between nylon meshes and inserted into a glass 
hybridisation tube. To the tube, 100m I of preheated hybridisation buffer (0.5M NaPi, 
7% SOS, 5mM EDT A) was added and the hybridisation tube incubated in a rotisserie 
oven for at least one hour at 42°C. The probe (2.5.6 DNA probe labelling), was then 
added to the hybridisation tube, taking care that the probe touches the hybridisation 
buffer before touching the meshes. The hybridisation tube was incubated overnight at 
42°C in the rotisserie oven. 
The probe and hybridisation buffer mixture was removed and stored safely for further 
experiments. A wash of 20ml of 2x SSe, 0.1 % SDS was added to the hybridisation 
tube and removed. This was followed by a second wash of 50ml of 2x sse, 0.1 % SOS, 
and the hybridisation tube incubated in a rotisserie for 10 minutes at 42°C and then the 
wash was removed. The third wash consisted of 70ml of 2x sse, 0.1 % SOS, with the 
rotisserie incubation lasting 15 minutes at 42°C. The final wash involved washing in 
looml of IX sse, 0.1 % SOS, and incubating in a rotisserie for 15 minutes at 65°e. 
The N-Hybond membranes were then developed in a cassette for approximately 72 
hours at -80°e. The film was then developed using a Fuji developper. 
2.10 Embryo culture 
2.10.1 In vitro fertilisation 
Frog husbandry was performed by Mr Robert Taylor and Mr Paul Jarrett. The female 
Xenopus laevis was induced to lay eggs using 2 hormone injections. The first injection, 
100 units of follicle stimulating hormone, was given between 8 hours and 4 days before 
the second injection, 600 units of human chorionic gonadotrophin. The female will start 
laying approximately 8 hours after the injections at room temperature. To increase this 
time period, the female is placed in cooled water to lower her body temperature. Whilst 
the female is laying, she is kept in Barth X, to stop jelly swelling around the eggs. The 
testis are removed surgically from the male after fatal injection and stored in Barth X on 
the day of use. To fertilise the eggs, the most of the Barth X was removed from the 
Petri dish of eggs and the testes teased using a pair of tweezers before brushing over the 
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eggs. After 5 minutes, 1-2ml of water was added and the eggs left to fertilize for at least 
20 minutes. 
The embryos were dejellied by treatment with 2% cysteine (pH 8) for 5 minutes. Once 
the embryos had been dejellied, the cysteine was removed by washing several times 
with 1110 Barth X. The embryos were incubated at 12-18°C in 1/10 Barth X and 30111 
gentamycin (Sigma) until they reached the required stages. 
2.10.2 Staging 
The embryos were staged according to Nieuwkoop and Faber (1994). 
2.10.3 Micro-injection 
Micro-injection was performed by Prof. Elizabeth Jones. For targeted micro-injection, 
a total of 18nl mRNNmorpholino oligonucleotide was injected into one V2 blastomere 
to target the left/right pronephros, or both V 1 cells to target the heart. As a control, 
GFP mRNA was also injected to confirm targeting (Fig. 2.2). Only those embryos that 
showed correct targeting by GFP fluorescence were used for analysis and for pronephric 
targeting, these were sorted for left/right targeting. Oocytes were injected with SOn 1 of 
mRN A and cultured as required. 
2.10.4 Fixing 
The embryos were fixed by incubating overnight (unless otherwise stated) at 4°C in 
either MEMFA (lOOmM MOPS pH 7.4, 4% Formaldehyde, ImM MgS04, 20mM 
EGTA pH 8) or Bouin's fix (25% Formaldhyde, 5% acetic acid) (Before bleaching after 
in situ bybridisation only). 
2.10.5 Animal cap dissections 
All animal cap injections were performed by Prof. Elizabeth Jones. Dissections were 
carried out using forceps and an eyebrow hair knife. Animal caps were dissected from 
stage 8/9 embryos and incubated to the required stage according to whole embryo 
controls. 
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Fig. 2.2 Targeted mRNA or morpholino micro-injections. Pod I or Darmin r mRNA or 
morpholino were co-injected with GFP mRNA. The injections were into either V2 
cells, to target one pronephro (A, a indicated by the red arrow), or both V I cells, to 
target the heart (B, a indicated by the red arrow), within an 8 cell embryo. GFP was 
u ed a a lineage tracer and would therefore authenticate the pronephric or heart 
targeting (A, B). GFP wa also u ed to indicate the left or right pronephric target. 
Embryos that did not have GFP fluore cence in the required region were discarded 
fr m the experiment. 
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For treated animal caps, the animal caps were incubated in concentrations of activin A 
and retinoic acid, made up in Iml volumes of Y2 Barth's X with 0.1 % BSA 24-well 
tissue culture plates. They were harvested at equivalent to stage 22 and RT-PCR was 
performed. 
2.10.6 Wax-sectioning 
Wax-sectioning was performed by Mr Surinder Bhamra. MEMFA fixed embryos were 
dehydrated gradually into ethanol and cleared with Histoclear II (Lamb) by 2 x 10 
minute washes on a nutator. Samples were then transferred into I: I Histoclear 
II:Paraplast X-tra (Sigma) for 30 minutes at 60°C. This was replaced with molten 
Paraplast X-tra for 2 x 30 minute washes and again for overnight incubation. One 
embryo was then embedded on a cushion of Paraplast X-tra per watchglass and allowed 
to set at room temperature. The blocks were sectioned on a Bright microtome to give 
IOl1m ribboned sections that were collected onto 45"C water and lifted onto Superfrost 
slides (SOH Laboratory Supplies). Slides were dried overnight on a slide warmer 
(Phototax), cleared with Histoclear II followed by Xylene washes and mounted with 
coverslips using DePex mountant (BDH Laboratory Supplies). 
2.10.7 Measurement of tissue area 
The phenotypes observed in the mis-expression embryos were quantified by 
measurements. The size of the glomus/pronephric anlagen and the length of the embryo 
were measured using the LUCIA programme (Laboratory Imaging Ltd.). The length of 
the embryo was measured to eliminate the factor of the size of the embryo on the size of 
the glomus/pronephric anlagen (Fig. 2.3). 
2.10.8 Pronephric Index 
The mis-expression phenotypes of the pronephric tubules were determined using the 
Pronephric Index (PNI) (Wallingford, et al., 1998) and subsequent statistical analysis. 
The PNI index is the number of tubule components (Fig. 2.4). A left/right difference in 
PNI greater than 2 on the same embryo is extremely rare by chance. The embryos were 
analysed by comparison of the injected side to not injected side only, as slight 
differences between embryo sets could not be discounted. 
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A B 
Length of emhryo ::;;mm 
Te t area ~.02 mm 2 
Test area ~.004 mm 2/mm 
Length of embryo 
C Injected side of embryo Not injected side of embryo 
Te t area length Test area Test area Length Test area 
Length Length 
mm2 mm mm
2/mm mm2 mm mm2/mm 
I 0.02 4.96 0.004 0.021 4.95 0.004 
2 0.014 4.46 0.002 0.017 4.50 0.004 
3 0.016 4.49 0.004 0.013 4.48 0.003 
4 0.008 4.82 0.003 0.009 4.83 0.002 
5 0.02 4.79 0.004 0.03 4.75 0.006 
Mean 0.016 4.70 0.003 0.Ol8 4.70 0.004 
Fig. 2.3 Example of measurement of test area relative to embryo length. (A-B) The length 
of the embryo (red) and the test area (in this case the glomus, blue) were measured 
using the LUCIA programme (Laboratory Imaging Ltd.). In order to reduce the effect 
of the size of the embryo on the measurements taken, the ratio of relative test area to 
length of embryo wa u ed in all tatistical analy is not involving left/right comparison 
of the same embryo. (C) An example of raw data obtained from LUCIA measurements. 
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Fig. 2.4 Pronephric Index (P NI). The Pronephric Index is achieved by counting the number of 
branche /component observed in the pronephric tubules. The PNI of the left and right 
sides of the arne embryo rarely differs by a number greater than 2 (Figure taken from 
Wallingford, et al., 1998). 
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Results Part 1 
Identification of Genes Involved in 
the Pronephric Development of Xenopus laevis. 
Chapter 3 
Screening of a stage 13 cDNA phagemid library with a subtracted probe. 
Chapter 4 
Analysis of potential pronephric UniGene cluster genes. 
Chapter 5 
Pod 1 and Darmin r are expressed in the developing pronephros. 
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Identification of genes involved in the pronephric development of 
Xenopus laevis 
Introduction 
The structural development of the pronephros is well documented and several genes 
have been identified to have specific roles in initiation and development of the 
pronephros (Introduction). However such information is limited, both by the number of 
known pronephric genes and the nature of their exact interactions. The first aim of this 
thesis is therefore, to identify genes that are involved in pronephric initiation and 
development. Genes with a potential role in pronephric development were identified 
using three different but complementary approaches: 
1. Screening of a stage 13 cDNA phagemid library with a subtracted probe, 
designed to identify genes expressed in the early development of the pronephros. 
2. Analysis of a set of UniGene cluster genes that have previously been shown to 
be expressed in the pronephros by in situ hybridisation. 
3. Data mining to identify Xenopus laevis homologues of vertebrate genes with a 
known function in kidney development. 
Once these genes had been identified, two genes were chosen for further study based on 
their spatial and temporal expression, to elucidate their role in pronephric development. 
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Screening of a stage 13 cDNA phagemid library with a subtracted 
probe. 
3.1. Introduction 
The first method employed to identify potential pronephric development genes was to 
screen a stage 13 cDNA phagemid library using a subtracted probe. The probe was 
made from mRNA extracted from animal caps treated with retinoic acid and activin A 
in combination, a condition known to induce pronephric tissues, subtracted from mRNA 
extracted from animal caps treated with retinoic acid and activin l' individually. This 
screen would potentially highlight genes that are involved in pronephros initiation and 
would include known and unknown Xenopus genes (Taira, et al., 1994; Brennan, et al., 
1999 and Osafune, et al., 2002). 
Animal cap experiments with activin A 
The animal cap assay was first described in 1961 by Yamada and Takata. An animal 
cap is the region of tissue that forms the blastocoelic roof within the animal pole of the 
blastula stage embryo. This tissue comprises two layers of ectodermal cells that are 
fated to form either epidermal or neural tissues. When left to develop after dissection, 
the animal cap will produce atypical epidermis. Where, however, the tissue is incubated 
in saline containing an inducer, the ectodermal cells will differentiate into different cell 
types, depending on the nature of the inducing factor. A refinement of this technique 
was added in 1990, where the animal cap cells were dispersed before treatment with an 
inducing factor, then gently pelleted for longer incubation (Green, et al., 1990). This 
technique established the importance of cell contacts in the developmental system being 
studied. The multi or pluripotency of animal cap cells is an invaluable tool in 
developmental biology (Green and Smith. 1990; Ariizumi and Asashima, 200 I and 
Okabayashi and Asashima, 2003). 
Activin A, thought of as a dorsal inducer, is a TGF-p family protein. Almost all types 
of mesodermal and endodermal tissues can be induced in amphibian animal caps by 
activin A in varying concentrations and with different modifiers. In fact. activin A will 
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induce more dorsal mesodermal structures as concentration of activin A treatment 
increases, suggesting a role in establishing axial organization in the embryo (Ariizumi, 
etal.,1991). 
With low concentrations of activin A. animal caps differentiate into mildly elongated 
structures containing blood-like cells (Table 3.1). Some of these cells exhibit 
erythrocyte morphology, and some are recognised by a leukocyte antibody. However, 
these cells do not react to anti Xenopus globin antibody, indicating that these cells may 
be primitive blood cells that are not terminally differentiated (Green, et al., 1990 and 
Miyanaga, et al., 1999). 
Muscle tissue is obtained from animal caps following treatment with slightly higher 
concentrations of activin A (Table 3.1). During this treatment the animal caps elongate, 
a process involving convergent extension, which is observed in gastrulation. During 
convergent extension, the organisation of actin filaments was found to be critical for 
muscle differentiation as treatment with cytochalasin B resulted in a reduction of muscle 
markers expressed (Tarnai, et al., 1999). The induction of cardiac muscle, however, 
requires higher concentrations of activin A, (Table 3.1) (Logan and Mohun, 1993). 
There is a sharp threshold response to activin A induction of muscle tissue or notochord. 
Antibody 121101 positive (muscle) cells are found after treatment with low levels of 
activin A, and notochord cells, detected with MZI5 antibody, are found with medium 
levels (Table 3.1) (Green, et al., 1997). Neural tissue can also be found in the same 
dose range as notochord, (Table 3.1) (Smith, et al., 1988). Interestingly, activin A is 
able to induce 'head' neural tissue, expressing goosecoid, at higher concentrations and 
more posterior neural tissue, expressing Xbra, at lower concentrations (Table 3.1) 
(Green, et al., 1997). This suggests that not only does activin A have a role in dorso-
ventral patterning, but also anterior-posterior axis patterning. 
In addition to tissue induction, activin A can induce more sophisticated organ structures. 
The induced cardiac tissue mentioned previously is able to contract, producing beating 
explants (Logan and Mohun, 1993). Sequential activin A and retinoic acid treatment 
can produce both pancreatic and pronephric tissue (Moriya, et al., 2000 and Taira, et al., 
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Table 3.1 
Activin A 
Induced tissue type nglOO units/ml 
Blood·like cells 0.1-1 . 
Muscle tissue 5·10 4·8 
Anterior neural ti sue - 4-16 
Notochord 10-50 8-16 
Posterior neural tissue - 8-32 
r t ,-"I . IIIIISde 100 80 
Relative concentrations of Activin A used to induce different tissues in 
animal cap assays. Low concentrations are highlighted in blue, medium in green and 
high in purple. Adapted from Green and Smith, 1990; Ariizumi and A. ac hima, 2001 
and Okabayashi and A ashima, 2003. 
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1994). The pancreatic tissue formed has some rudimentary cell structures and can 
produce insulin and glucagon (Moriya, et a/., 2000). 
An early pronephric marker, xLim /, was identified in retinoic acid and activin A treated 
animal caps (Taira, et a/., 1994). These caps were later found to contain all three 
components of the pronephros, the tubules, duct and glomus, (Brennan, et a/., 1999 and 
Osafune, et a/., 2002). Surprisingly, these three pronephric structures were shown to be 
functional after transplantation where the host pronephric rudiments had been removed, 
(Asashima, et a/., 2000). 
Investigating the gene expression resulting from the activin A and retinoic acid 
treatment of animal caps has identified many genes. The identification of these genes 
relies on the requirement for the double treatment of animal caps. That is, genes are 
selectively expressed during the treatment with both activin A and retinoic acid and are 
not expressed during the treatment with either activin A or retinoic acid alone. Probes 
containing cDNA of these enriched genes have been used to screen various libraries and 
resulted in the isolation of pronephric specific genes. For example, Annexin IV (Seville, 
et ai., 2002), XSMP-30 (Sato, et a/., 2000) and X-CypA (Masse, et a/., 2004) were found 
to be expressed in the pronephros. I have used probes designed in this way to screen a 
stage 13 eDNA library. Stage 13 was chosen as it is close to the point which all the 
elements of the pronephros are induced (Brennan, et a/., 1998). The screen would 
therefore identify genes that are involved in early pronephric development. 
Clontech PCR·Select™ Subtraction Hybridisation 
The subtraction probes used in this screen were made using the Clontech PCR-Select 
cDNA subtraction kit. The basic principle of this subtractive hybridisation is the PCR 
amplification of cDNA fragments that are unique to one experimental sample, the tester, 
but not the other, the driver, resulting in an enrichment of desired sequences. In this 
case enrichment of sequences induced by a combination of retinoic acid and activin A 
(tester) that are not induced by either treatment alone (driver), was desired. 
cDNA was synthesised from poly A+ mRNA from all experimental samples and 
digested using Rsa I, yielding blunt ends. The experimental sample containing desired 
eDNA, called the tester, was halved and ligated to either of two adaptors. The adaptors 
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were designed without a phosphate group, allowing for only one strand of each adaptor 
to attach to the 5' end of the cDNA. The cDNA sample to be excluded was left as 
excess driver cDNA. In the first of the hybridisations, the excess driver cDNA was 
added to each individual tester cDNA sample. The samples were then heat denatured 
and allowed to anneal. In the first hybridisation, commonly expressed sequences 
hybridised and differentially expressed sequences remain unhybridised. Also, the 
concentrations of sequences are equalised due to the more abundant sequences 
annealing faster then less abundant sequences. In the second hybridisation, the two 
cDNA samples are mixed without denaturing. This allowed for the differentially 
expressed unhybridised tester cDNA with different adaptors to hybridise. More excess 
driver cDNA was added to further enrich these differentially expressed sequences. The 
ends were filled in with DNA polymerase and PCR was conducted using nested primers 
within the tester adaptors. Only the differentially expressed tester cON A ligated with 
different adaptors should be amplified. 
This method was used to create four probes. Two forward probes that would identify 
sequences that were expressed with the treatment of animal caps with retinoic acid and 
activin A, one subtracted with cON A isolated from retinoic acid treated animal caps, 
and the other from cDNA from activin A treated animal caps. Two reverse control 
probes which contained genes that were only induced by retinoic acid or activin A 
individually were also made (Masse, et al., 2004) 
3.2 Results 
3.2.1 Preparation of probes and initial screening 
This section describes work previously conducted in our laboratory by Dr K Masse. 
The four probes were generated using animal caps taken at stage 9 and incubated in 
either 10-5 M retinoic acid and IOng/ml activin A. IOng/ml activin A alone, or 1O-5M 
retinoic acid alone. At stage 13, most of the animal caps were harvested (retinoic acid 
and activin A combined treatment ~ 1200, each individual treatment ~ 600) and mRNA 
extracted (retinoic acid and activin A combined treatment ~ 41lg, each individual 
treatment ~ 21lg per sample). Some were allowed to develop until stage 38, after which, 
pronephric tubules induced were identified using antibody staining with 3G8. 
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Pronephric ti ue were observed only in the animal caps treated with retinoic acid and 
activin A (Fig. 3.2) (Mas e, et at., 2004). 
cDNA was generated from extracted RNA using reverse transcription. Two test probes 
and two control probe were generated using the Cion tech PCR-Select cDNA 
Subtraction hybridisation kit (Fig. 3.1 and 3.3). The probes were as follows: 
• + " - forward probe containing cDNAs that are up regulated 
by treatment with both retinoic acid and activin A, and not retinoic acid 
alone. 
+ \I \ - forward probe containing cDNAs that are up regulated 
by treatment with both retinoic acid and activin A, and not activin A 
alone. 
RAJ(RA + A) - reverse control probe containing cDNAs that are up 
regulated by treatment with retinoic acid alone and not retinoic acid and 
activin A in combination. 
- reverse control probe containing cDNAs that are up 
regulated by treatment with activin A alone and not retinoic acid and 
activin A in combination. 
The four probes were initially used to screen an adult kidney cDNA library (Masse, et 
al., 2004), which identified kidney pecific genes switched on later in development. In 
this tudy, the arne probes were used to screen a stage 13 library, the point at which the 
pronephro i initially pecified. Consequently, this screen would therefore isolate 
gene that are involved in early pronephric development. 
The tage 13 library had previously been constructed in our laboratory. cDNAs from 
stage 13 Xenopus embryos were cloned into the pBluescript SK(+/-) phagemid using the 
STRA TAGENE cDNA Synthesis and Gold Cloning kit to create a stage 13 cDNA 
library (Seville and Barnett, unpublished). The phagemids were spread onto 20 LB agar 
plate after infection with XLI-Blue MRF' at a concentration of 50,000 colonies per 
plate and duplicate plaque lifts were performed per plate (Methods 2.9.1 Infection of the 
XLI-Blue MRF'). The plaque lifts underwent hybridisation using either the (RA + 
A)/A or the (RA + A)/RA forward probe (Methods 2.9.4 Southern Hybridisation). The 
plaque lift probed u ing the (RA + A)/RA forward probe gave 22 positive plaques, and 
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Fig. 3.1 CIon tech PCR·Select™ eDNA Subtraction Hybridisation. The subtraction probes 
used in this screen were made using the Clontech PCR-SelectTM cDNA subtraction kit. 
Step 1; cDNA was synthesised from poly A+ mRNA from all experimental samples and 
digested using Rsa I. The experimental sample containing desired cDNA, called the 
tester, was halved and ligated to either of two adaptors. The eDNA sample to be 
excluded was left as excess driver cDNA. Step 2; in first of the hybridisations, the 
excess driver cDNA was added to each individual tester eDNA sample. The samples 
were then heat denatured and allowed to anneal. The hybridisation gave the following 
products; (a) Commonly expressed tester cDNA hybridised to excess driver eDNA; (b) 
Unhybridised differentially expressed tester cDNA; (c) Excess driver cDNA hybridised 
to excess driver eDNA; (d) Abundantly expressed tester cDNA hybridised to 
abundantly expressed tester cDNA. Step 3,4; in the second hybridisation, the two 
cDNA samples are mixed without denaturing and more excess driver cDNA was added. 
The ends were filled in with DNA polymerase and PCR was conducted using nested 
primers within the tester adaptors. The PCR gave the following products; (a) 
Commonly expressed tester eDNA hybridised to excess driver eDNA - not amplified; 
(b) Unhybridised differentially expressed tester eDNA - not amplified; (c) Excess 
driver cDNA hybridised to excess driver cDNA - not amplified; (d,e) Tester cDNA 
hybridised to tester eDNA - only amplified where adaptors are different. The resulting 
amplified probe contains eDNA fragments that are present with the treatment of animal 
caps with retinoic acid and activin in combination (tester), but not retinoic acid alone 
(driver). 
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Stage 9 Animal cap treatment Stage 13 
mRNA extraction 
mRNA extraction 
Stage 38 
Pronephric tubules 
present 
_______ _ .-. No pronephric tubules 
present 
Fig. 3.2 In vitro induction of pronephric tubules. Animal caps were taken at stage 9 and 
incubated overnight in either 1O-5M retinoic acid (RA), lOng/ml activin (A) or both 
(RA + A). At stage 13, the mRNA was extracted from the majority the animal caps. 
The rest of the animal caps were then incubated unti l stage 38. The presence of 
pronephric tubule was identified using antibody staining with 3G8 (tubules). 
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RA treated animal cap eDNA RA + A treated animal cap eDNA 
Reverse subtraction Forward subtraction 
Probe C 
RA I(RA + Al (RA +Al/RA (RA + All A 
Fig.3.3 Probe synthesis from treated animal cap mRNA. The cDNA was generated from 
mRNA extracted from treated animal caps. Two forward probes (probes A and B) and 
two reverse control probes (probes C and D) were generated using the Clontech PCR-
Select cON A Subtraction hybridisation kit. Forward probe A contained cDNA of 
genes that were up regulated by animal cap treatment with retinoic acid and activin, but 
not retinoic acid alone. To make forward probe A, the cDNA from animal caps treated 
with retinoic acid alone was taken as the "excess driver eDNA" and the tester cDNA 
from animal caps treated with both retinoic acid and activin was the cDNA ligated to 
the adaptors (See fig. 3.1). This was a forward subtraction. In a reverse subtraction, 
probe C, the eDNA from animal caps treated with both retinoic acid and activin was 
taken as the "excess driver eDNA" and the tester cON A from animal caps treated with 
retinoic acid alone was ligated to the adaptors. Reverse probe C therefore contained 
cDNA of genes that were up regulated by animal eap treatment with retinoie acid alone, 
but not retinoic acid and activin together. The probes B and D were made in a similar 
manner, with the exception that the treatment was with aetivin alone instead of retinoic 
acid alone. 
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the plaque lifts probed using the (RA + A)/ A forward probe gave 57 positive plaques. 
The filters were subsequently stripped and re-hybridised with the reverse control probes. 
The reverse control probes contain cDNAs that are up-regulated by treatment with 
either retinoic acid or activin A alone and not retinoic acid and activin A in 
combination. The plaques that contain cDNAs that are up-regulated by the single factor 
treatment alone would be identified by the reverse control probes and excluded from 
further analysis. This reduced the number of positive plaques of interest to 21 for the 
positive (RA + A)/RA screened plaques and 53 for the positive (RA + A)/ A screened 
plaques. As the two plate lifts were identical, the false positives identified on one plate 
could be identified on the other. This reduced the number of positive plaques to 19 
«RA + A)/ RA) and 52 «RA + A)/A) plaques (Masse, unpublished) (Fig. 3.4). These 
plaques were picked, plated out and rescreened during this project. 
3.2.2 Selection of clones within positive plaques 
peR and Southern hybridisation of positive plaques 
peR was used to determine the degree of c10nality of the 71 plaques. The stage 13 
cDNA library had been cloned into pBluescript SK( +), flanked by T3 and T7 
polymerase binding sites (Appendix). Primers complimentary to T3 and T7 were used 
to amplify the cDNA fragments within the plaques. The peR products were run on a 
1% agarose gel and observed using UV light. The number of PCR products was used as 
an indication of c10nality of the plaques and the relative band intensity an indication of 
clone proportions within the plaque (Fig. 3.5). The migration distance of each peR 
product was determined before Southern blotting and hybridisation with the same initial 
probe used to screen the library «RA + A)/ RA or (RA + A)/A) (Fig. 3.6). Positive 
clones were identified by matching the PCR products from the X-ray film to those on 
the UV digital image. 24 plaques were chosen using these data on the basis of: 
• Size - plaques with larger PCR products/cDNA fragments were 
chosen as the genes would be easier to identify with more sequence. 
• Intensity - plaques with more intense PCR products/cDNA 
fragments were chosen as it was likely that the clone containing that 
cDNA fragment was more abundant within the sample. 
• Clonality - plaques with fewer PCR products/eDNA fragments were 
chosen to facilitate isolating clones. 
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Plated 
library 
Duplicate 
filters 
Dupl icate 
fi Iters 
Step 1 
ProbeB 
(RA +A)I A 
22 
plaques 
57 
plaques 
ProbeC 
RA/( RA + A) 
----4 
Step 2 
Probe D 
A/( RA +A) 
Co 
21 
plaques 
53 
plaques 
False positives 
eliminated 
Step 3 
False positives 
eUminated 
19 
plaques 
52 
plaques 
Fig. 3.4 Stage 13 phagemid cDNA library screening. Plaque lifts were taken of the phagemid cDNA library and analysed by hybridisation using 
the subtracted probes. Step 1 identified all the plaques that contained cDNA up regu lated in the animal caps treated with both retinoic acid 
and activin, but not activin (forward probe B) or retinoic acid (forward probe A) alone. Step 2 used the control probes generated by the 
reverse subtraction. This identified false positives by indicating samples containing cDNA up regulated in animal caps treated with either 
activin (reverse probe D) or retinoic acid (reverse probe C) alone and not the combined treatment of retinoic acid and activin. Step 3 
compared false positive plaques, identified in step 2, between the duplicate filters and eliminated them. The numbers within the boxes refer 
to the number of positive plaques at each stage. 
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Fig.3.5 First round peR of positive samples identified in initial screen. PCR was 
performed using primers complementary to T3 and T7 polymerase binding sites 
(positioned on either side of the insert) and a standard programme cycle (annealing 
temperature of 55'C with 30 cycles). The PCR products were then run on a 1% agarose 
gel with ethidium bromide. The gel was photographed using UV light with a ruler 
adjacent to the ladder for quantification of DNA migration. The samples were graded 
on the basis of signal intensity and clonality. Black numbering indicates selected 
samples. Underlined numbering represents probe used in screening (Number = (RA + 
A)/RA, Number = (RA + A)/A). 
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Fig. 3.6 Southern hybridisation of first round peR of positive samples identified in initial 
screen. Southern blotting and hybridisation of sample peR (Fig. 3.5). Underlined 
numbering represents probe used in hybridisation (Number = (RA + A)/RA = Probe A, 
Number = (RA + A)/A = Probe B). Positively hybridised peR products (indicated 
using black dots) were aligned with the original peR (Fig. 3.5) using distance migrated 
to identify them. Again, the samples were graded on the basis of signal intensity and 
clonality. The data from the peR and the Southern blot were compared and 24 samples 
were selected (numbered in black) for further analysis. 
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Selection of specific positive clones within chosen plaques 
The chosen plaques were plated out onto LB agar dishes following infection with XLI-
Blue MRF' and plaque lifts were performed, marking the edges of the dish to ensure 
correct orientation (Methods 2.9.1 Infection of the XLI-Blue MRF'). Hybridisation was 
performed using the same test probes that were used initially (Results 3.2). Using the 
markers for orientation, positive phage plaques were chosen on the basis of signal 
intensity and isolation on the plate, for ease of removal to obtain a pure clone (Fig. 3.7). 
For each sample, 3-6 phagemid picks were taken, resulting in 78 individual phagemid 
picks. PCR, using T3 and T7 primers, and Southern hybridisation of the phagemid 
picks, ensured the correct picks had been chosen, reducing the number of phagemid 
picks to 30 (Table 3.2). 
Sequencing of peR products 
The peR products from the 30 phage mid picks were sequenced in house using the T3 
primer (Table 3.2). The sequences were analysed with the BLAST on the NCBI 
website (www.ncbLnlm.nih.govIBLAST/) (Basic Local Alignment Search Tool, 
Altschul, et al., 1990) programs, using both direct cDNA sequence and conceptual 
translated amino acid sequences ("Traduc" using standard genetic code, 
www.infobiogen.fr). The resulting homologous genes and EST data allowed for the 
reduction of clone numbers. This was on the basis of ubiquitous expression, for 
example clone ~d encodes Elongation Factor la, a Xenopus gene known to be 
expressed ubiquitously, or recognised Xenopus kidney genes, such as clone 13D 
encodes Cold lnducible RNA Binding Protein 2, already known to be involved in 
Xenopus kidney development. From this investigation, 19 phagemid picks were chosen 
for further investigation. 
3.2.3 Characterisation of identified clones 
Plasmid recovery 
To recover the pBluescript SK (+) plasmids and allow for RNA in situ hybridisation 
probes to be made and complete sequencing, the plasmid was excised from the UNI-
ZAP XR vector and transfected into the SOLR strain (Methods 2.4 Bacterial Strains). 
The plasmid was obtained from the SOLR strain by miniprep protocols, with 6 
randomly chosen clones for each phagemid pick. As the phagemid picks were already 
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Fig. 3.7 Hybridisation of plaque lift showing typical clones chosen. (A) Depiction of a 
typical phage plate. (B) Auto-radiograph of plate lift hybridi sed using (RA +A)/A 32p 
labelled probe. Blue dots (. ) indicate a code, created by pricking the agar, which allows 
the phage plate to be directly lined up with the radiograph . Red circles (. ) denote 
phage plaques that align with positive signal s from the radiograph . Grey circles (.) 
represent phage plaques that do not align with the radiograph. The black arrows 
labelled a , b and c ymbolise the plaques that were subsequently removed for further 
creening (Phage picks). 
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Sample Phage Second Southern Size Sequencing and BLAST ana]y i 
Pick hybridi sation (bp) 
1 1B Positive 650 Xenopus laevis Mitochondrial xene 
3 3A Positive 701 Xenopus laevis Cytoskeletal actin Type S 
3B Positive 547 97% identi~ to Human Sec 23 
6 6C Positive 559 77% identity to Human Selen~rotein W 
7 7C Negative - -
9 9C Positive 643 Xen~us laevis Mitochondrial gene 
10 lOA Positive 808 Xenopus laevis Gene 6720465F 12 
loe Positive 789 Mouse Ubiquitous protein kin~e-like 
13 13D Positive 710 Xenopus laevis CIRP2 
15 15B Positive 607 Xenopus laevis Cytokeratin type II 
15C Positive 752 Xenopus laevis Rack 11 Xenopus fae"i 
Guanine nucleotide bindif1.KproteinJ12 
18 18B Posi tive 800 97% identity to Mouse VPS28 
18C Positive 575 BQ732066 
UniGene cluster xl.8071 - unidentified 
20 20B Positive 846 Xenopus laevis Mitochondrial gene 
2 2b Positive 85 1 Xenopus laevis Neuronal pentatraxin J 
4 4c Positi ve 1003 Xenopus laevis Rho A 
5 5f Positive 786 Xenopus laevis Skp J 
Q Qa Posi tive 1044 Xenopus laevis 
Hypothetical protein LOC398467 
6c Positive 982 Xenopus laevis Ribosomalprotein S22 
7 7d Negative - -
II 12a Positive 828 JC7 protein , UniGene cluster xl.15910 
lib Positive 710 BJ0388 13 
UniGene cluster xl.53737 - unidentified 
12 15a Positive 807 Xen~us laellis HMG-X 
12b Positi ve 864 61 % identity to Bos tauru 
Similar to NADH dehydrogena~e 
J2c Positive 9]2 MGC80798 protein 
UniGene cluster xl.24149 
15d Positive 955 Xenopus laevis Efl a 
18 18c Posi ti ve 771 Xenopus laevis Carnitine acetyltransfera~ 
20 20b Positive 871 85% identity to Rana syLvatica 
Mitochondrialpftosphate transporter 
20c Positive 900 Unknown 
21 21a Negative - -
31 3 1b Positive 635 AW766078 
4 1 41b Positive 1004 Xenopus laevis FRGY J 
46 46c Positive 1385 8J066388 
UniGene c1u~ter xl.53638 - unidentified 
50 50a Negative - -
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Table 3.2 Summary of results of PCR and Southern hybridisation of phage picks and 
sequencing of PCR products. 3 to 6 phage picks (second column) were taken from 
each sample (fir. t column) (only those resulting in a peR product of the correct size are 
included). peR and sub equent Southern hybridisation of the phage picks was 
performed. The re ult of thi "econd" Southern hybridisation i indicated in the third 
column. The re ulting peR product were al 0 equenced (fourth column) using the T3 
primer. Sequence that corre ponded to mitochondrial, other ubiquitously expressed 
gene or already known Xenopus kidney gene were not analysed further. Where the 
outcome of the Southern hybridi ation is negative, no further analysis was done. The 
phage picks that were eliminated from the study are shaded in grey. 
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clonal, one clone exhibiting the correct fragment sizes after restriction enzyme treatment 
was selected per phagemid pick. 
Initial wholemount in situ hybridisation 
Initial analysis of the spatial expression patterns of the 19 clones was completed by 
wholemount in situ hybridisation using antisense RNA DIG-labelled probes and the 
Xenopus albino (homozygous and heterozygous) embryo stages 13, 21 and 35 (Methods 
2.6.4 Wholemount in situ hybridisation). Stage 13 is the stage at which the pronephros 
is initiated, 21 is the stage at which the pronephric anlargen is formed and elongates and 
at stage 35 the pronephros is functional. Only the antisense RNA DIG-labelled probes 
were used for the initial wholemount in situ hybridisation to enable the faster screening 
of clones. The probes were made by digesting the pBluescript SK (+) plasmids at the 5' 
end of the cDNA fragment insert and transcribing with either T3 or T7 (Table 3.3). 
Staining in the pronephros was observed in 9 (3B5, 6C5, 18B I, ~f6, Qa4, 12al, l.5.b2, 
Uc7, 41 b2) of the 19 clones investigated (Table 3.4). The expression patterns of these 
clones were only apparent later in development, stage 27, and hybridisation was not 
exclusive to the pronephros. The lack of early staining may be due to the inability of 
the wholemount in situ hybridisation technique to detect low levels of expression. Later 
in this screen RT-PCR was used to detect lower levels of expression. 
Probes derived from 7 clones (lOA7, 15B7, :!c1, llb3, lic1, Jlb4, 46c9) did not 
indicate expression in the pronephros (Table 3.4). The genes identified in this screen 
should be up regulated by retinoic acid and activin A treatment in animal caps although 
false positives are possible. The combined treatment of retinoic acid and activin A in 
animal caps not only induces pronephric tissues, but also has the potential to induce 
anterior and posterior neural tissue, cardiac tissue and pancreatic tissues (Haldin, et at., 
2003 and Moriya, et al., 2000). Therefore, although it is expected that a high proportion 
of the genes isolated in this screen are expressed in the pronephros, not all genes will be. 
Probes from a small number of clones, 18C2, 2b5 and 20c I, failed to reveal staining 
patterns by wholemount in situ hybridisation. It is undetermined whether this was due 
to low levels of expression, or experimental error. The clones that did not indicate 
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Antisense Sense 
Clone Restriction RNA Restriction RNA 
enzyme polymerase enzyme polymerase 
3B5 Bam HI T7 - -
6C5 Bam HI T7 Xho 1 T3 
IOA7 Pst 1 T7 - -
15B7 Bam HI T7 - -
18BI Hind III T3 Bam HI T7 
18C2 Bam HI T7 - -
2b5 Xba 1 T7 - -
4cl Xba 1 T7 - -
5f6 EcoRl T7 Kpn I T3 
6a4 Xba 1 T7 Kpn 1 T3 
12al Bam HI T7 Kpn 1 T3 
12b3 Xba 1 T7 - -
15b2 Xba I T7 Kpn I T3 
15c7 Sac I T7 Kpn I T3 
18cl Xba I T7 - -
20cl Sac 1 T7 - -
31b4 Xba 1 T7 - -
41b2 Sac 1 T7 Kpn I T3 
46c9 Sac 1 T7 - -
Table 3.3 Preparation of antisense DIG-labelled RNA probes for initial whole mount in situ 
hybridisation. Whole mount in situ hybridisation was performed using antisense DIG-
labelled RNA probe. The probes were made by digesting the pBluescript SK (+) 
plasmids at the 5' end of the cDNA fragment insert and transcribing with either T3 or 
T7 as shown. 
70 
Clone Neurula (Stg. 13) Early tailbud (Stg. 21) Late tailbud (Stg. 35) 
3B5 No staining. Neural fold . Somite, head, pos ible 
staining in the pronephros. 
6C5 No taining. Anterior neural folds and Pronephric duct. head and 
eye placodes. somites. 
IOA7 No staining. Somites. neural folds. Head. 
migrating neural crest and 
eye placodes. 
15B7 Epidermis. notably clear in Epidermis. Epidermis and growth tip 
the neural plate. of the tail. 
18BI No taining. No tajning. Pronephric tubules and 
head 
18C2 No staining. No staining. No staining. 
~b5 No staining. No staining. No staining. 
~l Neural plate, e pecially So mites. eye placodes and Possible weak staining in 
neural groove. adhesive organ. the pronephros. area 
between somites and head. 
~f6 No staining. Brain. Pronephric tubules. head. 
lens and spinal cord. 
Qa4 Anterior and posterior ends Eye placodes and Brain, eye and anterior 
of the neural folds. mjgrating neural crest. duct. 
lial Neural plate. Neural fold. Pronephric tubule, 
somites and head . 
llb3 Neural plate. Neural folds. Spinal cord, eye and 
adhesive organ. 
~b2 Neural groove. Neural folds. migrating Pronephro ,eye 
neural cre t and eye components and head. 
placodes. 
~c7 Anterior neural plate. Blood island. Pronephric tubules and 
head . 
18cl Neural plate. Neural folds. Head and somites. 
~l No staining. No staining. No staining. 
.llb4 Anterior and posterior ends Neural folds. migrating Area between so mites and 
of the neural folds. neural crest and eye head. 
placodes. 
llb2 Ectoderm. Ectoderm. Pronephros and endoderm. 
46c9 Anterior neural plate. No staining. Head and somites. 
Table 3.4 Fir t round ill situ hybridisation of the 19 clones chosen in screening. Xenopus 
laevis embryo were taken at stage 13, 21 and 35 for expression analy is. In situ 
hybridisation was performed using anti ense DIG-labelled RNA probe. Areas of clone 
expression are indicated. The clone that do not show expre ion in the pronephros or 
have unclear expression pattern were not included in further analysi and are 
highlighted in grey. 
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pronephric expression, or had ambiguous expression patterns were not included in 
further screening. There were 9 clones continued in the screen (Table 3.4). 
Sequencing of eDNA from plasmid 
The full cON A fragments from these 9 clones were sequenced, using the T3 and T7 
flanking primers by the Molecular Biology Service, Biological Sciences, University of 
Warwick. Again, the sequences were analysed with the BLAST on the NCBI website 
(www.ncbi.nlm.nih.gov/BLAST/) (Basic Local Alignment Search Tool, Altschul, et al., 
1990) programs, using direct eDNA sequence and the conceptual amino acid sequences 
('Traduc' using standard genetic code, www.infobiogen.fr). One of the clones, 3B5, 
appeared to consist of two fused cDNA fragments, Sec 23 and xCIRP. As any further 
study of this clone would require recloning, no more work was carried out at this stage. 
A total of 8 clones were therefore carried on for further investigation (Table 3.5). 
Temporal expression patterns of clones 
To analyse the expression patterns of the selected target genes, RT-PCR and 
wholemount in situ hybridisation were used to elucidate the temporal and spatial 
expression patterns. The temporal expression pattern, given by RT-PCR, was cross-
referenced with important stages during the development of the pronephros. For each 
clone primers were designed to give a PCR product of between 150-400bp (Methods 
2.5.4 PCR). The RT-PCR was performed using cDNA prepared from Xenopus laevis 
embryos grown to stages 9, 13, 161h, 21, 26Y2, 30, 35 and unfertilised eggs (Methods 
2.6.2 Reverse Transcription PCR). Furthermore, the relative expression of the clones 
within the pronephros, or the presumptive pronephric region, compared to the whole 
embryo was analysed. This was carried out by performing RT-PCR with the cDNA 
isolated from dissected pronephric tissue along with the whole embryo at stages 12Y2. 
15.20.28 and 35 (Methods 2.6.2 Reverse Transcription PCR). 
Expression levels in unfertilised eggs represented maternal expression. Of the 9 clones. 
J.f6.l.fal. llc7. ilb2 and 18BI are expressed maternally (Fig. 3.8). In early Xenopus 
development. the majority of zygotic transcription does not occur until the mid-blastula 
transition. Maternally expressed mRNA therefore plays a critical role in early 
development until stage 8. This suggests that these clones have a role in early Xenopus 
development. 
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Clone T3 sequencing I T7 sequencing 
3B5 Human Sec 23 I x. laevis CIRP 
6C5 Human Selenoprotein W 
18Bl Mouse VPS28 
5f6 X. laevis Skp 1 
6a4 X. tropicalis Vitamin K epoxide reductase complex subunit 
12al X. laevis Hypothetical protein JC7 
15b2 X. laevis NADH dehydrogenasel alpha subcomplex 
15c7 Human Lysosome-associated membrane glycoprotein I precursor 
41b2 X. laevis FRGY 1 
Table 3.5 Complete sequencing of chosen clones. The clones were sequenced with both the 
T3 and T7 primers that lay on either end of the eDNA insert. Sequencing of clone 3B5 
resulted in 2 different cDNA sequences, suggesting the clone contained two fused 
eDNA fragments. This clone was not analysed further and is shaded in grey. 
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Fig.3.S Temporal expression patterns of clones identified in screens. RT-PCR analysis of 
clones identified in the screen. RT-PCR was carried out on embryos of stages from 
unfertilised eggs to stage 35. Clones are labelled vertically and embryo stages with 
controls are labelled horizontally. Input cDNA was approximately equalised using the 
ubiquitously expressed gene ODe, and a linearity using doubling dilutions of stage 35 
cDNA was performed. Negative controls were (-RNA) no RNA in the sample during 
RT reaction, (-RT) no reverse transcriptase in sample during RT reaction and (-) no 
cDNA in PCR reaction. 
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The specification of the pronephric anlagen has been shown to occur at stage 13. Genes 
that are up regulated at stage 13 could be involved in pronephros initiation. Clones ~f6, 
Qa4, gal and 1!b2 are up regulated at stage 13 (Fig. 3.8) and so may be involved in 
early pronephric development. Between stage 16 and 30, the pronephric anlagen is 
formed and extends along the anterior-posterior axis. During this period, the expression 
of clones Qa4, Ub2, Uc7 and 6C5 increases and the expression of ~f6, gal, llb2 and 
18B I remains constant (Fig. 3.8). At stage 35, the pronephros is functional, and all the 
clones indicate a high level of expression (Fig. 3.8). 
Figure 3.9 shows that all the clones are expressed in the pronephros and presumptive 
pronephric tissue, however, there is little, if any, enrichment in this region relative to the 
whole embryo. The exception to this is Qa4 whose expression in the pronephric tissues 
is equal to that within the whole embryo until the later stages 28 and 35, where the 
expression in the pronephric tissues is significantly reduced (Fig. 3.9). 
Confirmation of the spatial expression pattern of clones, fully controlled with sense 
probes 
The spatial expression pattern was revealed by wholemount in situ hybridisation of an 
antisense DIG-labelled RNA probe. In addition, a control sense DIG-labelled RNA 
probe was used to define the amount of non-specific staining present. The sense DIG-
labelled RNA probe was made by digesting the plasmid at the 3' end of the insert and 
transcribing with either T3 or T7 polymerase (Table 3.3). The probes were used for 
wholemount in situ hybridisation with albino (homozygous and heterozygous) Xenopus 
laevis between stages 10 and 42 (Methods ). 
In situ hybridisation of clone ~f6 shows expression in the neural folds, migrating neural 
crest and the eye placodes at stages 21 and 25. mRNA expression is first seen in the 
pronephric tubules at stage 27 and is maintained until stages 35 and 42 (data not shown 
for stage 42). Other head structures, such as the branchial arches, eye, auditory vesicle 
and the brain are also stained. The sense control treated embryos are unstained 
throughout the stages tested and are a good indication of the specificity of the staining 
observed (Fig. 3.1 OA). 
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Fig.3.9 Comparison of whole embryo and pronephric temporal expression patterns of 
clones identified in screens. RT-PCR analysis of identified clones in dissected 
presumptive pronephros compared to whole embryo. mRNA was extracted from whole 
embryo (w), or dissected pronephric or presumptive pronephric tissue (k). Clones are 
labelled vertically and embryo stages with controls are labelled horizontally. Input 
cDNA was approximately equalised using the ubiquitously expressed gene ODe, and a 
linearity using doubling dilutions of stage 35 cDNA was performed. Negative controls 
were (-RNA) no RNA in the sample during RT reaction, (-RT) no reverse transcriptase 
in sample duri ng RT reaction and (-) no cDNA in peR reaction . 
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Fig. 3.10 In situ hybridisation analysis of clones ~f6 and ~a4. In situ hybridisation using 
clones that were identified using the (RA + NA) probe. Clones were analysed with 
both antisense and sense RNA probes as indicated. (A) Spatial expression of mRNA 
corresponding to the transcript of the clone ~f6; (i) stage 20 embryos show RNA 
expression in the eye placodes (e) and neural folds (n). (ii) antisense treated stage 25 
embryos with intense staining along the neural folds (D), migrating neural crest (DC), 
brain (br) and in the eye (e). (iii) RNA expression seen in the pronephric area (p), the 
branchial arches (b), eye (e), brain (br) and the otic vesicle (0) of stage 27 embryos. At 
stage 35 (iv and magnified v) it is clear by morphology that the pronephric region 
stained is the tubules (t). The branchial arches (b) also show expression. Sense control 
embryos (vi, vii, viii, ix and x) are clear throughout all the stages analysed. (8) Spatial 
expression of mRNA corresponding to the transcript of the clone ~a4; (i) RNA 
expression is present on the whole surface of the stage 13 embryo, except for the 
blastopore (bl). There is no sense control staining at stage 12 (vi). At stage 22 there is 
antisense probe staining along the neural folds (D) and the anterior region of the 
embryo, which are not present with the sense probe treated embryos (vii). Stage 27 
embryos (iii) reveal staining in the branchial arches (b) and the eye (e), although the eye 
staining (e) is not distinct from the sense control embryo (viii). The §a4 RNA is clearly 
visible in the tubules (t) at stage 34 (iv). The branchial arch (b) staining visible at stage 
34 is present both in the antisense (iv) and sense (ix) treated embryos. Stage 41 (v) 
reveals RNA expression in the duct (d), not seen in the sense embryos (x). 
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Clone Qa4 expression is present on the whole surface of the stage 13 embryo, except for 
the blastopore corresponding to ectodermal structures. There is no sense control 
staining at stage 12. At stage 22 there is antisense probe staining along the neural folds 
and the anterior region of the embryo, which is not present with the sense probe treated 
embryos. Stage 27 embryos reveal staining in the branchial arches and the eye, 
although the eye staining is not distinct from the sense control embryo. The Qa4 RNA 
is clearly visible in the tubules at stage 34. The branchial arch staining visible at stage 
34 and is present both in the antisense and sense treated embryos. Stage 41 reveals 
RNA expression in the duct which is not seen in the sense control embryos (Fig. 3.lOB). 
Clone llal has strong expression in the eye placodes and in the migrating neural crest 
cells which are not visible in the sense control embryos. At stage 28 there is a high 
level of expression in the head, branchial arches and the pronephric region. The 
pronephric expression is still present at stage 36, but not stage 41. The sense treated 
embryos are unstained at stages 28.36 and 41 (Fig. 3.11 A). 
In situ hybridisation using clone 12b2 gives little staining until stage 21-25, where the 
migrating neural crest cells, the eye placode and the somites are stained (data not 
shown). Pronephric expression is first identified at stage 27 and is apparent throughout 
the whole pronephric region. All three components of the pronephros are stained in late 
tadpole stages. The head region and the somites are strongly stained in all the stages 
tested. The sense control embryos are unstained suggesting there is little unspecific 
background staining (Fig. 3.11 B). 
Clone 12c7 RNA expression is present in the blood islands at stage 21-29. Expression 
is also seen in the pronephric tubules from stage 29 to stage 42, the last stage tested 
(data not shown). The sense control embryos are clear, suggesting high probe 
specificity (Fig. 3.12A). 
In situ hybridisation of clone 41 b2 illustrates expression in the ectoderm in all the stages 
analysed before stage 35 where expression is seen in the endoderm. Pronephric 
expression is seen between stages 25 and 29, although it is unclear what region within 
the pronephros is stained. Other areas of expression include the migrating neural crest 
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Fig. 3.llln situ hybridisation analysis of clones 12al and 15b2. In situ hybridisation using 
clones that were identified using the (RA + NA) probe. Clones were analysed with 
both antisense and sense RNA probes as indicated. (A) Spatial expression of mRNA 
corresponding to the transcript of the clone 12al; (i and ii) there is strong expression in 
the eye placodes (e) and in the migrating neural crest cells (nc) which is not visible in 
the sense control embryos (vi). At stage 28 (iii) there is a high level of expression in the 
head (h), branchial arches (b) and the pronephric region (p). The pronephric expression 
is still present at stage 36 (iv), but not stage (v). The sense treated embryos are clear at 
stages 28, 36 and 41 (vii, viii, ix). (D) Spatial expression of mRNA corresponding to 
the transcript of the clone 15b2; At stage 25 (i) there is staining in the migrating neural 
crest cells (nc), the head (h) and the somites (s). Expression is seen in the pronephros 
(p), branchial arches (b), somites (s), eye (e) and otic vesicle (0) in stage 27 embryos 
(ii). Later tail bud staining (iii and magnified iv) reveals continued strong expression in 
all three components of the pronephros, the glomus (g), the tubules (t) and the duct (d) 
and in the heart (ht). The sense embryos are completely clear in all the stages analysed 
(v, vi, vii and viii). 
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Fig. 3.12/n situ hybridisation analysis of clones 15c7 and 41b2. In situ hybridisation using 
clones that were identified using the (RA + NA) probe. Clones were analysed with 
both antisense and sense RNA probes as indicated. (A) Spatial expression of mRNA 
corresponding to the transcript of the clone 15c7; (i, ventral view) stage 25 antisense 
treated embryos show RNA expression in the blood islands (bi). not present in the sense 
control treated embryos (v, ventral view). At stage 29 (ii) RNA expression is seen in 
the pronephric tubules (t) and the blood islands (b). Stage 35 embryos (iii and 
magnified iv) indicate RNA expression in the tubules (t) and the branchial arches (b). 
No staining was observed in the sense control treated embryos (v, vi, vii and viii). (B) 
Spatial expression of mRNA corresponding to the transcript of the clone 41b2; Stage II 
embryos have staining visible around the whole embryo. excluding the blastopore (data 
not shown). (i) this ectoderm patterning is continued at stage 20, where the whole 
embryo appears stained, with the exception of the posterior most point (po). Stage 25 
(ii) embryos show RNA expression in the pronephric area (p) and migrating neural crest 
cells (nc) as well as a general expression all over the embryo. The antisense probe at 
stage 29 (iii) has labelled the pronephric area (p), and the branchial arches (b) and the 
epidermis. Expression is observed in the endoderm (en) and the nasal pit (np) of stage 
35 embryos (iv). The sense embryos are completely clear in all the stages analysed (v, 
vi, vii and viii). 
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and in late tail bud stages, the nasal pit. There is no apparent sense control staining in 
any of the stages tested (Fig. 3.12B). 
The spatial expression pattern of clone 6C5, as determined by in situ hybridisation, is in 
the brain and the eye from stages 27 to 31. At stage 39, there is no unique staining on 
the antisense treated embryos that is not also seen in the sense treated embryos (Fig. 
3.13A). 
In situ hybridisation with antisense clone 18B I reveals little expression until stage 25 
where embryos indicate expression in the head. Antisense probe treated embryos staged 
28 to 42 (data not shown for stage 42) show staining in the pronephric tubules, the head 
region and the notochord. The sense treated embryos do not have any staining and so 
suggest the antisense probe is highly specific (Fig. 3.13B). 
3.3. Discussion: Screening of a stage 13 cDNA phagemid library with a 
subtracted probe 
The aim of this work was to identify new genes with a potential role in pronephros 
development. The work in this chapter describes a screen of a stage 13 cDNA 
phagemid library using subtracted probes made from animal caps treated with retinoic 
acid and activin A individually and in combination. 
From the 71 preliminary positive plaques (Masse, unpublished), 8 positive clones were 
chosen for further analysis. Clone ~f6, identified as Skp J, is a transcription factor 
specifically involved in the RNA polymerase II transcription complex. Knock down 
analysis by RNA inhibition results in early embryonic arrest in C. elegans 
(Kostrouchova, et al., 2002), suggesting a critical role in development. The RT -PCR 
findings are therefore unsurprising, showing a constant level of expression at all stages 
tested. The spatial expression pattern revealed by wholemount in situ hybridisation 
suggests expression in the pronephric tubules from stage 27. The specificity of Skp 1 
expression in the pronephric tubules, together with an identified developmental role in 
C. elegans, suggests a possible role in development which would make it an attractive 
gene for further analysis. 
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Fig. 3.131n situ hybridisation analysis of clones 6CS and 18B1. In situ hybridisation using 
clones that were identified using the (RA + NA) probe. Clones were analysed with 
both antisense and sense RNA probes as indicated. (A) Spatial expression of mRNA 
corresponding to the transcript of the clone 6CS; From stages 27 to 31 (i, ii), there is 
staining with the antisense probe in the brain (br) and the eye (e) which is not present in 
the sense control embryos (iv, v). At stage 39 staining is present in the somites (s) and 
the head (h) of both antisense, iii, and sense probe, vi, treated embryos. (B) Spatial 
expression of mRNA corresponding to the transcript of the clone 18Bl; The brain (b) is 
highlighted in stage 25 antisense embryos (i). Stage 28 (ii) antisense probe treated 
embryos show expression in the pronephros (p), notochord (n), brain, (br), otic vesicle 
(0), eye (e) and the branchial arches (b). Later tail bud embryos (iii and magnified iv) 
show RNA expression in the tubules (t), branchial arches (b) and the nasal pit (np). 
Sense control embryos are clear in all the stages tested (v, vi, vii and magnified viii). 
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Clone Qa4 encodes a hypothetical protein, LOC398467, UniGene x1.21907. A revised 
BLAST on the NCBI website (www.ncbLnlm.nih.gov/BLASTI) (Basic Local 
Alignment Search Tool, Altschul, et al., 1990) search revealed 83% identity to the X. 
tropicalis vitamin K epoxide reductase complex. subunit 1. Vitamin K epoxide 
reductase complex is the enzyme responsible for reducing and so activating vitamin K 
2,3-epoxide in blood clotting. It is found predominantly in the liver, but can also be 
found in the kidney (Thijssen, et al .. 1986). Kidney, liver and blood tissues of Xenopus 
laevis originate from the mesodermal layer of the embryo. It is therefore surprising that 
expression is seen in the ectodermal layer of the gastrula. Pronephric expression of this 
gene is detected around the time the kidney first begins to function, in late tail bud 
embryos. Expression may therefore be induced as the tissue begins to function. If this 
is the case, expression within the liver would be expected from stage 42 as the liver bud 
grows. 
Clone llal encodes a sequence identified as the Xenopus UniGene cluster x1.15910 
coding for the hypothetical protein JC7. A revised search of this UniGene cluster 
revealed a 56.08% amino acid identity to the rat nuclear ubiquitous casein kinase 2. 
Nuclear ubiquitous casein kinase 2 is involved in cell growth, proliferation and survival 
(Yu, et al., 2001). The high level of expression, therefore. observed during the embryo 
stages tested could be due to the high level of cell growth and proliferation during 
Xenopus development. Nuclear ubiquitous casein kinase 2 may also have a role in 
neural crest cell development as the strong expression seen in the migrating neural crest 
cells was followed through to some neural crest containing tissues, the branchial arches, 
brain and pronephros. 
Searches using the clone ~b2 sequence identified the clone as the Xenopus NADH 
dehydrogenase 1 alpha subcomplex, rather than the Bos taurus similar to NADH 
dehydrogenase. Although an important respiratory mitochondrial protein, and therefore 
expected to be ubiquitous, whole mount in situ hybridisation show strong expression in 
the developing tail bud pronephros. Expression is seen, however, in many actively 
developing tissues and is relatively absent from the undeveloped endoderm until later 
stages. Expression appears to be only present in tissues undergoing high energy 
requiring processes as anticipated of a respiratory mitochondrial protein. 
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A revised search using clone Uc7 sequence identified hypothetical protein MGC80798, 
UniGene xl.24 149. The hypothetical protein has approximately 40% amino acid 
similarity with lysosome-associated membrane glycoprotein I precursor, a protein 
involved in intracellular transport and spermatogenesis (Falcon-Perez, et al., 2005 and 
Moreno, 2003). Wholemount in situ hybridisation indicates specific expression in the 
blood islands and the pronephric tubules. The temporal expression pattern does not 
align with pronephric development and so is unlikely to play any role in the 
development of this organ. 
Clone 41b2 encodes Xenopus FRGYl, an activational Y box transcription factor. 
FRGY J is believed to be a ubiquitous transcription factor providing basal levels of 
transcriptional activity for the transcription factor IlIA gene in somatic cells (Tafuri and 
Wolffe, 1990 and Ranjan, et al., 1993). Northern analysis demonstrated up-regulation 
of mRNA in developing oocytes, however translation was repressed. FRGYI mRNA 
was found to be stored in mRNP storage particles and then transported to the ribosomes 
prior to transcriptional activation of the zygotic genome (Tafuri and Wolffe, 1993). 
Northern analysis also showed up-regulation during gastrulation, which was confirmed 
in this study by RT-PCR analysis, however there was no enrichment in the pronephric 
tissues. Northern analysis of adult Xenopus organs indicated high expression in the 
metanephros (Tafuri and Wolffe, 1990), although in this work pronephric expression 
was only seen in the mid tail bud stages, not later, by whole-mount in situ hybridisation. 
Clone 6C5, human Selenoprotein W, is a selenium incorporated protein important in 
muscle metabolism and immune response (Brown and Arthur, 2001). Wholemount in 
situ hybridisation reveals little staining suggesting that this gene plays little role in 
development and may be a false positive from the screen. 
Clone 18B I encodes VPS28, a class E vacuolar sorting protein involved in intracellular 
transport (Rieder, 1996). Of the clones resulting from the screen, clone 18B 1 is the only 
clone to down regulate at stage 13, making it unlikely to be involved in pronephric 
induction. Wholemount in situ hybridisation analysis however. indicates very specific 
late expression in the pronephric tubules which could indicate a role in development or 
tubule function. 
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Despite the clones originating from a stage 13 cDNA library, wholemount in situ 
hybridisation analysis suggested few of the clones were expressed at stage 13 at 
significant levels (data not shown). The RT-PCR data indicates that all clones are 
expressed at stage 13. This demonstrates the relative insensitivity of the wholemount in 
situ hybridisation to RT-PCR, as a method of detecting mRNA transcripts. 
Not all clones identified in the screen were expressed in the pronephros. The clones 
resulting from the screen were expressed during retinoic acid and activin A treatment in 
animal caps. This combined treatment of retinoic acid and activin A in animal caps 
does not only induces pronephric tissues, but also anterior and posterior neural tissue, 
cardiac tissue and pancreatic tissues (Haldin, et al., 2003 and Moriya, et al., 2000). 
Therefore, although it is expected that a high proportion of these genes are expressed in 
the pronephros, not all genes identified in such a screen will be. Furthermore, the 
screen does not account for the down regulation of genes. If any of the animal cap 
treatments were to down regulate a gene, then it may be picked up by the probes as a 
false positive. 
None of the clones in the screen were expressed uniquely in the pronephros, as revealed 
by wholemount in situ hybridisation analysis. However, all the clones were expressed 
in the pronephros, shown by RT-PCR, and, except 18BI, were up regulated at stage 13. 
The pronephric expression, however, was not enriched, as compared to the whole 
embryo. For these reasons, it is unlikely that the clones resulting from the screen are 
specific pronephric development genes and were not analysed further by mis-expression 
experiments in this work. 
During the course of this work the wholemount in situ hybridisation protocol was 
refined. Earlier methods (Methods 2.6.4 Wholemount in situ hybridisation) resulted in 
a high level of background staining as indicated by the hybridisation of control sense 
DIG-labelled RNA probe. The clones highlighted in this screen were all analysed using 
the original whole-mount in situ hybridisation protocol. The high level of background 
masked the true expression pattern of some of these clones. In situ hybridisation was 
repeated using the new protocol and for some of the clones (18B I, ~f6, lib2, lic? and 
41b2) the expression patterns were greatly improved. The expression patterns shown in 
this work include the improved data. Therefore, although some of the clones, 18B I and 
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~f6, appear to be ideal candidates for further analysis, they were not chosen in the early 
stages of this work based on the information available at the time. 
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Analysis of potential pronephric UniGene cluster genes 
4.1 Introduction 
The second method of identifying potential pronephric development genes was to 
analyse four UniGene cluster genes that had previously been found to be expressed in 
the pronephros. These UniGene cluster genes were selected using wholemount in situ 
hybridisation on stage 27 Xenopus laevis embryos using an EST from the cluster 
(Personal communication from Pollet, N.). 
The NCBI UniGene site 
The UniGene site, part of the National Center for Biotechnology Information service 
(www.ncbi.nlm.nih.gov), automatically groups submitted EST sequences into a non-
redundant set of gene-oriented clusters (Wheeler, et al., 2(05). The system was used to 
find unique genes by aligning EST sequences using statistically significant sequence 
similarity in the 3' UTR and identifying gene sequence characteristics. Related EST 
sequences were classed under one UniGene cluster. UniGene clusters were also 
generated containing EST sequences that contain possible homologous genes across 
organisms. Today, more than 26,980 3'-anchored Xenopus UniGene clusters exist, a 
number which is updated every 2 months. The UniGene sets are put into a public 
searchable database (www.ncbLnlm.nih.gov), which contains other relevant gene 
centred information, such as homologies and expression profiles. 
UniGene cluster gene analysis 
4 UniGene cluster genes were identified by N. Pollet (Faculte de Medicine, Universite 
de Rennes, Rennes, France) as having a distribution that included the pronephros. We 
were kindly given the UniGene cluster numbers for these clones. The spatial expression 
pattern of the UniGene cluster genes was analysed using wholemount in situ 
hybridisation with a representative EST, at a variety of embryonic stages using both 
antisense and control sense DIG-labelled RNA probes. In addition, the temporal 
expression pattern was elucidated by RT-PCR using RNA from various stages of whole 
embryo and pronephric tissue. 
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4.2 Results: Temporal and Spatial expression patterns of UniGene cluster 
genes 
The UniGene cluster genes whose expression included the pronephros (Personal 
correspondence from Pollet, N.), are numbered x1.511O, x1.5983, x 1.1 2848 and x 1.1 6795. 
The preliminary wholemount in situ hybridisation data carried out in France showed 
that U niGene cluster genes xl.5110 and xl.5983 are expressed in the pronephric tubules 
and xl.12848 and xl. I 6795 are expressed in the glomus of early tail bud embryos. In 
this study, the temporal and spatial expression patterns of the UniGene cluster genes 
were analysed by RT-PCR and wholemount in situ hybridisation, using a representative 
EST, to confirm and further elucidate their roles in pronephric development. 
Temporal expression patterns of UniGene cluster genes 
RT-PCR was used to investigate the expression of UniGene cluster genes during 
important stages in the development of the pronephros. Primers were designed to give 
PCR products of between 150-400bp using a representative EST for each UniGene 
cluster gene (Methods Table 2.1). The ESTs representing the UniGene cluster genes 
were chosen to cover the whole coding sequence and the maximum amount of 3' UTR. 
Primers were designed to incorporate 3' UTR where possible to increase PCR 
specificity. The cDNA used in the RT-PCR was prepared from Xenopus laevis embryos 
grown to stages 9, 13, 16, 21, 26, 30, 35 and unfertilised eggs (Methods 2.6.2 RT-
PCR). The relative expression of the UniGene cluster genes within the pronephros, or 
the presumptive pronephric region, compared to the whole embryo was analysed. This 
was carried out by performing RT-PCR with the cDNA isolated from dissected 
pronephric tissue along with the whole embryo at stages 12Y2, 15, 20, 28 and 35 
(Methods 2.6.2 RT-PCR). 
All of the selected UniGene cluster genes were found to be expressed in unfertilised 
eggs and were therefore maternally expressed (Fig. 4.1). As the majority of 
transcription does not occur until the mid-blastula transition, maternal expression plays 
a critical role in early development until stage 7-8. This suggests that these UniGene 
cluster genes may have a role in directing the earliest stages of Xenopus development. 
Development of the three components of the pronephros are initiated at stage 13-14. 
Genes that are up regulated in this region at stage 13 may be involved in pronephros 
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Fig. 4.1 Temporal expression patterns of selected UniGene cluster genes. RT-PCR analysis 
of UniGene c1u ter gene ex pres ion in an embryo stage series. RT-PCR was carried out 
on embryos of stages from unfertili ed eggs to stage 35. UniGene cluster genes are 
labelled vertically and embryo tages with controls are labelled horizontally. Input 
cDNA was approximately equalised using the ubiquitou Iy expressed gene ODe, and a 
linearity using doubling dilution of stage 35 cDNA was performed. Negative controls 
were (-RNA) no RNA in the sample during RT reaction , C-RT) no reverse transcriptase 
in sample during RT reaction and C-) no cDNA in PCR reaction. 
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initiation. Between stages 16 and 30, the pronephric anlagen is formed and extends 
along the anterior-posterior axis and at stage 35, the pronephros is functional. It is 
expected that the temporal expression pattern of a gene involved in pronephric 
development would alter at these stages. The temporal expression of the 4 UniGene 
cluster genes, however, remained constant throughout the stages tested (Fig. 4.1). 
Figure 4.2 shows that all the UniGene cluster genes were expressed in the pronephros 
and presumptive pronephric tissue, however, there was little, if any, enrichment in these 
samples relative to the whole embryo. The exception being x1.5983, at stage 28 where 
expression in the pronephric tissues appeared to be greater than that within the whole 
embryo. However, this result was not repeatable and was probably due to pipetting 
error in the RT -PCR assay (Data not shown). 
Spatial expression patterns of UniGene clusters 
An EST from the database was chosen for each of the UniGene cluster genes which 
included a ATG and a stop sequence, thus including the full length coding region. This 
EST was then acquired from the IMAGE consortium (http://image.llnl.gov/). Table 4.1 
includes the details of the clones ordered. 
Wholemount in situ hybridisation was used to analyse the spatial expression patterns of 
the selected UniGene cluster genes. Both antisense and sense RNA DIG labelled 
probes were used on Xenopus albino (homozygous and heterozygous) embryo stages 10 
to 41 (Methods 2.6.4 Wholemount in situ hybridisation). The antisense probes were 
made by digesting the IMAGE plasmids at the 5' end of the EST insert and transcribing 
with either SP6, T3 or T7 polymerase (Table 4.1). Similarly, the sense probes were 
made by digesting the IMAGE plasmids at the 3' end of the EST insert and transcribing 
with either SP6, T3 or T7 polymerase (Table 4.1). 
Wholemount in situ hybridisation investigation of UniGene cluster gene xl.5110 
(represented by EST BE508547) revealed expression in the neural folds and the eye 
placodes of stage 20 embryos. In mid tail bud stages, expression was seen in the 
somites, the eye and the adhesive organ. The first indication of pronephric expression 
was in the tubules at stage 31 and continued to stage 39. The control sense probe 
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Fig. 4.2 Temporal expression patterns of selected UniGene clusters genes in dissected 
kidney anlagen. RT-PCR analysis of UniGene cluster gene expression in dissected 
presumptive pronephros compared to whole embryo. mRNA was extracted from whole 
embryo (w), or di sected pronephric or presumptive pronephric tissue (k). UniGene 
cluster genes are labelled vertically and embryo stages with controls are labelled 
horizontally. Input cDNA was approximately equalised using the ubiquitously 
expressed gene ODe, and a linearity using doubling dilutions of stage 35 cDNA was 
performed. Negative controls were (-RNA) no RNA in the sample during RT reaction, 
(-RT) no reverse transcriptase in sample during RT reaction and (-) no cDNA in PCR 
reaction. 
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Antisense Sense 
UniGene GenBank IMAGE Plasmid Restriction RNA Restriction RNA 
Cluster EST number enzyme polymerase enzyme polymerase 
xl.5110 BE508547 3397387 pCMV -SPORT6 SpeI SP6 KpnI T7 
xl.5983 BC043955 5571335 pCMV-SPORT6 Kpn I T7 Xho I SP6 
x1.12848 CA974150 6326648 pBLUESCRIPT SK KpnI T3 Not I T7 
x1.16795 CA981992 6870563 pBLUESCRIPT SK Kpnl 
.. _. __ !3 Not I T7 
Table 4.1 IMAGE consortium data and preparation of antisense and sense RNA DIG labelled probes for initial wholemount in situ 
hybridisation. UniGene clusters, chosen representative EST sequences and IMAGE consortium data. Wholemount in situ hybridisation was 
performed using antisense DIG labelled RNA probe. The probes were made by digesting the plasmids at the 5' or 3' end of the EST insert and 
transcribing with either SP6, T3 or T7 polymerase as shown. 
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treated embryos showed little staining, implying minimal background colouring (Fig. 
4.3A). 
The expression of UniGene cluster gene xl.5983 (represented by EST BC043955) was 
not visible by wholemount in situ hybridisation until stage 30, where it was observed in 
the glomus, eye socket, and adhesive organ. Later tail bud embryos displayed 
continued expression in the glomus and eye with additional expression in the branchial 
arches. Background, indicated by control sense probe analysis, was present in the eye, 
suggesting the eye staining may be unspecfic (Fig. 4.3B). 
Spatial expression pattern analysis of UniGene cluster gene xl.12848 (represented by 
EST CA974 I 50) revealed expression in the tubules, eye, auditory vesicle and branchial 
arches of stage 28 embryos when cleared. Pronephric tubule expression is continued to 
stage 39 where low level expression is also seen in the pronephric duct. Control sense 
probe treated embryos showed staining in the eye, suggesting that the eye staining is 
non-specific (Fig. 4.4A). 
Wholemount in situ hybridisation using UniGene cluster gene xl. 16795 (represented by 
EST CA98 1992) revealed expression in the eye placodes and neural folds of stage 20 
embryos. Expression was seen in the brain and eye of tail bud embryos. Pronephric 
staining was only weakly present in late tail bud embryos. Background staining was 
minimal, as indicated by control sense probe staining (Fig. 4.4B). 
4.3 Discussion: Potential future analysis of UniGene cluster genes 
The UniGene cluster numbered xl.5110 consists of one EST, BE508547, that has 
homology to the Arabidopsis extensin-like protein (32.45 % amino acid similarity) 
(www.ncbLnlm.nih.gov). The initial wholemount in situ hybridisation indicated 
expression in the pronephric tubules and brain in early tail bud embryos. The 
pronephric tubule expression was confirmed and appears between stage 25 and 30 (Fig. 
4.3A). The temporal expression of the UniGene cluster gene remained constant 
throughout the stages tested and was unchanged during important events in pronephric 
development (Fig. 4.1). Comparative pronephric and whole embryo RT -PCR indicated 
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Fig.4.3 In situ hybridisation analysis of UniGene cluster genes xl.51l0 and x1.5983. In situ 
hybridisation of UniGene cluster genes. DIG-labelled RNA probes were made using 
representative ESTs and were either antisense or sense as indicated. (A) Spatial 
expression of mRNA transcribed from EST BE508547 representing UniGene cluster 
gene xl.51l0; Antisense probe staining is observed in the neural folds, n and the eye 
placodes, e, of stage 20 embryos (i). At stage 31, uncleared embryos (ii) show 
expression in the somites, s and the head region, h, including the eye and the brain (ii). 
Cleared stage 31 embryos (iii) indicate additional expression in the tubules, t and the 
otic vesicle, o. Later at stage 39 (iv, magnified and cleared v), embryos continue to 
have staining in the head region, h, including the otic vesicle, 0, and the eye, but 
excludes the adhesive organ, a. Again, the cleared embryos, (v) reveal expression in the 
tubules, t. Sense probe treated embryos (vi, vii and viii) are unstained, with some 
colouring in the eye, e, at stage 39. (B) Spatial expression of mRNA transcribed from 
EST BC043955 representing UniGene cluster gene xl.5983; There is little expression 
until stage 30 (i and cleared ii), where there is staining in the glomus, g, eye, e, and 
surrounding the adhesive organ, a. When cleared (ii) the expression in the eye includes 
the eye socket, es. Stage 39 antisense treated embryos (iii, magnified iv) indicates 
continued expression in the glomus, g, and some staining in the eye, e, and branchial 
arches, b. Sense control embryos (v, cleared vi, and vii) have some low level 
background staining in the eye, e. 
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no enrichment in pronephric tissue, where expression was reduced compared to whole 
embryo beyond stage 20 (Fig. 4.2). 
The UniGene Cluster numbered xl.5983 contains 122 EST sequences, 2 of which 
include the start site and the poly-adenylation signal. Conceptual translation revealed 
60-90% protein sequence similarity with GOP dissociation inhibitor of various 
organisms (www.ncbi.nlm.nih.gov). GOP dissociation inhibitors regulate rad GTP-
binding proteins by inhibiting GOP-GTP conversion during intracellular transport. 
Expression was not found in the Xenopus adult kidney of 7719 ESTs tested, but was 
found in the adult human. in 10 1 of 180994 ESTs. and in the adult mouse, in 82 of 
117542 ESTs (www.ncbLnlm.nih.gov). Although the preliminary wholemount in situ 
hybridisation (Personal correspondence from Pollet, N.), showed expression in the 
pronephric tubules, the UniGene cluster gene xl.5983 expression was found only in the 
glomus (Fig. 4.3B). This discrepancy is due to the difficulty in separating these two 
structures at stage 27. The staining in the glomus appeared to be very weak, especially 
when contrasted to the signal in the eye. The temporal expression decreased during the 
period of pronephric anlagen elongation, stages 20-30, and increased as the pronephros 
began to function (Fig. 4.1). Furthermore pronephric expression was reduced compared 
to the whole embryo in the stages analysed (Fig. 4.2). This expressional behaviour is 
not indicative of a pronephric development gene. 
The UniGene cluster numbered xl. 1 2848 (previously numbered x1.4229) consists of 85 
EST sequences, one of which includes the start site and the poly-adenylation signal. 
Hypothetical translation indicated 85-90% amino acid sequence similarity to human and 
mouse alpha 3 type IV collagen binding protein, a major constituent of the basement 
membrane (www.ncbLnlm.nih.gov). Introductory wholemount in situ hybridisation 
(Personal correspondence from Pollet, N.), showed expression in the glomus in early 
tail bud embryos. Whole mount in situ hybridisation performed in this study revealed 
expression in the tubules, not the glomus (Fig. 4.4A). As before, this inconsistency 
could be due to difficulty in distinguishing tubules and glomus tissue at stage 26. The 
glomus was only visible when the stage 30 embryo had been cleared, however, RT -PCR 
analysis indicates pronephric expression in all stages tested (Fig. 4.2). Since the initial 
analysis, alpha 3 type IV collagen binding protein has been implicated in podocyte 
function, specifically in diabetes (Chen, et aI., 2004). 
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Fig.4.4 In situ hybridisation analysis of UniGene cluster genes xl.12848 and x1.16795. In 
situ hybridisation of UniGene cluster genes. DIG-labelled RNA probes were made 
using representative ESTs and were either antisense or sense as indicated. (A) Spatial 
expression of mRNA transcribed from EST CA974150 representing UniGene cluster 
gene xl.12848; Little staining is seen in uncleared antisense treated embryos at stage 28 
(i), except in the eye. e. Cleared stage 28 embryos (ii). show expression in the glomus. 
g. eye. e. otic vesicle. 0, and the branchial arches. b. Some staining is seen in the 
pronephros at stage 39 (iii. magnified iv), specifically in the tubules, t. and faintly in the 
anterior duct. d. Control sense probe treated embryos (v. cleared vi and vii) indicate 
little background staining, with the exception of the eye. e. (B) Spatial expression of 
mRNA transcribed from EST CA98 1992 representing UniGene cluster gene x1.16795; 
Expression is first seen at stage 20 (i), in the anterior neural folds. n. and the eye 
placodes, e. Early tailbud embryos (ii). reveal expression in the brain. br. otic vesicle. 
0, and eye, e. The brain, br, and eye, e, expression continues in stage 29 embryos, (iii). 
Stage 39 antisense probe treated embryos (iv). display colouring in the head. h. and 
faintly in the pronephric region, p. Sense probe treated embryos (v, vi, vii and viii) are 
clear, except for some non specific eye. e, staining. 
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The UniGene cluster numbered xl.l6795 was renamed x1.2936 during the course of this 
study and although no homologies have been found, the hypothetical translation is 
known as protein LOC496295 (www.ncbi.nlm.nih.gov).Initial whole mount in situ 
hybridisation (Personal correspondence from Pollet, N.), showed expression in the 
glomus in early tail bud embryos. Unfortunately the wholemount in situ hybridisation 
performed in this study was unable to confirm this observation. The data indicated that 
the UniGene cluster gene xl.16795 was expressed very weakly in the pronephros at 
stage 39, however, due to the weak staining, it is unclear whether the glomus or the 
tubules was stained (Fig. 4.4A). The temporal expression was constant throughout the 
stages tested and there was no enrichment of expression within the dissected pronephric 
tissue (Fig. 4.1 and Fig. 4.2). The low level of pronephric expression and temporal 
expression behaviour are not consistent with a pronephric development gene. 
These UniGene cluster genes were investigated after showing highly specific 
wholemount in situ patterns, identified by N. Pollet (Faculte de Medicine, Universite de 
Rennes, Rennes, France). However, since publication of other UniGene cluster gene 
expression patterns, an issue of UniGene cluster numbering has led to considerable 
confusion (Pollet, et at., 2005). This may explain why that although all UniGene cluster 
genes were found to be expressed in the pronephros, they were not all expressed in the 
regions expected. 
Wholemount in situ hybridisation analysis of the 4 UniGene cluster genes indicated 
specific, though weak, expression in the pronephros (Fig. 4.3A-B and Fig. 4.4A-B). 
These data contrasted with the high level of specificity which originally led to the 
acquisition of these clones. Furthermore, RT-PCR data revealed that the 4 UniGene 
cluster genes were expressed in the pronephros (Fig. 4.2). The pronephric expression, 
however, was not enriched, as compared to the whole embryo and temporally, the 
expression did not alter with respect to pronephric development (Fig. 4.1 and Fig. 4.2). 
For these reasons, the UniGene cluster genes were not investigated further by mis-
expression experiments in this work. 
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Pod 1 and Darmin r are expressed in the developing pronephros 
5.1 Introduction 
The first two methods of identifying potential pronephric development genes were to 
screen a stage 13 cDNA phagemid library using a subtracted probe and to analyse four 
cDNA sequences that had previously been found to be expressed in the pronephros. 
The third method was to review the current literature and select potential genes of 
interest. The genes were chosen on the basis of their expression pattern and functional 
analysis in either Xenopus or mouse. Two genes were chosen after consideration of the 
literature and were subjected to further temporal and spatial expression analysis by RT-
PCR. Clones were obtained for the two chosen genes from existing NCBI EST 
databases (www .ncbi.nlm.nih.gov). 
5.1.1 Pod 1 
During development, basic helix-loop-helix transcription factors are involved in cell 
lineage commitment and organogenesis. They bind to E box regions (CANNTG) 
(Murre, et al., 1989) and are classified into two groups, ubiquitous class A and tissue 
specific class B (Lassar, et al., 1991). Pod 1, also known as Epicardin, Capsulin, 
Transcription factor 21, is a class B basic helix-loop-helix transcription factor (Hidai, et 
ai., 1998, Quaggin, et al., 1998, Robb, et al., 1998). 
Mouse Pod 1 expression 
In murine development, whole mount in situ hybridisation suggests Pod 1 is first 
expressed 8.5 dpc in the heart (Lu, et al., 1998). Detailed analysis was carried out using 
wholemount in situ hybridised and sectioned 13.5 dpc mouse embryos. This showed 
expression in the proepicardial organ of the heart and the mesenchymal cells 
surrounding epithelium of the gut, lungs and metanephros (Hidai, et al., 1998, Lu, et al., 
1998 and Robb, eta!., 1998). 
In the analysis of adult mouse tissues, RT-PCR revealed highest expression in the lung 
then the ovary, spleen, kidney, intestine, uterus and heart (in order of expression levels) 
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(Hidai, et al., 1998). Wholemount in situ hybridisation analysis, however, indicated 
that expression was restricted to the podocytes lining the glomerulus, interstitial cells of 
the heart, interstitial cells within the alveolar wall, the submucosa of the gut and urinary 
bladder and the stroma of the uterus (Lu, et al., 1998). 
Role of Pod 1 in mouse development 
Pod J has been shown to have multiple roles in vertebrate development. The Pod 1 null 
mouse died from multiple organ failure with hypoplastic lungs and kidneys and 
aspleenism. The post mortem analysis revealed failure of the lung epithelium to 
undergo branching morphogenesis, resulting in the absence of alveoli. The kidneys also 
had severe branching defects and lacked mature glomeruli and the splenic area was 
devoid of cells (Quaggin, et al., 1999 and Lu, et al., 2000). 
From studying neonatal knock-out mice, Pod J appeared to have a role in ureteric bud 
branching and the differentiation of cell groups within the nephron (Quaggin, et al., 
1999). During development, ureteric branching was reduced both in the number of 
branches and the number of ureteric branch tips (Quaggin, et al., 1999), suggesting a 
critical role in branching morphogenesis. 
Pod J may also have a role in the conversion of condensing mesenchyme into nephric 
epithelium. The loss of Pod 1 resulted in the increase of metanephric condensing 
mesenchyme (Quaggin, et ai., 1999 and Cui, et ai., 2003). Differentiation of the 
condensing mesenchyme, specifically into S-shaped bodies and capillary loop 
glomeruli, was delayed in chimeric mice (chimeric mice were generated by combining 
null Pod 1 and heterozygous Pod 1 ES cells with wild type embryos) (Quaggin, et al., 
1999). Differentiation was delayed rather than blocked, as at birth, a small number of 
capillary loop glomeruli were found that were formed from null Pod 1 cells (Quaggin, 
et al., 1999). 
Pod 1 is involved in the terminal differentiation of specialised cell types in the kidney. 
In chimeric mice, a few nephrons were formed from null Pod 1 cells that have normal 
tubular structures, however, their proximal tubular cells lacked the specialised brush 
border (Quaggin, et al., 1999). In the glomerulus, podocytes were specified but failed 
to undergo terminal differentiation and formed no foot processes (Quaggin, et al., 1999 
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and Cui, et at., 2003). Spindle-shaped cells were missing from null Pod J mice kidneys 
and in chimeric mice kidneys were only formed by GFP wild type cells, implying a cell 
automonous role in spindle-shaped cell development. The condensing mesenchyme of 
null Pod J mice kidneys does not develop, whereas in chimeric mice kidneys the 
condensing mesenchyme will develop in the presence of GFP wild type stromal cells. 
This indicates a non cell automonous role of Pod J. Therefore the role of Pod I in 
differentiation may be both cell autonomous and non cell automonous (Cui, et at., 
2003). 
It has been proposed that Pod 1 has a role in patterning the airways of the lungs 
(Quaggin, et aI., 1999). Knock-out studies have shown that structurally, there are 
abnormal bronchi, reduced primordial tubules, a lack of acinar tubules and no terminal 
alveoli. RT-PCR analysis has indicated an increased expression of early lung 
specification markers and a reduced expression of terminal differentiation markers in 
null Pod I embryos. Compromised lung function due to missing alveoli and type II 
pneumocytes is the primary cause of neonatal fatality. 
Early markers of spleen specification were present in null Pod 1 embryos at 12.5 dpc. 
However, at birth null Pod J mice lacked any spleen tissue. Analysis of TUNEL 
staining revealed an increase in apoptotic cell death in the splenic lineage-forming-
region of null Pod 1 embryos. Pod J may therefore be required for the proliferation and 
survival of the splenic lineage (Lu, et al., 2000). 
In skeletal muscle, exogenous expression of Pod J has been shown to inhibit the 
terminal differentiation ofC2C12 myoblasts (Funato, et aI., 2003). Myo R-1- and Pod r 
1- mice, however, lose mastication muscles originating from the primary branchial arch 
and possess a cleft palate and a defective diaphragm (Lu, et ai., 2002). The role of Pod 
I in skeletal muscle development is therefore unclear. 
Pod J is also involved in gonadogenesis. At 13.5 dpc Pod J was strongly expressed in 
the male and weakly expressed in the female mouse. Later, at 3 months, high 
expression was seen in the female and low expression was seen in the male mouse. 
This suggested a role in male/female specification. Pod 1 and SF I, a regulator of 
sexual differentiation, have complementary expression patterns (Tamura, et at., 2001). 
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Null Pod 1 male mice were externally feminised. The testes failed to descend, lacked 
testicular cords and were in some cases attached to the adrenal glands. Similarly, in 
female mice the ovaries were also attached to the adrenal gland and remained close to 
the kidneys (Cui, et al., 2004). Pod 1 has been shown to transcriptionally repress 
steroidogenic factor I in Leydig derived cells (Tamura, et al., 2001, Cui, et al., 2004). 
However, over-expression of SF 1 does not phenocopy the Pod 1 knock-out animal 
(Cui, et al., 2004). 
Pod 1 is also required for capillary remodelling, chimeric null Pod 1 mice have large, 
dilated and poorly organised vascular structures (Cui, et al., 2003). Pod 1 knock-down 
using antisense oligonucleotides, inhibited the differentiation of stratified cells to 
differentiated epithelia in stomach tissue cultures in the presence of I JlM 
hydrocortisone. Furthermore, gland formation and mucin granule formation were 
inhibited using Pod 1 morpholino oligonucleotides (Andersson, et ai., 2001). This 
indicated that Pod 1 may also playa role in stomach epithelium development. 
Dimerisation of Pod 1 
As a group/class B basic helix-loop-helix transcription factor, Pod J is expected to 
either form homodimers or heterodimerise with group A basic helix-loop-helix 
transcription factors. Although a number of studies have been carried out, it is unclear 
which is the case in vivo. Gel mobility shift assays using E-box sequences as the probe 
have shown that Pod 1 alone does not bind to DNA, but a heterodimer of Pod 1 and E12 
does bind to DNA (Lu, et at., 1998). Yeast two-hybrid screens have identified other 
possible Pod I heterodimer complexes, HEB, HEB-s and ITF-2 (Miyagishi, et ai., 
2000a, Miyagishi, et at., 2000b). However, sequence analysis and in vitro experiments 
have shown that Pod 1 alone is capable of binding cognate E-box consensus sequences 
and activating transcription (Hidai, et ai., 1998). 
Pod 1 and transcription 
Using Gal4-fused Pod 1 deletion mutants, Pod 1 has been shown to exhibit both 
activational and repressor activities, depending on cell line. The C-terminal region of 
Pod 1 was able to activate transcription in HTlO80 and HeLa cells and the C-terminus 
and N-terminus were able to repress transcription in HepG2 cells. The bHLH region 
was unable to affect transcription (Miyagishi, et al., 2000). 
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To identify the Xenopus Pod J homologue, the human Pod I protein sequence (043680) 
was used to search the translated NCBI database by using the tBLASTn software (Basic 
Local Alignment Search Tool, Altschul, et al., 1990). Conceptual translation of the 
Xenopus EST CF270487 gave 82.3% identity with the human Pod I protein sequence 
and was chosen for further investigation. 
5.1.2 Darmin r 
Darmin-related was identified by a direct secretion screen (Pera, et al., 2003). The 
technique involved transfecting human 293T cells with pools of cDNA from a Xenopus 
expression library. The newly translated proteins were labelled using 35S methionine or 
cysteine and were isolated using SDS PAGE and autoradiography. Single positive 
clones were selected in a second cycle of screening and partially sequenced (Pera and 
De Robertis, 2000). 
Analysis of Xenopus Darmin r showed expression in the glomus and the eye of stage 32 
embryos. Temporal RT-PCR revealed high levels of maternal expression and later 
zygotic expression in late tail bud embryos. Over expression of Darmin r did not 
indicate any endodermal phenotype, no morpholino knock-down was carried out and 
there was no specific analysis of pronephric structures (Pera, et al., 2003). 
Darmin r, registered as EST BU993920, showed 99% identity to Xenopus laevis 
cytosolic non-specific dipeptidase, UniGene cluster xU 0218. Cytosolic non-specific 
dipeptidase has a broad specificity and is inhibited by bestatin, a known peptidase 
inhibitor (Lenney, 1985). Optimum degradation of carnosine by human Cytosolic non-
specific dipeptidase was found to be at pH 9.5 in the presence of 0.1 mM Mn2+. The 
presence of magnesium ions was found to be critical for activity. The enzyme has a 
specific activity of 1.0Ilmormin/mg of histidine formed as obtained at pH 9.5 from 
1.8 x 109 transiently transfected CHO cells. Human Cytosolic non-specific dipeptidase 
has a molecular mass of 52.8 kDa and forms a homodimer of 90 kDa. 
Cytosolic non-specific dipeptidase (also known as tissue carnosinase and carnosine 
dipeptidase II) is in the metallopeptidase family M20, specifically M20.005, which are 
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generally involved in the hydrolysis of dipeptides in the cytosol of mammalian cells 
(MEROPS: Rawlings, et al., 2006). 
The first isolations by Hanson and Smith, of cytosolic non-specific dipeptidase in 1949 
were contaminated with the related serum carnosinase (also known as carnosine 
dipeptidase II. carnosinease I. glutamate carboxypeptidase-like protein 2) therefore 
much early work was subject to confusion. It was not until 1990 that the two 
dipeptidases were individually characterised by Lenney and colleagues (1990). 
Human cytosolic non-specific dipeptidase is ubiquitously expressed throughout adult 
tissues, with high expression in the kidney and liver (Teufel, et al., 2003 and Janssen, et 
al., 2005) and in the pig and rat, expression can be found in the kidney, brain and liver 
(Lenney, 1990). The enzymatic properties and spatial expression suggest that it acts as 
a non-selective cytosolic dipeptidase rather than a selective carnosinase and therefore 
may function as a housekeeping enzyme in the catabolism of dipeptidic substrates 
(Teufel, et aI., 2(03). 
5.2 Results 
In this study, the temporal and spatial expression patterns of Pod 1 and Darmin r were 
analysed by RT -PCR and wholemount in situ hybridisation to further elucidate their 
potential roles in pronephric development. 
5.2.1 Temporal expression patterns of Pod 1 and Darmin r 
To analyse the temporal expression patterns of the selected genes, RT -PCR was used. 
Important stages during the development of the pronephros were chosen to provide 
appropriate samples for RT -PCR analysis. For each clone, primers were designed using 
the EST sequences (Pod I. CF270487 and Darmin r, BU993920) to give a PCR product 
of between 150-400bp (Methods Table 2.1). The RT-PCR was performed using cON A 
prepared from Xenopus {aevis embryos grown to stages 9, 13, 16,21, 26, 30, 35 and 
unfertilised eggs (Methods 2.6.2 RT-PCR). Furthermore, the relative expression of the 
two genes within the pronephros, or the presumptive pronephric region, compared to a 
whole embryo at the same stage was analysed. This was carried out by performing RT-
PCR with the cDNA isolated from dissected pronephric tissue along with the whole 
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embryo at stages 12Y2, 15, 20, 28 and 35 (Methods 2.6.2 RT-PCR). The input cDNA 
was approximately equalised using ODC which is ubiquitously expressed, and a 
linearity using doubling dilutions of stage 35 cDNA was performed to ensure 
amplification was in the linear phase. 
Pod 1 
This temporal RT -PCR analysis indicated that Pod 1 expression was initiated by stage 
13 after which there was a gradual increase in Pod 1 expression from stages 16 to 26 
and maintenance at this concentration through to stages 30 and 35 (Fig. 5.1 A). The 
temporal RT-PCR of whole embryo and kidney dissections revealed an increased 
expression of Pod 1 in the developing pronephros compared to the whole embryo (Fig. 
5.lB). No expression was seen in stage 12.5 whole embryos or dissected pronephros, 
thus confirming the initiation of Pod 1 expression at stage 13, the start of neurulation 
and the start of kidney specification. 
Darmin r 
Consistent with published work, Darmin r has been shown to have a high level of 
maternal expression (Pera, et al., 2003). This expression decreased to negligible levels 
at stage 16 and subsequently increased at stage 26 until stage 35 (Fig. 5.1 A). This 
patterning corresponds to the initial high level of maternal expression followed by 
zygotic expression during tail bud stages. Darmin r expression was observed within the 
pronephric tissue dissections, however no elevation in expression in the dissected 
kidney anlagen relative to the whole embryo samples was observed (Fig. 5.1 B). 
5.2.2 Spatial expression patterns of Pod J and Darmin r 
The ESTs identified for Pod 1 (CF270487) and Darmin r (BU993920) from Pera, et al., 
2003 were obtained from the IMAGE consortium (hup://image.llnl.gov/). Pod 1 
antisense DIG-labelled RNA probe was made by digesting the pCMV SPORT 6 
plasmid containing the Pod 1 insert with Eco Rl (5' end of insert) and transcribing with 
T7 RNA polymerase. The control sense probe was made by digesting with Not 1 (3'end 
of insert) and transcribing with SP6 RNA polymerase. Similarly, the Darmin r 
antisense DIG-labelled RNA probe was made by digesting the pCMV SPORT 6 
plasmid containing the Darmin r insert with Eco Rl and transcribing with T7 RNA 
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Fig. 5. I Temporal expression patterns of Pod 1 and Darmin r. (A) RT-PCR analysis of Pod 
1 and Darmin r expres ion in an embryo stage erie. RT-PCR was carried out on 
embryos of stages from unfertilised eggs to stage 35. (B) RT-PCR analy is of Pod 1 
and Darmin r in di ected presumptive pronephros and isolated pronephric regions. 
RT-PCR of gene comparing the whole embryo to the kidney or presumptive kidney 
dissections (Embryo dissections; (w) indicates whole embryo and (k) indicates 
pronephric or pre umptive pronephric tissue) shows enrichment of Pod J, but not 
Darmin r in the pronephric regions. Genes are labelled vertically and embryo stages 
with controls are labeIled horizontally. Input cDNA was approximately equalised using 
the ubiquitously expres ed gene ODC, and a linearity using doubling dilutions of stage 
35 cDNA was performed. 
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polymerase. The control sense probe was made by digesting with Not I and transcribing 
with SP6 RNA polymerase 
Pod I 
Wholemount in situ hybridisation of Xenopus embryos gave little staining before stage 
28 with either the anti-sense probe or the control sense probe, even when visualised 
after clearing the embryos (data not shown). The first indication of specific staining 
was seen initially in the anterior branchial arch and glomus at stage 28 (Fig. 5.2). 
Between stages 28 to 32 the anterior branchial arch, followed by the remaining arches, 
were stained. Hybridisation of antisense probe to the developing glomus was first 
observed from stage 28 and persisted to stage 40, the last stage tested. No hybridisation 
to the glomus was observed in any of the negative control, sense hybridised, embryos. 
At stage 40 the presumptive epicardium, the posterior end of the forming gut and the 
pronephros showed Pod I expression. 
Darmin r 
Expression was first seen by wholemount in situ hybridisation in the adhesive organ 
(cement gland) at stage 21 (Fig. 5.3). Pronephric expression was observed in the 
tubules at stage 32, and continued to stage 42, the last stage analysed. Non-specific 
staining was not observed in the pronephros in any of the stages tested on sense 
embryos. This was not consistent with published work (Pera, et al., 2003), that stated 
that Darmin r was expressed in the glomus. By clearing the stained embryos, tubular 
structures could be identified, confirming that it is the pronephric tubules that are 
stained. Darmin r expression was also present in the eye, auditory vesicle and the 
adhesive organ. The latest stage tested, stage 42, showed antisense probe hybridisation 
in the tubules, not the glomus, and in the pigmented cells of the epidermis. Sense-
probed embryos suggest the staining seen in the head and eye was non-specific, a 
problem with late stage embryos (Fig. 5.3). 
5.3 Discussion: Potential future analysis of selected genes 
Pod J has been shown to have a well established role In mammalian kidney 
development. However, the role of the Xenopus Pod J homologue remains unknown. 
The Xenopus temporal expression pattern is comparable to that observed in mouse 
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Fig.5.2 Pod 1 is expressed in the developing pronephros. Wholemount in situ hybridisation 
with a Pod 1 DIG-labelled antisense (i, iii, iv, vi, vii and viii) and sense (ii, v and ix) 
RNA probe was performed on embryos at the stage indicated. No staining above 
background was present in embryos between stages 9 and 22 (data not shown). First 
observable expression is seen in the glomus, g, and predominantly the anterior branchial 
arch, b, at stage 28 (i). Stage 28 sense RNA probed embryos do not show staining in 
the branchial arch or the glomus. Continued expression is found in the glomus, g, and 
the branchial arches, b, of stage 32 embryos (iii, magnified iv). Sense probe treated 
embryos at stage 32 are unstained (v). Late tail bud antisense treated embryos, stage 40 
(vi, magnified vii and viii), are stained in the glomus, g, proepicardium within the heart, 
pe, and the coelum, c. No non specific staining is seen in the late stage sense control 
embryos, (ix). 
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Fig.5.3 Darmin r is expressed in the developing pronephros. Wholemount in situ 
hybridisation with a Darmin r DIG-labelled antisense (i, iii, v, vii and viii) and sense (ii, 
iv and ix) RNA probe was performed on embryos at the stage indicated. Embryos iii, iv, 
vii, viii and ix were cleared using Murray's solution. No staining was observed in 
embryos between stages 9 and 20 (data not shown). Expression is first seen in the 
adhesive organ at stage 21 (i). Expression in the pronephros is identifiable at stage 32 
(iii) where the tubules, t, appear to be stained. In addition, stage 32 antisense RNA 
probed embryos (iii) have staining in the eye, e, otic vesicle, 0, and the adhesive organ, 
a. Pronephric tubule expression, t, is continued in stage 38 (v) embryos. Late tail bud 
antisense treated embryos, stage 42 (magnified vii and viii), are stained in the tubules, t, 
duct, d and in the ciliated cells of the epidermis, ceo No non specific staining is seen in 
the sense control embryos, (ii, iv and ix), except in the eye, e. 
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embryos. Detection of Pod I in mouse embryos by Northern blot analysis showed first 
expression at 8.5 dpc in the branchial arches, after which there was an increase to 15.5 
dpc where it peaked at and persisted to 17.5 dpc (Hidai, et al., 1998). By comparing the 
developmental stages at the start of neurulation, stage 13 in Xenopus iaevis, 8-9 dpc in 
mouse, the onset of Pod I expression is temporally similar. The increased Xenopus Pod 
J expression in the kidney, compared to the whole embryo was also observed in the 
mouse, where Northern blot analysis at 15.5 dpc revealed higher expression in the 
kidney, lung and intestine than in the whole embryo (Hidai, et al., 1998). In murine 
development in situ hybridisation has revealed expression from 9.5dpc with high levels 
in the presumptive epicardium and the mesenchymal cells surrounding the gut, lung and 
kidney (Hidai, et al., 1998). This may be comparable to the staining pattern in the 
Xenopus laevis stage 40 embryos where expression is observed in the heart, gut and 
kidney, although anterior branchial arch expression is identified earlier. 
In summary, the results from the initial analysis indicated that Pod I had a high level of 
expression in the kidney by both RT-PCR and wholemount in situ hybridisation. In 
addition, this expression was early, around initiation, in the development of the 
pronephros. The early expression also appeared to be restricted to the glomus. To 
conclude, the data implied that Pod I might be involved in early glomus initiation and 
may be an important developmental gene. 
The role of Pod J in development has mainly been studied within the metanephros, the 
most complicated of the three progressive kidney structures. This has meant that much 
of the data has involved the analysis of sophisticated structural phenotypes or highly 
specialised individual cells. The pronephros, however, is the simplest and the earliest of 
the three progressive kidney structures, comprising just one nephron. It is difficult to 
study the pronephros in mammals due to the inaccessibility of the embryo at early 
stages and the speed at which it is formed and degraded. The pronephros is the only 
kidney structure of the larval stages of Xenopus laevis, and forms just under the 
epidermal layer. Therefore, although the role of Pod I in mammalian kidneys has been 
well researched, important information may still be gathered from studying the 
behaviour of the gene in Xenopus at the earliest stages of kidney development. 
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The role of Darmin r or cytosolic non-specific dipeptidase, in development is unknown. 
Hypothetically, a dipeptidase may be involved in signalling, metabolism, and the 
regulation of biologically active peptides. Even though the developmental function of 
Darmin r is unclear, high expression has been identified in the adult kidneys of the rat, 
pig and human (Lenney, 1990, Teufel, et al., 2003 and Janssen, et al., 2(05). Initial 
analysis indicated high pronephric tubule expression in the mid to late tail bud stages by 
wholemount in situ hybridisation, and continued expression within the kidney region 
throughout the stages tested by RT -PCR. The high level tubule expression makes this 
an appealing gene to manipulate due to the exclusivity within one nephron subunit and 
the relative selectivity within the embryo. The high maternal expression, followed by 
mid tailbud zygotic expression is not clearly aligned with the developmental stages of 
the pronephros, but does suggest an important role in development. 
To conclude the whole mount in situ hybridisation analysis of the genes indicated 
specific expression within the pronephros and RT -PCR data revealed expression within 
the developing pronephros. Furthermore, published literature indicated important roles 
in development for both genes. For these reasons, Pod J and Darmin r were chosen for 
further investigation by mis-expression experiments in this work. 
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Identification of genes involved in the pronephric development of 
Xenopus laevis 
Part 1 Conclusion 
The first aim of this study was to identify genes that are involved in pronephric 
initiation and development. This was to be done by using three different but 
complementary approaches: 
1. Screening of a stage 13 cDNA phagemid library with a subtracted probe, 
designed to identify genes expressed in the early development of the pronephros 
(Chapter 3). 
2. Analysis of a set of UniGene cluster genes that have previously been shown to 
be expressed in the pronephros by in situ hybridisation (Chapter 4). 
3. Data mining to identify Xenopus laevis homologues of vertebrate genes with a 
known function in kidney development (Chapter 5). 
Screening of a stage 13 cDNA phagemid library with a subtracted probe did identify 
genes that are expressed in the pronephros and whose expression was up-regulated 
during pronephric initiation. However, their expression within the pronephros did not 
appear to be unique, nor enriched. For these reasons, the clones identified in the screen 
were not chosen for further analysis. Since this decision was made, the data has been 
re-examined and 2 of the 13 clones could prove interesting if examined further. 
The second approach was to analyse four UniGene cluster genes that had previously 
been found to be expressed in the pronephros by wholemount in situ hybridisation on 
stage 27 Xenopus laevis embryos (Personal correspondence from Pollet, N.). The 
UniGene cluster genes were found to be mainly expressed within the pronephros. 
Although, expression was not enriched within the pronephros and it did not alter with 
respect to pronephric development. The UniGene cluster genes were therefore not 
investigated further. 
The two genes chosen for further study were Pod J and Darmin r. The two genes were 
chosen after consideration of the literature and the data obtained from the temporal and 
spatial expression analysis. The genes were then investigated further, looking at 
homologue protein sequence similarity, adult spatial expression, and mis-expression. 
Some of the data presented in Chapter 5 has been published (Simrick, et al., 2005). 
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Results Part 2 
The Developmental Role of Pod 1 
in Xenopus laevis. 
Chapter 6 
Pronephric lineage targeted Pod lover-expression results in a reduced glomus. 
Chapter 7 
Pod 1 expression is required for glomus development. 
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The Developmental Role of Pod 1 in Xenopus laevis. 
Introduction 
The second aim of this thesis was to elucidate the role of the chosen genes in the 
development of the pronephros. The first gene chosen for further investigation was Pod 
J. Initial analysis indicated that Pod J might playa role in early glomus development 
(Chapter 5). In order to further elucidate the role of Pod J in pronephric development, 
the following were investigated: 
Chapter 6 
Comparison of amino acid sequences of vertebrate Pod J homologues to 
establish the degree of evolutionary conservation. 
• Establish the spatial expression pattern within adult organs by RT -PCR 
which might indicate functional roles in the adult. 
Carry out over-expression studies in developing embryos, using targeted 
micro-injected mRNA. 
Chapter 7 
• Carry out knock-down analysis of Pod I translation using morpholino 
oligonucleotides. 
• Initiate a gene network investigation to try to establish the position of Pod 
J in the regulatory network controlling pronephric glomus development 
using animal cap assays and RT -PCR. 
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Pronephric lineage targeted Pod lover-expression results in a reduced 
glomus. 
6.1 Introduction 
Pod 1, also known as Capsulin, Epicardin and Transcription factor 21 is a class B basic 
helix-loop-helix transcription factor. Pod I has been shown to be expressed in the 
podocytes lining the glomerulus of mice kidneys as well as the ovary, spleen, intestine, 
uterus and heart (Lu, et al., 1998 and Hidai, et al., 1998). From studying null and 
chimeric Pod J mice, Pod J appeared to have a role in branching morphogenesis and/or 
differentiation in the kidney, lungs, spleen, gut and skeletal muscle (Quaggin, et al., 
1999, Lu, et al., 2000, Andersson, et al., 2001, Lu, et al., 2002, Cui, et al., 2003 and 
Funato, ef al., 2003). Pod J also has been shown to have a role in gonadogenesis, 
possibly in sex determination (Tamura, et al., 2001, Cui, et al., 2004) (Chapter 5 
Background). 
Previous analysis of the developmental role of Pod I in the kidney has focused on the 
mouse metanephros. By studying the role of Pod I in the pronephros of Xenopus laevis, 
the effect of Pod 1 on the nephron and early initiation events can be more easily 
investigated. The Xenopus Pod I homologue, EST CF270487, was identified using the 
translated NCBI database, tBLASTn (Basic Local Alignment Search Tool, Altschul, et 
ai., 1990). We have previously shown by wholemount in situ hybridisation and RT-
PCR analysis (Chapter 5) that Pod J expression is initiated at the same time as the 
developing pronephros and is enriched in the pronephros compared to the whole 
embryo. 
In this chapter, the evolutionary conservation of Pod J was investigated by comparing 
the amino acid sequences of the mouse, rat and human Pod I homologues. The region 
of Pod J expression within the pronephros was determined using RT-PCR with mRNA 
extracted from a dissected stage 42 pronephros. The Xenopus adult spatial expression 
pattern of Pod J transcript was elucidated using RT -PCR analysis of adult tissues. 
These data gave an indication of the possible functional role of Pod 1 in adult tissues. 
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The importance of Pod I in pronephric development was investigated using over-
expression analysis. 
6.2 Results 
6.2.1 Pod 1 is evolutionarily conserved through a number of vertebrate species 
The full length Xenopus Pod 1 EST, CF270487, was obtained from the IMAGE 
consortium (http://image.llnl.gov, IMAGE No. 5512805) and sequenced in house. The 
published NCBI nucleotide sequence (http://mgc.nci.nih.gov/) of this clone fails to 
identify a translational start site. In house sequencing corrected the sequencing error by 
identification of the translational start site at an equivalent point to that of the mouse 
sequence (EST AF029753). The open reading frame runs from 23bp to 560bp, 
encoding a 179 amino acid protein that is approximately 25kDa when separated on a 
10% SDS polyacrylamide gel (Fig. 6.4). 
The conceptual translation of the Xenopus Pod I sequence was performed using the 
INFOBIOGEN web site (www.infobiogen.fr). The Xenopus Pod 1 amino acid sequence 
was compared with the H. sapiens, NP _003197, M. musculus, NP _035675 and R. 
norvegicus CorIo XP _341738, Pod I homologues. The alignment showed 100% 
conserved identity in the basic helix-loop-helix region between the vertebrate Pod I 
homologues of the mouse, rat and human (Fig. 6.1 A). A similarity of approximately 
85% among the Pod I vertebrate homologues was identified over the whole length of 
the protein (Fig. 6.IB). 
6.2.2 Pod 1 expression is concentrated in the pronephric glomus 
The pronephros from a Xenopus laevis stage 42 embryo was dissected into the glomus, 
tubules and duct regions. and RT-PCR was performed on mRNA extracted from the 
dissected pieces. The input cDNA was approximately equalised using EF 1 a and a 
linearity using doubling dilutions of whole embryo cDNA was performed. The purity 
of the pronephric dissections were ascertained by Dr Caroline Haldin using WT 1 for the 
glomus, Pax8 for the tubules and X c-ret for the duct. The pronephric dissection RT-
PCR suggested a greater expression of Pod 1 in the glomus compared to the tubules and 
duct (Fig. 6.2). 
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X.laevis - - - -
H.sapiens 87 - - -
M.musculus 85 96 - -
R.norvegicus 85 97 99 -
Fig. 6.1 Alignment of homologous Pod 1 amino acid sequences. (A) Alignment of the 
predicted X. laevis amino acid equence (conceptually translated from CF270487), H. 
sapiens Pod 1 (NP _003197), M. musculus Pod 1 (NP _035675) and potential R. 
norvegicus homologue Corl (XP _341738). Black shading indicates identical amino 
acids, whereas the gray hading specifies the same amino acid family. (B) Percentage 
identity (%). The table indicates paired percentage identity as given by BLAST (Basic 
Local Alignment Search Tool, Altschul et at., 1990). 
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Fig.6.2 Spatial pronephric expression of Pod 1 in stage 42 X. laevis. The pronephros from a 
Xenopus Laevis stage 42 embryo was dissected into the glomus, tubules and duct tissues, 
and an RT-PCR using Pod 1 primers was carried out. Equalisation was carried out 
using EFla and linearity and negative controls carried out as described in the methods. 
A fine dissection of the pronephros of a stage 42 X. laevis tadpole reveals the spatial 
expression of Pod1 within the pronephros. Pod 1 appear to be most expressed in the 
glomus, less in the tubules and weakest in the duct. 
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6.2.3 Pod 1 is expressed highly in a number of adult tissues 
The Xenopus adult spatial expression was elucidated using RT-PCR analysis on mRNA 
isolated from adult tissues. These data gave an indication of any potential role of Pod 1 
in adult tissues. The input cDNA was approximately equalised using EF 10. and a 
linearity using doubling dilutions of kidney cDNA was performed. The RT-PCR 
indicated that Pod 1 expression is highest in the rectum and the spleen, with significant 
expression in the duodenum, heart, kidney, lungs, pancreas, skin, liver and muscle (Fig. 
6.3). 
6.2.4 Pronephric lineage targeted Pod lover-expression 
The role of Pod 1 in pronephric development was investigated using over-expression 
analysis. Over-expression of Pod 1 was performed by injecting in vitro transcribed Pod 
1 mRNA into a V2 blastomere of an embryo at the 8 cell stage. Xenopus Pod 1 mRNA 
was synthesised using SP6 mMessage mMachine kit (Ambion). Pod I cDNA from the 
IMAGE clone (http://image.llnl.gov, IMAGE No. 5512805) was cloned into the pCS2+ 
plasmid using Eco R1 and Xba 1 (Appendix). Mouse Pod 1 mRNA was also synthesised 
for over-expression analysis, to indicate the degree of functional conservation. The 
mouse Pod 1 mRNA was also synthesised using SP6 mMessage mMachine kit 
(Ambion). Mouse Pod 1 cDNA from the IMAGE clone (http://image.llnl.gov, IMAGE 
No. 6529241) was cloned into the pCS2+ plasmid using Eco RI and Xba I (Appendix). 
The translation of Pod 1 mRNA was analysed using in vivo translation within Xenopus 
oocytes. Xenopus oocytes were injected with either Xenopus Pod 1 mRNA, mouse Pod 
1 mRNA or water and incubated in Barth X containing 35S methionine and cysteine. 
This radioactively labelled any new proteins synthesised after oocytes were injected. 
The mRNA-injected oocytes and the water-injected oocytes were compared. Both Pod 
1 homologues were translated, giving proteins of approximately 25kDa (Fig. 6.4). The 
human Pod I protein had been previously found to be 26kDa (Miyagishi, et al., 2000a). 
The in vitro transcribed Pod 1 mRNAs were injected into the embryos at the 8 cell stage 
(Methods Fig. 2.3). The mRNA was immediately translated in the embryo, yielding 
higher levels of Pod 1 expression at an earlier stage than that observed during 
endogenous expression. The Pod 1 mRNA was injected into one V2 cell of an 8 cell 
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Fig.6.3 Expression pattern of Pod 1 in the adult organs of X. laevis. RT-PCR was perfonned 
on mRNA isolated from the organs of an adult Xenopus laevis. The RT-PCR was 
equalised using EFla and linearity and negative controls performed as described in the 
methods. Pod J expression in adult X. laevis organs appears to be greatest in the spleen 
and rectum. Other, more moderate expression is seen in the duodenum, heart, kidney, 
lungs, pancreas and skin. There are also low levels in the liver, muscle, spinal cord and 
stomach. 
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Fig.6.4 Oocyte translation of Xenopus and mouse Pod 1 mRNA. Oocytes were injected and 
incubated overnight in full strength Barth X containing 35S labelled methionine and 
cysteine. The protein from the oocytes was extracted and run on a 10% SDS PAGE gel 
and exposed for autoradiography. Oocytes were injected and lanes were loaded as 
indicated. Protein product of the injected Pod J mRNA transcripts are highlighted by 
the black arrow. As indicated, the size of both Xenopus and mouse Pod 1 protein is 
approximately 25kDa. The lanes labelled "No injected mRNA" are negative controls 
were no mRNA wa injected and no Pod 1 protein is observed. 
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embryo to target the effect of exogenous Pod 1 to the pronephric region. Lineage 
tracing was performed by co-injecting with GFP and sorting the embryos for pronephric 
left or right fluorescence at stage 25-30 (Methods 2.10.3 Micro-injection). GFP mRNA 
was also used as a negative control. indicating the effect of injecting an embryo with a 
developmentally irrelevant mRNA. 
The phenotypes observed in the embryos were quantified by measurements and 
validated using statistical analysis. The over-expression phenotype of the pronephric 
tubules was determined using the Pronephric Index (PNI) (Wallingford. et al .• 1998) 
(Methods 2.10.8 Pronephric Index) and the morphology of the pronephric duct was 
scored by eye. The size of the glomus/pronephric anlagen and the length of the embryo 
were measured as detailed in the methods (Methods 2.10.7 Measurement of tissue area). 
Where the comparison was within the same experimental set. left and right comparison 
of the same embryo was used to identify potential phenotypes. The significance of 
difference within the same set of measurements or Pronephric Index (PNI) (Methods 
2.10.8 Pronephric Index) was validated using either the paired t-test. if the data were 
normal, or the Wilcoxon paired test, if the data were not normal. 
Where the comparison was between different sets of embryos, the ratio of 
glomus/pronephric anlagen area to embryo length of each set was used in the analysis. 
The statistical analysis of measurements or Pronephric Index (PNI) involved a Kruskal 
Wallis test. and a Dunn's post test to indicate the significant differences between the 
groups of test subjects. All statistical analysis was performed using the InSTAT 3 
programme, (GraphPad Software Inc). 
6.2.4.1 Pronephric lineage targeted Pod lover-expressIOn results in a reduced 
glomus phenotype as indicated by Wfl andximxlb in situ analysis 
In vitro transcribed mRNA was injected into one V2 cell of an 8 cell embryo. Embryos 
were injected with either 0.6ng Xenopus Pod J mRNA and GFP mRNA, 0.6ng mouse 
Pod J mRNA and GFP mRNA or GFP mRNA alone. The embryos were sorted using 
GFP fluorescence to indicate targeting of the left or right side of the embryo. 
Wholemount in situ hybridisation using a Wfl antisense DIG-labelled RNA probe was 
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performed on stage 33-35 embryos. The glomus area on each side of the embryo and 
the length of the embryo was measured as detailed in the methods (Methods 2.10.7 
Measurement of tissue area). 
Comparison of the 0.6ng Xenopus Pod 1 mRNA and GFP mRNA injected side of the 
embryo and the not injected side of the embryo revealed a reduction in glomus area, as 
indicated by wn expression (Fig. 6.5A). The mean area of glomus of the injected side 
of the embryos was 0.020mm2, and the not injected side of the embryo was 0.027mm2 
(N = 38). These measurements are actual sizes of the glomus and are not relative sizes 
of glomus, that is, they have not been divided by the embryo length to give ratio of 
glomus area to embryo length. The measurements were found to be significantly 
different using a two-tailed paired t-test, p < 0.0001. 
In experiments comparing the GFP alone injected embryos, the mean area of the 
glomus on the injected side was 0.030 mm2, and the mean area of the glomus on the not 
injected side was 0.029 mm2. The glomus areas of the embryo did not reveal any 
significant difference in the measurements, p = 0.04348 (number of embryos = 36) (Fig. 
6.5B). Again, these measurements are actual sizes of the glomus and are not relative 
sizes of glomus, that is, they have not been divided by the embryo length to give ratio of 
glomus area to embryo length 
Comparison of the mean relative areas of the glomus on the injected side of the embryo 
injected with 0.6ng Xenopus Pod 1 mRNA and GFP mRNA with the equivalent side of 
the GFP mRNA alone embryos, further confirmed that the reduction of glomus area 
was due to exogenous Pod J. In order to remove any distortion in data caused by 
variation in the length of the tadpole, the ratio of area of glomus (mm2) to length of 
tadpole (mm) was calculated (Methods 2.10.7 Measurement of tissue area). The 
following data are therefore a ratio of area of glomus (mm2) to length of tadpole (mm), 
and mean values are from all embryos injected with the stated mRNA. The mean of the 
ratio of glomus area (mm2) to tadpole length (mm) of the 0.6ng Xenopus Pod J mRNA 
and GFP mRNA injected embryos on the injected side was 0.004mm2/mm, and the 
GFP mRNA alone injected equivalent was 0.005mm2/mm. The mean values indicated 
a reduction in mean area due to Pod J over expression. These measurements were 
significantly different according to Kruskal Wallis test, and had a Dunn's post test p 
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Fig. 6.5 Xenopus and mouse Pod 1 show the same over-expression phenotype demonstrated 
by WTl in situ indicating the size of the glomus. Embryos were injected with either: 
0.6ng Xenopus Pod 1 mRNA and GFP mRNA (A), GFP mRNA (B), 0.6ng mouse Pod 
1 mRNA and GFP mRNA (C) or GFP mRNA (D). Injections were done at the 8 cell 
stage into one V2 cell to target the pronephros. Embryos were sorted using GFP 
fluorescence. checking for left or right pronephric targeting. Not injected sides and 
injected sides of the same embryos are as indicated. Wholemount in situ hybridisation 
was preformed with a WT 1 DIG-labelled antisense RNA probe on stage 33-35 embryos. 
(A) Xenopus Pod lover expression decreases the size of the glomus as indicated by 
wn expression. (C) Embryos injected with mouse Pod 1 also have a decreased glomus. 
(B. D) GFP, used as an injected mRNA control, does not affect the size of the glomus. 
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value of less than 0.01. These tests also indicated that no significant differences were 
measured between the GFP injected embryos and the un injected embryos (p > 0.05). 
This Xenopus Pod lover-expression experiment was repeated 3 times and consistently 
resulted in a reduction of glomus area, as indicated by WT 1 expression. The result was 
also statistically significant in each case. 
Comparison of the 0.6ng mouse Pod I mRNA and GFP mRNA injected side of the 
embryo and the not injected side of the embryo also revealed a reduction in glomus 
area, as indicated by WTl expression (Fig. 6.5C). The mean area of the injected side of 
the embryos was 0.0 19mm2, and the not injected side of the embryo was 0.023mm2 (N 
= 31). The measurements were found to have a significant difference using a Wilcoxon 
paired test, p = 0.0083. As before, the GFP alone injected embryos (injected side 
0.025mm2, not injected side 0.027mm2), did not show a significant difference in the 
measurements, p = 0.1294 (N = 22) (Fig. 6.50). 
Comparison of the injected sides of the embryos did reveal a significant difference 
between 0.6ng mouse Pod 1 mRNA and GFP mRNA injected embryos, 0.004mm2/mm, 
and GFP mRNA alone injected embryos, 0.005mm2/mm. The Kruskal Wallis test 
indicated significant variation among the medians and the Dunn's post test had a p value 
of less than 0.05. These tests were also used to indicate no significant differences 
between the GFP injected embryos and the uninjected embryos (p > 0.05). 
The mouse Pod lover-expression experiment was repeated 4 times and consistently 
resulted in a reduction of glomus area, as indicated by WT 1 expression. However, this 
result was not statistically significant in each case (data not shown). This may be due to 
subtle differences in the mouse Pod 1 protein structure making it less functionally 
efficient in X. laevis. It may also reflect the difficulty of being able to inject sufficiently 
high amounts of mRNA without generating gross developmental abnormalities. 
The Xenopus Pod lover-expression experiment was repeated and 3 embryos from both 
sets (0.6ng Xenopus Pod 1 mRNA and GFP mRNA; GFP mRNA alone) were wax 
embedded and transverse sections collected across the glomus region (All sections were 
performed by Mr Surinder Bhamra) (Methods 2.10.6 Wax Sections and Fig. 6.60). 
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Fig. 6.6 Sections of Xenopus Pod lover-expression analysis in embryos confirms a 
reduction in glomus size. Injections were done at the 8 cell stage into one V2 cell to 
target the pronephros. Embryo were injected with either; O.6ng Pod I mRNA and GFP 
rnRNA (A, B) or GFP rnRNA (C). Embryos were sorted using GFP fluorescence, 
checking for left or right pro nephric targeting. Not injected sides and injected sides of 
the same embryo were as indicated. The embryos were fixed at stage 33-35 and 
wholemount in situ hybridisation with a wn DIG-labelled antisense RNA probe 
followed by wax ections were performed. Two sequential sections are shown per 
embryo. (D) Images of embryo indicating plane of section (Cartoon from Nieuwkoop 
and Faber, 1994). (E) Cartoon diagram of area stained during whole mount in situ 
hybridisation using a WTJ DIG-labelled antisense RNA probe. (A, B) Pod lover 
expression deere a es the size of the glomus as indicated by area stained, although no 
observable difference in cellular organisation was observed (data not shown). GFP 
injected tadpole have a normal glomus on the not injected and injected sides of the 
embryo. 
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Consistent with the glomus area measurements, the 0.6ng Xenopus Pod 1 mRNA and 
GFP mRNA injected side of the embryo showed less wn staining (Fig. 6.6A-B). The 
GFP injected embryos portrayed normal regions of wn expression in the injected and 
not injected sides of the embryo (Fig. 6.6C). There were no differences in cellular 
organisation between the two sides of any of the injected embryos (Data not shown). 
WT 1 pronephric expression is in the glomus and the coelom edge of the pronephric 
capsule (Carroll and Vize, 1996). Analysis of wholemount in situ hybridisation using a 
WTJ antisense DIG-labelled RNA probe will therefore not only stain the glomus. To 
confirm that the effect of over-expressed Pod 1 was on the glomus and not just WTI 
expression, a second glomus marker, xlmxlb was used to analyse further over-
expression experiments. 
Xenopus Pod 1 mRNA and GFP mRNA was injected and the embryos were left/right 
sorted as before. The embryos were fixed at stage 33-35 and wholemount in situ 
hybridisation using an xlmxl b antisense DIG-labelled RNA probe was performed. The 
glomus area was measured and statistical analysis was conducted. 
The 0.6ng Xenopus Pod 1 mRNA and GFP mRNA injected side of the embryo had a 
reduced glomus compared to the not injected side of the embryo, as indicated by xlmxlb 
expression (Fig. 6.7 A). The mean area of the injected side of the embryos was 
0.Olmm2, and the not injected side of the embryo was 0.012mm2 (N = 28). These 
measurements are actual sizes of the glomus and are not relative sizes of glomus, that is, 
they have not been divided by the embryo length to give ratio of glomus area to embryo 
length. The measurements were significantly different according to the Wilcoxon 
paired test, p = 0.0393. The control GFP injected embryos did not show a significant 
difference between the injected side, 0.019 mm2, and the not injected side, 0.017mm2, 
(p = 0.5789, N = 14) (Fig. 6.7B). 
Reduction of the glomus by exogenous pronephric Pod 1 expression is therefore 
confirmed using two glomus markers, WTI and xlmxlb. 
136 
A 
Not Injected side 
B 
Not Injected side 
O.6ng Pod 1 mRNA 
Injected side 
GFPmRNA 
Injected side 
Fig. 6.7 Xenopus Pod lover-expression glomus phenotype confirmed by xlmxlb 
expression analysis. Embryos were been injected with either; O.6ng Pod 1 mRNA 
and GFP mRNA (A) or GFP mRNA (B). Injections were done at the 8 cell stage into 
one V2 cell to target the pronephros. Embryos were sorted using GFP fluorescence, 
checking for left or right pronephric targeting. Not injected sides and injected sides of 
the same embryos are a indicated. Wholemount in situ hybridisation with a xlm.xl b 
DIG-labelled antisense RNA probe was performed on stage 33-35 embryos. (A) Pod 1 
over expres ion decreases the size of the glomus as indicated by xlm.xl b expression. 
(B) GFP, used as an injected mRNA control, does not affect the size of the glomus. 
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6.2.4.2 Pronephric lineage targeted Pod lover-expressIon does not effect the 
pronephric tubules and duct as indicated by 3G8 and 4A6 antibody staining 
The 0.6ng Xenopus Pod J mRNA and GFP mRNA and GFP mRNA alone injections 
were conducted as before and the embryos were sorted using GFP fluorescence to 
indicate targeting to the left or right side of the embryo. Antibody staining using 3G8 
and 4A6 was performed on stage 40 embryos. The PNI index was used to analyse the 
organisation of the tubules (Wallingford, et al., 1998) (Methods 2.10.8 Pronephric 
Index) and the morphology pronephric duct was ascertained by eye. 
Very few of the embryos exhibited a PNI embryo difference greater than 2 in either of 
the sets, the 0.6ng Xenopus Pod J mRNA and GFP mRNA injected embryos (Fig. 
6.8A) or GFP mRNA only injected embryos (Fig. 6.8B). The median values from the 
injected side of both experimental and control sets of embryos were 4 in each case (N = 
23, 21). The same was true of the not injected sides. The data did not have a normal 
distribution, so the Wilcoxon paired test was used. Neither set indicated any significant 
difference in PNI, 0.6ng Xenopus Pod J mRNA and GFP mRNA injected embryos, p = 
0.0946, or GFP mRNA only injected embryos, p = 0.5186. 
The pronephric duct appeared similar on the injected and not injected sides of the 
embryo of both the 0.6ng Xenopus Pod J mRNA and GFP mRNA injected embryos and 
the GFP mRNA only injected embryos (Fig. 6.8A-B). 
6.2.4.3 Pronephric lineage targeted Pod lover-expressIOn does not effect the 
pronephric anlagen as indicated by Xliml in situ hybridisation 
The mRNA injections were performed as before and the embryos were sorted and fixed 
at stage 20-25. Wholemount in situ hybridisation using a Xliml antisense DIG-labelled 
RNA probe was conducted and the pronephric anlagen each side of the embryo and the 
length of the embryo was measured (Methods 2.10.7 Measurement of tissue area). 
Exogenous Xenopus Pod J expression did not have an effect on the area of the 
pronephric anlagen, as indicated by Xliml expression (Fig. 6.9A). The mean areas of 
the injected and not sides of the Xenopus Pod I mRNA and GFP mRNA injected 
embryos was 0.044mm2 (N = 28). The mean area of GFP mRNA only injected side of 
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Fig. 6.8 Histochemical analysis of the Xenopus Pod lover expression phenotype showed no 
observable effect on either pronephric tubule or duct. Embryos were injected with 
either; O.6ng Pod J mRNA and GFP mRNA (A) or GFP mRNA (B). Injections were 
done at the 8 cell stage into one V2 cell to target the pronephros. Embryos were sorted 
using GFP fluorescence, checking for left or right pronephric targeting. Not injected 
sides and injected sides of the same embryos are as indicated. Embryos underwent 
antibody staining with 3G8, to detect the pronephric tubules and 4A6, to detect the 
pronephric duct performed on stage 40 embryos. (A) Xenopus Pod J over expression 
does not effect the structure of the pronephric tubules or duct. (B) GFP, used as an 
injected mRNA control, does not have an effect on the tubules or duct. 
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the embryos was 0.063mm2, and the not injected side of the embryo was 0.069mm2 (N 
= 18) (Fig. 6.9B). These measurements were found to have no significant differences 
using a Wilcoxon paired test and a two-tailed paired t-test; Xenopus Pod J mRNA and 
GFP mRNA injected embryos p = 0.7998, GFP mRNA only injected embryos p = 
0.3922. 
6.2.5 Pod lover-expression has no clear effect on heart development 
Wholemount in situ hybridisation using a Pod J antisense DIG-labelled RNA probe was 
conducted on stage 40.5 embryos using the enhanced in situ protocol. The embryos 
were photographed (Fig. 6.lOi-iv) then wax sectioned to show the area of expression 
within the heart (All sections were performed by Mr Surinder Bhamra) (Fig. 6.1 Ov-viii). 
The area of Xenopus Pod J expression within the heart was confirmed to be the 
proepicardium. The region of Pod J expression was below the truncus arteriosis in a 
ventral-posterior direction, between the heart and the endoderm (Kolker, 2000) (Fig. 
6.lOi-iv). In amphibian embryos, proepicardium cells form ventrally to the sinus 
venosus (Fransen and Lemanski, 1990). The region of Pod J expression was therefore 
believed to be the proepicardium (Horb and Thomsen, 1999). Wax sections of the heart 
also confirm location of the Pod J expression to the left ventral region of the heart, 
consistent with the proepicardium (Fig. 6.lOvi-viii). 
6.2.5.1 Pod lover-expression fails to result in a clear heart phenotype although 
may result in an altered heart position. 
The role of Pod J in heart development was investigated using over-expression analysis. 
Xenopus Pod J and GFP mRNA were in vitro transcribed and injected into both VI 
cells of an 8 cell embryo to target the heart. 0.6ng of Xenopus Pod I mRNA and GFP 
mRNA was injected into both V I cells, giving a total of 1.2ng of injected Xenopus Pod 
J mRNA. GFP mRNA was also injected as a negative control, indicating any effect of 
injecting an embryo with mRNA. Lineage tracing was performed using the co-injected 
GFP mRNA and sorting the embryos for heart region fluorescence at stage 25-30 
(Methods 2.10.3 Micro-injection). 
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Fig. 6.9 Xenopus Pod lover expression analysis with Xlim 1 does not indicate a 
pronephric anlagen phenotype. Embryos were injected with either; 0.6ng 
Xenopus Pod 1 mRNA and GFP mRNA (A) or GFP mRNA (B). Injections were 
done at the 8 cell stage into one V2 cell to target the pronephros. Embryos were 
sorted using GFP fluorescence, checking for left or right pronephric targeting. 
Not injected sides and injected sides of the arne embryos are as indicated. 
Wholemount in situ hybridi ation with a Xlim 1 DIG-labelled antisense RNA 
probe was performed on tage 20-25 embryos. (A) Pod lover expres ion does 
not have an effect on the size of the pronephric anlagen as indicated by XUm 1 
expression. (B) GFP, u ed a an injected mRNA control, does not affect the size 
of the pronephric anlagen. 
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Fig. 6.10 Analysis of the Xenopus Pod 1 heart expression pattern by wholemount in situ 
hybridisation and sectioning. Wholemount in situ hybridisation with a Pod 1 DIG-
labelled antisense RNA probe perfonned on stage 40 embryos (i-iv) which are later 
sectioned (vi-viii). Image of stage 40 embryo indicating plane and direction of sections 
(v) (Nieuwkoop and Faber, 1994). Areas of heart observed are shown relative to Pod 1 
expression (iv). Pod 1 expression appears to be below the truncus arteriosis, between 
the truncus arteriosis and the endoderm, an area considered to be the proepicardium (i-
iv). Sections indicate that Pod 1 is expressed in the proepicardium (vi-viii). 
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Wholemount in situ hybridisation with a Cardiac troponin I antisense DIG-labelled 
RNA probe was used to reveal the heart morphology. The heart phenotypes observed in 
the embryos were quantified by measurements and validated using statistical analysis. 
The size of the heart was measured on both sides using the LUCIA programme 
(Laboratory Imaging Ltd.). The length of the embryo was measured to eliminate the 
factor of the size of the embryo on the area of the heart (Methods 2.10.7 Measurement 
of tissue area). The ratio of heart area to embryo length was compared across sets of 
embryos using a Kruskal Wallis test, and a Dunn's post test to indicate the significant 
differences between the sets. All statistical analysis was performed using the InSTAT 3 
programme, (GraphPad Software Inc). 
Embryos injected with 1.2ng Xenopus Pod 1 mRNA and GFP mRNA did not show any 
difference in heart area compared to the GFP mRNA alone injected embryos (Fig. 
6.11). The mean areas of hearts were 0.024 mm2, left and 0.025 mm2, right for 1.2ng 
Xenopus Pod 1 mRNA and GFP mRNA injected embryos (N = 35), and 0.034 mm2, 
left and 0.024mm2, right for I GFP mRNA alone injected embryos (N = 30). There was 
no significant variation between the sets with the Kruskal Wallis test (p = 0.0965) and 
so the Dunn's post test was not performed. 
In order to maximise any possible effects the embryos were injected with 1.2ng 
Xenopus Pod I mRNA and GFP mRNA, double the concentrations used previously and 
wholemount in situ hybridisation with a Cardiac troponin I antisense DIG-labelled 
RNA probe was conducted. 3 embryos from each set (1.2ng Xenopus Pod 1 mRNA and 
GFP mRNA; GFP mRNA alone) were then wax embedded and transverse sections 
were cut across the heart (Fig. 6.12C). 
Exogenous Pod I expression does not appear to effect the morphology of the heart, but 
may have an effect on the positioning of the heart. Comparison of the wax sections 
from 1.2ng Xenopus Pod 1 mRNA and GFP mRNA injected embryo with the GFP 
mRNA alone injected embryos indicated no overall difference in heart morphology 
(Fig. 6.12A-B). The ventricle chamber was observed in both embryo sections (Fig. 
6.12A iii and Fig. 6.12B iii). The 3 chambers, atrium, ventricle and truncus arteriosis 
are also present in both embryo sections (Fig. 6.12A iv and Fig. 6.12B iv). The atrium 
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Fig 6.11 Xenopus Pod lover expression does not have an effect on the heart, as indicated 
with Cardiac troponin I expression. Embryos were injected with either; 1.2ng Pod 1 
mRNA and GFP mRNA (A) or GFP mRNA (8). Injections were done at the 8 cell 
stage into both V 1 cells to target the heart. Embryos were sorted using GFP 
fluorescence, checking for heart targeting. Who1emount in situ hybridisation with a 
Cardiac troponin 1 DIG-labelled antisense RNA probe was performed on stage 35-37 
embryos. (A) Pod lover expression does not appear to have an effect on the heart as 
indicated by Cardiac troponin I expression. (8) GF?, used as an injected mRNA 
control, does not affect the heart. 
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Fig. 6.12 Transverse sections of wax embedded embryos over-expressing Pod 1 suggest a 
possible heart phenotype. Embryos were injected with either; 1.2ng Pod I mRNA and 
GFP mRNA (A) or GFP mRNA (B). Injections were done at the 8 cell stage into both 
V I cells to target the heart. Embryos were sorted using GFP fluorescence, checking for 
heart tissue targeting. Wholemount in situ hybridisation with a Cardiac troponin I 
DIG-labelled antisense RNA probe was performed on stage 42 embryos and which were 
then wax sectioned. The black arrow indicates direction of sequential sections and the 
red dotted line shows the sectioning plane (C) (Image from Nieuwkoop and Faber, 
1994). (A) Pod lover expression effects the positioning of the heart as indicated by 
area stained. The heart appears to have formed displaced to the left of the embryo. The 
GFP injected tadpoles have a normally positioned heart (D). 
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(Fig. 6.12A vi and Fig. 6.12B vi) and the sinus venosus (Fig. 6.12A viii and Fig. 6.12B 
viii) structures are also apparent. 
The position of the heart in the 1.2ng Xenopus Pod 1 mRNA and GFP mRNA injected 
embryo wax sections appears to be displaced to the left. In each case, sectioned Pod J 
over-expression embryos showed this displacement to the left with the corresponding 
area to the right filled with cells similar to the endodermal cells found more ventral and 
posterior to the heart. This phenomenon was observed in all three Pod J over-
expression sectioned embryos. However, further analysis is required to ascertain 
whether this was a result of variation in the plane of embryo sections, or a Pod J over-
expression phenotype. 
6.3 Discussion 
There was a high percentage of protein sequence similarity of the hypothetically 
translated Xenopus laevis Pod J homologue with other vertebrates, especially within the 
basic helix-loop-helix region suggesting a conserved DNA binding function. Further 
more, mouse Pod lover-expression was able to induce the same phenotype as Xenopus 
laevis Pod lover-expression, strongly suggesting that there is a conserved 
developmental function. 
The pronephric dissection RT -PCR indicated Pod J expression in the three components 
of the pronephros with high expression in the glomus. This is comparable to mouse 
kidney expression, where Pod 1 is expressed in several differentiated cell types within 
all three main components of the nephron, particularly the glomerulus and the tubules 
(Cui, et al., 2003). The Xenopus adult organ RT-PCR also indicated a similar 
expression pattern to the mouse, where Northern blot analysis have shown Pod J 
expression in the lung, kidney, heart liver, spleen and testis (Lu, et al., 1998 and 
Miyagishi, et al., 2000). However, unlike the Pod J expression in Xenopus laevis, there 
is no expression in the muscle (Lu, et al., 1998 and Miyagishi, et aI., 2000). 
Xenopus Pod lover-expression in the pronephros resulted in a reduction of glomus 
area. The effect was observed using two glomus markers, WTl and xlmxlb and was 
found to be statistically significant. A further significant difference was found between 
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embryos with exogenous Pod 1 and GFP expression, indicating that the glomus 
phenotype observed was not due to the mechanics of injecting mRNA into an embryo. 
Pod 1 is known to promote differentiation, and in some cases inhibit proliferation 
(Andersson, et al., 200 I, Lu, et al., 2000, Cui, et al., 2003 and Funato, et al., 2003). 
Exogenous Pod 1 expression in the pronephros may reduce the size of the glomus 
directly, by inhibiting glomus competent cells from proliferating, or indirectly, by 
advancing the development of the glomus before critical cell numbers are achieved or 
recruited. 
In accordant with the whole embryo measurements, sectioned Pod lover-expression 
embryos also showed a reduction in glomus, as revealed by wn expression. However, 
sections also indicated no difference in cell organisation between a pronephros with Pod 
1 or GFP over-expression (data not shown). This suggests the phenotype was not a 
result of compacted glomus cells. 
The exogenous Pod 1 expression did not appear to have an effect on the pronephric 
anlagen. The reduced glomus was therefore not due to an overall reduced cell number 
forming the pronephros. The pronephric tubules and duct were also unaffected by Pod 
lover expression, which would suggest that the tubules and duct were not amassing 
pronephric anlagen cells at the expense of the glomus. Accordingly, it is improbable 
that the reduced glomus was a specific effect due to a reduced number of pronephric 
glomus competent cells available. 
The reduced glomus may have been formed by glomus competent cells undergoing 
apoptosis. This is unlikely as the sectioned Pod lover-expression embryos do not show 
any lesions or obvious spaces left by missing cells. However, this could be looked into 
by further analysis using TUNEL staining. 
The reduced glomus may have also been formed by later differentiation events 
occurring earlier due to the presence of Pod 1. Pod 1 is known to be involved in the 
terminal differentiation of specialised kidney cells (Quaggin, et al., 1999 and Cui. et al., 
2(03). The pronephric anlagen may develop into the three component subunits 
sequentially, for example later glomus differentiation events could trigger the onset of 
tubule formation which in tum trigger duct formation. If this was the case, Pod 1 could 
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be differentiating pronephric anlagen competent cells into glomus competent cells 
earlier, which triggers tubule formation before enough pronephric anlagen cells have 
been recruited into glomus formation. The later pronephric tubule and duct events 
would carryon as normal. This would explain why the pronephric anlagen, pronephric 
tubules and duct remain unchanged by Pod J over-expression, and yet the glomus is 
reduced. 
The lack of pronephric anlagen, tubule and duct over-expression phenotype may be due 
to the absence of an appropriate Pod I binding partner. This is unlikely as a glomus 
phenotype was observed. Thus there would be a requirement for a separate binding 
partner for tubule and duct tissues from the glomus. 
Pod J expression in the heart was found to be within the proepicardium, consistent with 
the mouse Pod J expression (Hidai, et al., 1998). The proepicardium is the region from 
which epicardial cells originate before migrating into and over the heart (Horb and 
Thomsen, 1999). Proepicardium cells are found mainly in the visceral pericardium 
surrounding the heart. By transplanting a quail donor proepicardial serosa into chick 
hearts, Manner (1999) also found proepicardial cells in the myocardium of the 
ventricles, outflow tract and the atria and the atrioventricular cushions. Some 
proepicardial cells go through an epithelial-mesenchymal transition and are found in 
connective tissue and coronary vascular elements (MUnoz-Chapuli, et al., 2(02). This 
transition occurs just before cell migration (Morabito, et ai., 200 I ). Pod J 
proepicardium expression was only visible briefly at stage 40.5. As Pod 1 is known to 
be expressed in mesenchymal cells and involved in epithelial and mesenchymal 
interactions (Hidai, et ai., 1998, Lu, et aI., 1998, Lu, et al., 2000, Robb, et ai., 1998, 
Quaggin, et al., 1999 and Andersson, et al., 200 1), the brief expression of Pod 1 in the 
Xenopus proepicardium may therefore be involved with, or a result of the epithelial-
mesenchymal transition. 
Although significantly contributing to the heart structure, the proepicardium does not 
derive from the cardiac loop (Fransen and Lemanski, 1990). This could explain why no 
structural phenotype was observed in the heart with exogenous Pod 1 expression. The 
positioning of the heart to the left has not been analysed fully with repeat sections and 
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markers identifying the different regions of the heart, however, it is interesting that the 
heart lies to the left, similar to the proepicardium. 
Further analysis of the heart phenotype would include observation of the proepicardium 
in Pod lover-expression embryos. A lack of proepicardium markers in Xenopus have 
so far hindered this line of investigation. Looking into a Xenopus homologue of a 
mouse proepicardial marker such as Tbx18 (Kraus, et al., 2001) may resolve this issue. 
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Pod 1 expression is required for glomus development. 
7.1 Introduction 
The potential role of Pod 1 in pronephric development, suggested in Chapter 5, was 
strengthened in Chapter 6, by a reduction in glomus size resulting from Pod 1 over-
expression. To further investigate the function of Pod 1 during pronephric 
development, Pod 1 knock-down phenotypes were investigated and an attempt to place 
Pod 1 in a genetic hierarchy by network analysis using animal caps was performed. 
7.2 Results 
7.2.1 Pod J knock-down 
Conventional knock-out experiments are impossible to perform in Xenopus laevis due to 
the tetraploid nature of the organism and lack of embryonic stem cell lines. However, 
knock-down experiments are possible with the use of morpholino oligonucleotides. A 
morpholino oligonucleotide is typically 18 to 25 bases in length, differing from DNA by 
the backbone consisting of 6-membered morpholino rings joined by non-ionic 
phosphorodiamidate links compared to DNA which has 5-membered deoxyribose rings. 
For knock-down properties, the morpholino oligonucleotide is usually designed to be 
complementary to a selected mRNA across the start site of the coding region. The 
morpholino oligonucleotide binds directly to the selected mRNA after transcription, 
preventing the assembly of ribosome on the mRNA. Without ribosome assembly, the 
selected mRNA will not be translated and no protein product will be formed. The 
morpholino oligonucleotide can therefore specifically knock-down the translation of a 
selected mRNA by inhibiting translation (Fig. 7.1). 
The 6-membered morpholino ring backbone of the morpholino oligonucleotide is not 
recognised by cell nucleases and is so not degraded. The molecules are therefore stable 
in the cells for up to seven days after delivery into embryos, with activity only 
diminishing due to dilution by cell division. The backbone is also non-ionic, 
minimising interactions with proteins, and so reducing non-specific effects. Morpholino 
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Antisense morpholino 
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binds to sense mRNA 
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Normal translation 
__ Protein product 
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__ No protein product 
Adapted from www.gene-lools .com 
Fig. 7.1 Morpholino oligonucleotides bind to mRNA inhibiting translation . Sense mRNA is 
tran cribed by the cell. During normal translation, ribosomes bind to the mRNA and 
tran late the mRNA into the protein product. A morpholino oligonucleotide is typically 
18-25 ba e long and i de igned to be complementary to a specific mRNA sequence 
over the tran lation . tart ite of the coding region. In the presence of a morpholino 
oligonucleotide, the morpholino oligonucleotide bind to the mRNA and inhibit the 
assembly of ribo 'orne on the mRNA. As the ribosome cannot bind to the mRNA. 
tran lation is inhibited and no protein product is formed. 
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oligonucleotides have a high affinity for mRNA. similar to that of DNA. and a 
minimum inactivating length of 14 (based on the minimum length sufficient to avoid 
attack on essentially all non-target sequences in a human RNA pool). They are also 
water soluble. allowing for embryo micro-injection (www.gene-tools.com). Together 
this high efficiency and specificity means that these molecules can decrease protein 
expression to levels undetectable by Western blot. 
Pod 1 knock-down by Pod 1 morpholino oligonucleotide 
The Pod J morpholino oligonucleotide (PMO) was designed by Gene Tools 
(www.gene-tools.com) using the Xenopus Pod J sequence (EST CF270487). The PMO 
binds to the Xenopus Pod J mRNA across the translational start site (Fig. 7.2A). 
Sequence analysis using the NCBI EST database indicated that the designed PMO is 
able to bind to Pod J pseudoalleles (data not shown. www.ncbi.nlm.nih.gov). The PMO 
was able to specifically knock-down exogenous Pod J expression in vivo (Fig. 7.2B) as 
indicated by an autoradiograph showing translation of Pod J mRNA in oocytes in the 
presence of radioactive amino acids. Xenopus Pod J mRNA, synthesised using SP6 
mMessage mMachine kit (Ambion), was injected alone. with the PMO and with the 
control morpholino oligonucleotide (CMO). The oocytes were incubated in Barth X 
containing 35S methionine and cysteine. This radioactively labelled any new proteins 
synthesised after oocytes were injected. The Xenopus Pod 1 protein. identified by size 
(25kDa) and absence from the water injected oocytes, was present only in oocytes 
injected with Xenopus Pod J mRNA alone and with the CMO. The lack of Pod I 
protein in the Xenopus Pod J mRNA and PMO co-injected oocytes indicated that the 
morpholino oligonucleotide inhibited translation of the mRNA. 
The ability of PMO to inhibit xPod J translation was further confirmed by western 
analysis using c-myc tagged xPod J mRNA injected into oocytes (Fig. 7.2C). The 
injections were performed as previously. except c-myc tagged xPod J mRNA was used 
and the oocytes were not radioactively labelled. Instead, Western analysis using anti-
myc antibody (MAB 9E 1 0) followed by an anti-mouse alkaline phosphatase secondary 
antibody (SIGMA) was performed. The Xenopus Pod 1 protein was absent from the 
PMO injected oocytes. 
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The effect of the PMO on the translation of mouse Pod 1 mRNA, transcribed from 
BC053525 (previously cloned into pCS2+ and synthesised using SP6 mMessage 
mMachine kit), was also analysed using radioactively labelled oocytes. Translation of 
the mouse Pod 1 mRNA was not effected by the presence of the PMO or CMO, as 
indicated by the presence of the protein in the injected oocytes (Fig. 7.2B). Mouse Pod 
1 mRNA was therefore used to rescue the Pod 1 knock-down phenotypes. 
Phenotyping of PMO knock-down 
The morpholino oligonucleotides were injected into one V2 cell of an 8 cell embryo to 
target the effect of Pod 1 knock-down to the pronephric region. GFP was also co-
injected for lineage tracing and the embryos were sorted for left or right pronephric 
fluorescence at stage 25-30 (Methods 2.10.3 Micro-injection). The phenotypes 
observed in the embryos were quantified by measurements and validated using 
statistical analysis similarly to the over-expression experiments. 
The morphology of the pronephric tubules was determined using the Pronephric Index 
(PNI) (Wallingford, et al., 1998) (Methods 2.10.8 Pronephric Index). The morphology 
of the pronephric duct and presence of the glomus/pronephric anlagen was scored by 
eye. The size of the pronephric anlagen was measured in accordance with the methods 
(Methods 2.10.7 Measurement of tissue area). 
Comparisons within the same experimental set involved left and right comparison of the 
same embryo to identify potential phenotypes. For PNI and pronephric anlagen 
measurements, this involved using the paired t-test, if the data were normal, or the 
Wilcoxon paired test, if the data were not normal. Where the data were categorical 
(presence or absence of the glomus/pronephric anlagen), the data were analysed using 
the Fisher's exact test. Fisher's exact test was used rather than the better known Chi 
Square test due to the table producing 1 degree of freedom, and the low values within 
the table. All statistical analysis was performed using the InST AT 3 programme, 
(GraphPad Software Inc). 
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Fig. 7.2 Pod 1 morpholino specifically knocks-down Xenopus Pod 1 mRNA translation in 
vivo. 
(A) The Xenopus Pod I sequence (EST CF270487, www.ncbi.nlm.nih.gov) was used to 
design the Pod J morpholino oligonucleotide by Gene Tools (www.gene-tools.com). 
The Pod I rnorpholino oligonucleotide bind to the Xenopus Pod J mRNA across the 
translational r lie, inhibiting translation. The Pod I rnorpholino oligonucleotide 
(CGG TGG ACA TGA TCT GTT ATG CTG C3) is shown in reverse to indicate 
binding region. Mouse Pod I rnRNA (BC053525) was used to rescue the Pod I 
knock-down phenotype as it will not anneal to the rnorpholino oligonucleotide. (B) 
Autoradiograph howing ill vivo translation of Xenopus and mouse Pod 1 mRNA in 
Xenopus oocyte in the pre ence and absence of morpholino oligonucleotides. The 
oocytes were injected and incubated overnight in full strength Barth X containing 35S 
labelled methionine and cysteine (lOIlCi) . The protein from the oocytes was extracted 
and run on a 10% SDS PAGE gel and exposed for autoradiography. The protein 
products from injected Xenopus and Mou e Pod I mRNA are highlighted by the black 
arrow and protein size is shown in kDa. The oocytes were injected and lanes were 
loaded as indicated, with the "No injected mRNA" as the negative control. xPod 1 
translation wa knocked-down specifically by the Pod 1 morpholino oligonucleotide 
and not by the control rnorpholino oligonucleotide. However, mouse Pod I translation 
was not affected by the pre ence of either of the morpholino oligonucleotides. (C) 
Western blot and autoradiograph showing in vivo translation of c-myc tagged Xenopus 
Pod I mRNA in the pre ence of morpholino oligonucleotides. As previously, the 
oocytes were injected and lane were loaded as indicated. The western blot (to the left) 
using anti-rnyc antibody, hows the translated Pod I protein (black arrow) was 
knocked-down by the Pod 1 morpholino oligonucleotide and not by the control 
morpholino oligonucleotide. An autoradiograph (to the right) is also shown to verify 
the size, approximately 35kDa, of the c-myc tagged Pod I protein. A smaller band 
(~J'C < ) wa also apparent in the western and the autoradiograph which may be a 
degradation product of the c-myc tagged Pod I protein . 
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7.2.1.1 Pod 1 expression is required for glomus development 
Pod 1 knock-down obliterates expression of the glomus marker WTl. 
The 8 cell embryos were injected into one V2 cell with either; 40ng PMO and GFP 
mRNA to indicate the effect of Pod 1 knock-down; 40ng PMO, 0.6ng mouse Pod 1 
mRNA and GFP mRNA to rescue the effect of the Pod 1 knock-down, confirming that 
a reduction in Pod 1 expression caused any phenotype observed; or 40ng CMO and 
GFP mRNA to show the non-specific consequences of injecting an embryo with a 
morpholino oligonucleotide. GFP fluorescence was used to indicate left or right 
pronephric targeting between stages 25 to 30. The embryos were fixed at stage 33 to 35 
and wholemount in situ hybridisation was performed with a WTl DIG-labelled 
antisense RNA probe. 
Pod 1 expression was found to be required for WTl expression in the glomus (Fig. 7.3). 
The 40ng PMO and GFP mRNA injected embryos showed a complete reduction of 
WTJ expression in the glomus on the injected side of 13 out of 22 embryos tested 
(Appendix). Comparing the presence of WTl expression in the glomus on the injected 
and not injected sides of the embryo with the Fisher's exact test, indicated a significant 
correlation between whether the side of the embryo was injected and the observed down 
regulation of the WTl expression domain (p < 0.0001). The rescued embryo injected 
with 40ng PMO, 0.6ng mPod 1 mRNA and GFP mRNA did not show a correlation 
using Fisher's exact test (p = 0.0557) with only 7 out of 35 embryos missing WTl 
expression. The PMO phenotype was therefore partially rescued using mouse Pod 1 
mRNA, which confirms that the specificity of the phenotype was caused by Pod 1 
knock-down. The 40ng CMO and GFP mRNA injected embryos also did not show a 
glomus phenotype by the Fisher's exact test (p = I, N = 32) suggesting that the 
phenotype was not a product of injecting the embryos with any morpholino 
oligonucleotide or an injection artefact. 
Pod 1 knock-down prevents expression of Xlmxlb in the glomus 
In order to observe whether Pod 1 knock-down had an effect on the glomus, not just 
WT 1 expression, a second glomus marker, xlmx 1 b, was used to analyse the Pod 1 
knock-down phenotype. The 8 cell embryos were injected as previously into one V2 
cell, using GFP as a lineage marker. The embryos were sorted for left/right pronephric 
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Fig.7.3 Pod 1 expression is required for WTl expression in the glomus. Embryos were 
injected into one V2 cell of an 8 cell embryo. The injections were; 40ng Pod J 
morpholino oligonucleotide and GFP mRNA (A), 40ng Pod J morpholino 
oligonucleotide, O.6ng mPod J mRNA and GFP mRNA (B) and 40ng control 
morpholino oligonucleotide and GFP mRNA (C). GFP fluorescence was used as a 
lineage trace, checking for left or right pronephric targeting. Not injected sides and 
injected sides of the same embryos were as indicated. Whole mount in situ hybridisation 
was performed with a Wfl DIG-labelled antisense RNA probe on stage 33-35 embryos. 
Pod 1 expression is required for WfJ expression in the glomus, as indicated by the lack 
of WTl expression in the Pod 1 morpholino oligonucleotide injected side of the embryo 
(A). This phenotype was rescued using mouse Pod J mRNA which does not bind to the 
Pod J morpholino oligonucleotide (B). The control morpholino oligonucleotide 
injected embryos have normal WfJ expression in the glomus (C). 
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targeting using GFP fluorescence and fixed at stage 35 to 38. Wholemount in situ 
hybridisation was performed with an xlmxlb DIG-labelled antisense RNA probe to 
highlight expression. 
The data confirmed that Pod 1 expression is also required for xlmxlb expression (Fig. 
7.4). The glomus, indicated by xlmx 1 b expression, was missing on the injected side of 
the 40ng PMO and GFP mRNA injected embryos in II out of 22 embryos (Appendix). 
The Fisher's exact test gave a p value of 0.0002, showing a significant correlation 
between whether the side of the embryo was injected and the presence of the glomus. 
The phenotype was rescued in embryos injected with 0.6ng mouse Pod 1 mRNA with 
the Fisher's exact test implying no significant correlation in injected or not injected side 
of the embryo with the presence of the glomus (N = 20, P = 0.1818). The embryos 
injected with the CMO also indicated no significant correlation (N = 23, p = 1). The 
phenotype observed was therefore from the knock-down of Pod 1 expression and not 
from the mechanics of injecting a non-specific morpholino oligonucleotide. 
These experiments studying the effect of Pod 1 knock-down on the glomus, were 
repeated 6 times, each time with the phenotype being observed. 
Histological analysis of Pod 1 knock-down embryos shows a lack of any glomus 
structure. 
The embryos were injected as before, and wholemount in situ hybridisation was 
performed on embryos staged 33 to 35, with a WI'1 DIG-labelled antisense RNA probe. 
To observe the effect of Pod 1 knock-down in the glomus at the cellular level, 3 
embryos from the 3 injection sets (40ng PMO and GFP mRNA; 40ng PMO, 0.6ng 
mouse Pod 1 mRNA and GFP mRNA; 40ng CMO and GFP mRNA - data not shown) 
were wax embedded and transverse sections were collected across the glomus region 
(All sections were performed by Mr Surinder Bhamra) (Methods 2.10.6 Wax-sectioning 
and Fig. 7.5). As expected from the earlier whole embryo analysis, the embryo injected 
with PMO did not appear to have any WTl expressing cells in the glomus region. 
Furthermore, there did not appear to be any cells in the glomus region, when compared 
to the other not injected side of the embryo. The rescued embryo, injected with PMO 
and mouse Pod 1 mRNA, had a normal glomus on the injected and not injected sides of 
162 
A 
Injected ide 
8 
Injected ide 
C 
Injected side 
40ng PMO 
ot injected ide 
40ng PMO + O.6ng mPod 1 mRNA 
ot inje ted .. ide 
40ng CMO 
t injected ide 
163 
Fig.7.4 Pod 1 expression is required for glomus development. 8 cell stage embryos were 
injected into one V2 cell. The embryos were injected with; 40ng Pod 1 morpholino 
oligonucleotide and GFP mRNA (A), 40ng Pod 1 morpholino oligonucleotide, O.6ng 
mPod 1 mRNA and GFP mRNA (B) and 40ng control morpholino oligonucleotide and 
GFP mRNA (C). Left or right pronephric targeting was identified using GFP 
fluorescence. The not injected sides and injected sides of the same embryos were as 
indicated. Wholemount in situ hybridisation was performed with an xlmx 1 b DIG-
labelled antisense RNA probe on stage 35-38 embryos. Pod I knock-down results in 
the complete reduction of the glomus, as shown by xlmx I b expression (A). The 
phenotype was rescued using mouse Pod 1 mRNA which will not bind to the Pod 1 
morpholino oligonucleotide (B). The control morpholino oligonucleotide injected 
embryos have normal glomus development (C). 
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Fig. 7.5 Pod 1 knock-down may reduce survival of glomus cells. The embryos were injected 
at the 8 cell stage into one V2 cell, with; 40ng Pod 1 morpholino oligonucleotide and 
GFP mRNA (A) or 40ng Pod 1 morpholino oligonucleotide, 0.6ng mPod 1 mRNA and 
GFP mRNA (B). Embryos were sorted using GFP fluorescence, checking for left or 
right pronephric targeting. The injected side (I) and the not injected side (N) of the 
embryo are indicated. Wholemount in situ hybridisation was performed with a Wfl 
DIG-labelled antisense RNA probe on stage 33-35 embryos. The embryos were then 
wax-sectioned. The black arrow indicates the anterior to posterior direction of 
sequential wax sections and the red dotted line shows the sectioning plane (C) (Image 
from Nieuwkoop and Faber, 1994). (A) Embryos injected with Pod 1 morpholino 
oligonucleotide appear to be missing WTl expressing cells on the injected side of the 
embryo. Embryos that have been rescued by co-injecting mPod 1 mRNA have a normal 
glomus on the injected and not injected sides of the embryo (B). In addition, pronephric 
tubule tissue also appears to be missing in the Pod 1 morpholino oligonucleotide 
injected embryos (A). 
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the embryo. further evidence that the mouse Pod 1 mRNA is able to rescue the Pod 1 
knock-down phenotype and restore the glomus structure. 
7.2.1.2 Pod 1 knock-down disrupts tubule morphology 
In order to establish whether other components of the kidney were effected. the 
experiment was repeated and the embryos fixed at stage 38 to 42. Wholemount 
immuno-histochemistry analysis was performed and the monoclonal antibodies. 308 to 
highlight the pronephric tubules. and 4A6 to show the duct. were used. The PNI was 
used to analyse the morphology of the tubules (Wallingford. et al .• 1998) (Methods 
2.10.8 Pronephric Index) and the structure of the pronephric duct was scored by eye. As 
slight differences between embryo sets could not be discounted. the embryos were 
analysed by comparison of the injected side to not injected side only. 
The pronephric tubules on the injected side of the Pod J knock-down embryos were 
disorganised. having a PNI median of 2. compared to the not injected side. with a PNI 
median of 4 (Fig. 7.6) (Appendix). A Wilcoxon paired test revealed the difference in 
PNI between the injected and not injected sides of the embryo to be significant. p = 
0.0004. Furthermore. a PNI difference of 2 or more was observed in 13 of the 17 
embryos. The tubules themselves were larger and appeared to consist of just one tubule 
branch. 
The phenotype was rescued in mouse Pod 1 mRNA co-injected embryos which have 
relatively normal pronephric tubules on both sides of the embryo. each with a PNI 
median of 4. There was no significant difference observed in the data after analysis 
with the Wilcoxon paired test. p = 0.0730 (N = 23). The effect on the pronephric 
tubules could therefore be attributed to the knock-down effect of Pod 1. and not a by-
product of injecting the PMO. The CMO injected embryos also had normal pronephric 
tubule morphology. with PNI of 4 for the injected side of the embryo and 5 for the not 
injected side of the embryo (N = 24). Again. the Wilcoxon paired test revealed no 
significant differences. p = 0.0897. 
Differences in the pronephric duct structure were difficult to ascertain due to a lack of 
staining in the pronephric duct region. This could either be due to abnormal staining or 
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Fig. 7 .6 Pod 1 knock-down disrupts tubule morphology. Embryos were injected at the 8 cell stage into one V2 cell. The 
injections included; 40ng Pod 1 morpholino oligonucleotide and GFP mRNA (A), 40ng Pod 1 morpholino oligonucleotide, 
O.6ng mPod 1 mRNA and GFP mRNA (B) and 40ng control morpholino oligonucleotide and GFP mRNA (C). The left or 
right pronephric targeting was indicated using GFP fluorescence. Not injected sides and injected sides of the same embryos 
are as shown. Wholemount immunohistochemistry was performed stage 39 to 42 embryos, identifying the pronephric 
tubules, 3G8 (purple), and the duct, 4A6 (red). The pronephric tubules of Pod 1 knock-down pronephroi were disorganised 
compared to the not injected side of the same embryo (A). The phenotype was rescued in mouse Pod 1 mRNA injected 
embryos which have a normal pronephros (B). The control morpholino oligonucleotide injected embryos have normal 
pronephric tubule morphology (C). 
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a phenotypic difference. Further repeat experiments and section analysis will resolve 
this issue. 
Although striking, these data have not been repeated, since they were achieved late in 
the project. Further analysis is therefore required to clarify the true nature of the 
pronephric tubule phenotype during Pod 1 knock-down. However, the success of the 
mouse Pod 1 rescue suggests the phenotype discovered was genuine. 
7.2.1.3 Pod 1 knock-down has no obvious effect on Xliml expreSSIOn, but 
abrogates Pax 8 expression in the pronephric anlagen 
The embryos were injected and sorted as previously. To visualise the pronephric 
anlagen, wholemount in situ hybridisation was performed on embryos staged 20 to 25, 
with an Xliml DIG-labelled antisense RNA probe. The area of Xliml expression was 
measured on both sides of the embryo using the LUCIA programme (Laboratory 
Imaging Ltd.). The data indicated that Pod 1 knock-down did not have an effect on 
Xliml expression in the pronephric anlagen (Fig. 7.7) (Appendix). There was no 
significant difference observed by the Wilcoxon paired test between the injected and not 
injected sides of the embryo in the 40ng PMO injected embryos (N = 31, P = 0.1042), 
the 40ng PMO and 0.6ng mouse Pod 1 mRNA injected embryos (N = 26, P = 0.8117) 
and the 40ng CMO injected embryos (N = 28, P = 0.6556). 
Another marker for the pronephric anlagen is Pax 8 (Carroll and Vize, 1999). Pod 1 
expression in animal caps was shown to effect Pax 8 expression by RT-PCR (Chapter 7, 
paragraph 7.2.3). The PMO experiment was repeated with the exception that the probe 
used in the whole mount in situ hybridisation analysis was a Pax 8 DIG-labelled 
antisense RNA probe. In addition, 1.2ng of mouse Pod 1 mRNA was required to rescue 
the PMO phenotype. Pod 1 knock-down eliminated Pax 8 expression in the pronephric 
anlagen of 12 out of 25 embryos (Fig. 7.8). Fisher's exact test indicated a significant 
correlation in the observation of Pax 8 expression and whether the side of the embryo 
was injected, p < 0.0001. Co-injection with mouse Pod 1 mRNA restored Pax 8 
expression in the pronephric anlagen of 16 out of 21 embryos, and no correlation with 
the presence of expression domain in the injected and not injected side of the embryos, 
was found after Fisher's exact test, p = 1836. The control morpholino oligonucleotide 
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Fig. 7.7 Pod 1 knock-down has no effect on early Xliml expression. The 8 cell embryos were 
injected into one V2 cell with either; 40ng Pod J morpholino oligonucleotide and GFP 
mRNA (A) or 40ng control morpholino oligonucleotide and GFP mRNA (B). Left or 
right pronephric targeting was identified using GFP fluorescence. The injected and not 
injected sides of the same embryo are as shown. Wholemount in situ hybridisation was 
perfonned with an Xfim 1 DIG-labelled antisense RNA probe on stage 20 to 25 
embryos to indicate the pronephric anlagen. Pod I knock-down did not appear to have 
an effect on early X/im J expression (A). The control morpholino oligonucleotide 
injected embryo al 0 had normal X/im 1 expression (B) . 
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Fig.7.8 Pod 1 expression is required for Pax 8 expression. The embryos were injected at the 
8 cell stage into one V2 cell, with; 40ng Pod 1 morpholino oligonucleotide and GFP 
mRNA (A), 40ng Pod 1 morpholino oligonucleotide, 0.6ng mPod 1 mRNA and GFP 
mRNA (B) and 40ng control morpholino oligonucleotide and GFP mRNA (C). GFP 
fluorescence was used to identify left or right pronephric targeting. The not injected 
sides and injected sides of the same embryos were as shown. Wholemount in situ 
hybridisation was performed with a Pax 8 DIG-labelled antisense RNA probe on stage 
20-25 embryos. Pod 1 knock-down eliminated Pax 8 expression in the pronephric 
anlagen (A). Pax 8 expression was restored by co-injecting mouse Pod 1 mRNA, as it 
does not bind to the Pod 1 morpholino oligonucleotide (B). The control morpholino 
oligonucleotide injected embryos showed normal Pax 8 expression (C). 
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injected embryos showed normal Pax 8 expression on both sides of the embryo and also 
gave no correlation with Fisher's exact test, p = I (N = 20). 
7.2.2 Pod J expressIOn was initiated at the same stage as other pronephric 
development genes 
The temporal expression pattern of Pod I was determined using RT-PCR in Chapter 5. 
The same method was used to compare the temporal expression patterns of other 
pronephric development genes and class A basic helix-loop-helix transcription factors to 
that of Pod I. This might indicate which genes Pod I expression might influence 
during pronephric development. RT-PCR was performed using primers designed for 
E12, E47, ITF2b, Lim I, Pax 2, Pax 8, W[] and xlmxlb (Methods Table 2.1). The 
mRNA was extracted from stages 9, 13, 16, 21, 26, 30, 35 and unfertilised eggs and 
cDNA was generated. As previously, the input cDNA was equalised using ODe and a 
linearity was produced using doubling dilutions of stage 35 cDNA. The class A basic 
helix-loop-helix transcription factors, E12. E47, and ITF2b were expressed in 
unfertilised eggs or early in the blastula and did not have similar temporal expression 
patterns to Pod 1 (Fig. 7.9). The pronephric development genes, however, were all up 
regulated at stage 13. pronephros initiation. except for WT 1 expression which was 
initiated at stage 21. 
7.2.3 Pod J expreSSIOn in animal caps can up-regUlate other pronephric 
development genes 
Pod 1 is a basic helix-loop-helix transcription factor and is, therefore likely to be 
involved in a transcriptional network of genes resulting in the formation of the 
pronephros. It may be possible, using an animal cap system, to investigate the genetic 
pathway within which Pod 1 acts. As described previously (Chapter 3), an animal cap 
is dissected from the animal pole region of the embryo at stage 8/9. This region of the 
embryo is multipotent and under the influence of 'differentiating factors', can form 
different tissues (Okabayashi and Asashima. 2(03). The response of an animal cap to 
an injected mRNA could be interpreted as a simplification of events that occur in the 
whole embryo. Therefore, by analysing dissected animal caps injected with Pod I 
mRNA the Pod 1 or other pronephric development genes down stream in the genetic 
network could be revealed. 
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Fig.7.9 Pod 1 temporal expression compared to a selection of pronephric development 
genes and class A basic helix-loop-helix transcription factors. RT-PCR was 
performed on unfertilised Xenopus laevis eggs (UF) and whole Xenopus laevis embryos 
at tage 9, 13, 16,2 1,26,30 and 35, using Pod i, E12, E47, Lim 1, Pax 2, Pax 8, WI i , 
ITF2b, xlmxi b primers. Equalisation was carried out usi ng ODC as a loading control 
and linearity was performed with doubling dilutions of input cDNA from stage 35 
embryos. Negative controls include (-RNA) no RNA in the reverse transcription 
reaction, (-RT) no rever e transcriptase in the reverse transcription reaction and (-) no 
cDNA in the PCR reaction. RT-PCR analysi indicated that the class A basic helix-
loop-helix tran cription factors, E12, E47, and ITF2b were expressed in unfertilised 
eggs or early in the blastula. The pronephric development genes, Pod i, Lim i, Pax 2, 
Pax 8, and xlmxi b were all up regulated at stage 13. except for WJ J expre sion which 
was initiated at tage 21. 
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Pax 2, Pax 8, or wn mRNA was transcribed as described in Table 7.1 and Pod 1 
mRNA was made as described in Chapter 6. Embryos were injected with 
approximately O.6ng of mRNA at the I cell stage. The animal caps were dissected from 
stage 8/9 embryos and incubated until stage 25. mRNA was extracted from the animal 
caps and cDNA was made. PCR was performed using primers designed for Pax 2, Pax 
8, Pod I, wn and Podocalyxin 1 (Methods Table 2.1). Podocalyxin 1 is known to be 
expressed in the podocytes and is induced by WTl (Palmer, et al., 200 I). EF 1 a was 
used to equalise the input eDNA. A linearity and negative controls were performed as 
previously described. 
Pod 1 appeared to up-regulate Pax 2, Pax 8, Podoca/yxin J and WTl in animal caps 
(Fig. 7.10). Pod I, however, was not up-regulated by Pax 2, Pax 8, nor WT I, 
suggesting that these genes are downstream of Pod 1 in the hypothetical pathway. 
Interestingly, Pax 8 and WTl injected animal caps behaved similarly, and up-regulated 
Pax 2 and Podocalyxin 1. Pax 8 and WT 1 injected animal caps were also able to 
increase the expression of each other, which may indicate a regulatory loop in the 
pathway. 
7.2.4 Co-injection of Pod 1 with class A basic helix-loop-helix transcription 
factors E12, E47, HER and ITF-2 fails to indicate any potential association 
Pod 1 is a class B basic helix-loop-helix transcription factor (Hidai, et al., 1998, 
Quaggin, et al., 1998, Robb, et al., 1998). Conventionally, class B basic helix-loop-
helix transcription factors are expected to either form homodimers or heterodimerise 
with class A basic helix-loop-helix transcription factors. As detailed in Chapter 5, it is 
unknown whether Pod 1 homo- or heterodimerises in vivo. Possible binding partners 
include E12, HEB, HEB-s, ITF-2 (Lu, et al., 1998, Miyagishi, et al., 2000a, Miyagishi, 
et al., 2000b) and there is evidence of homodimerisation (Hidai, et al., 1998). One way 
to investigate potential binding partners was to inject Pod 1 and selected class A basic 
helix-loop-helix transcription factors into embryos alone and in combination, and 
perform RT -PCR on dissected animal caps for known pronephric development genes. 
An up-regulation of a pronephric development gene in a co-injection would suggest an 
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Gene Plasmid Digest mMessage mMachine Source 
kit (Ambion) 
Xenopus E12 EI2 pSP64 Xpm Xba 1 SP6 Kindly donated by Prof. Gurdon, (Rashbass, et aI., 
1992) 
Human E47 hE47p pGEM Teasy Sst II SP6 Kindly donated by Dr Caroline Haldin 
MouseHEB HEB pBluescript KS Not 1 T3 BC037097, ordered from the IMAGE consortium 
(hup:/limage.llnl.gov, IMAGE No. 5345693) and 
cloned into pBluescript KS with Eco RV and Not 1. 
Mouse ITF2b ITF2b pBluescript Not 1 T3 BC043050, ordered from the IMAGE consortium 
KS (hup://image.llnl.gov, IMAGE No. 5708370) and 
cloned into pBluescript KS with Eco RI and Not I. 
Xenopus Pax 2 xPax 2 pSP64TS Sst 1 SP6 Kindly donated by Dr Tom Carroll 
Xenopus Pax 8 xPax 8 pCS2+ Sst II SP6 Kindly donated by Dr Tom Carroll 
Xenopus WT 1 xWTI pSP64TS Sst 1 SP6 Kindly donated by Dr Tom Carroll 
Table 7.1 mRNA sources used in animal cap assays. Details of mRNA preparation for subsequent injection into embryos for animal cap 
assays. For full plasmid details, please refer to the Appendix. 
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Fig. 7. 10 Pod 1 may up-regulate other pronephric development genes. Approximately O.6ng 
of either Pod J, Pax 2, Pax 8, or WTl mRNA was injected into embryos at the 1 cell 
stage (labelled horizontally). Animal caps were taken at stage 8/9 and incubated in Y2 
strength Barth' X. mRNA wa extracted from animal caps and whole embryos when 
they reached tage 25 and cDNA was generated. PCR was performed using primers 
designed for Pax 2, Pax 8, Pod l, PodocaLyxin land WTl, as indicated vertically. 
Negative controls include, (-RNA) no RNA in the reverse transcription reaction , (-RT) 
no rever e tran cripta e in the rever e transcription reaction and (-) no cDNA in the 
PCR reaction . A linearity control was performed using doubling dilutions of whole 
embryo cDNA and the loading of cDNA in the peR reaction was equalised u ing EFla. 
Levels of expres ion were compared with animal caps taken from not injected embryos 
(Not injected). Pod 1 appeared to up-regulate Pax 2, Pax 8, Podocalyxin land WTJ . 
Pax 8 and WTl behaved similarly, up-regulating Pax 2, Pax 8, PodocaLyxin land WTl. 
Pax 2 weakly up-regulated Podoca/yxin J. Pod I, however, is not up-regulated by Pax 
2, Pax 8, or WTl, ugge ting it lie close to the start of the regulatory cascade. 
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interaction and may be taken as evidence of heterodimerisation with the class A basic 
helix-loop-helix transcription factor. 
The mRNA for the class A basic helix-loop-helix transcription factors, E12, E47, HEB 
and ITF2b were generated according to Table 7.1. Approximately 0.6ng of Pod 1, E12, 
E47, HEB and ITF2b mRNA was injected into I cell embryos alone and in pairs (Pod 1 
+ E12, Pod 1 + E47, Pod 1 + HEB and Pod 1 + ITF2b). The animal caps were 
dissected from stage 8/9 embryos and were incubated until stage 20-25. The mRNA 
was extracted from animal caps and some stage control whole embryos and cDNA was 
generated. PCR was performed using primers designed for Pax 2, Pax 8, Pod 1, 
Podocalyxin I, Xlim I, xlmxlb and WTI (Methods Table 2.1). The input cDNA was 
equalised using EF 1 a and a linearity and negative controls were performed. The up-
regulation of pronephric genes by Pod I was not enhanced by the class A basic helix-
loop-helix transcription factors injected, suggesting Pod 1 may act as a homodimer or at 
least failed to heterodimerise with the class A transcription factors tested (Fig. 7.11). 
E12 alone was able to up-regulate all the pronephric development genes tested, except 
Podocalyxin 1. This was an unexpected property for a class A basic helix-loop-helix 
transcription factor. E 12 may have a role in pronephric development gene regulation or 
may be binding to a different class B transcription factor involved in pronephric 
development. The E12 mRNA injected animal caps were extended, indicating 
mesoderm formation which could explain the up-regUlation of the genes (Data not 
shown). This intriguing result may benefit from further investigation. 
7.2.5 Retinoic acid and activin A effects Pod 1 expression in treated animal caps 
Retinoic acid and activin A can induce many different tissues, including the pronephros 
(Taira, et al., 1994, Brennan, et al., 1999 and Osafune, et al., 2002), in treated animal 
caps, as detailed in Chapter 3. It is probable, therefore, that retinoic acid and activin A 
treatment in animal caps could effect the expression of pronephric development genes. 
To observe their effects on Pod 1 expression, Xenopus animal caps were treated with 
different concentrations of retinoic acid and activin A. The animal caps from stage 8/9 
embryos were dissected and incubated overnight in a range of 0 to I x 10-4M of retinoic 
acid and 0 to 20ng/ml of activin A. as previously described (Chapter 3). Following 
treatment, the animal caps were incubated in Barth X until the equivalent of stage 22 
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Fig. 7. 11 Pod 1 pronephric gene up-regulation was not enhanced by the presence of class A 
basic helix-loop-helix transcription factors El2, E47, HEB and ITF2b. 
Approximately 0.6ng of Pod I mRNA and class A basic helix-loop-helix transcription 
factor mRNA, E12, E47, HEB and ITF2b, were injected into 1 cell embryos, alone and 
in combination (labelled horizontally). Animal caps were di sected from stage 8/9 
embryos and incubated until stage 20-25. The mRNA was extracted from animal caps 
and tage control whole embryo and eDNA wa generated. peR was performed using 
primer designed for Pax 2, Pax 8, Pod / , Podocalyxin 1, Xlim 1, xlmxlb and WTl, as 
indicated vertically. Negative controls include, (-RNA) no RNA in the reverse 
transcription reaction, (-RT) no reverse transcriptase in the reverse transcription 
reaction and (-) no cDNA in the peR reaction. A linearity check was performed using 
doubling dilutions of whole embryo cDNA and the cDNA in the peR reaction was 
loading equalised u ing EF 1 a. Levels of expres ion were compared with animal caps 
taken from not injected embryo (Not injected). Pod 1 up-regulation was not enhanced 
by the class A ba ic helix-loop-helix transcription factors injected. Interestingly, the 
class A ba ic helix-loop-helix tran cription factor E12 was able to up-regulate all the 
pronephric development genes tested, except PodocaLyxin 1. 
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when the mRNA was extracted (animal cap treatment and mRNA extraction carried out 
by Dr Caroline Haldin). eDNA was generated and PCR was performed using Pod J 
primers (Methods). EF Ja was used as a loading control and a linearity control was 
performed with doubling dilutions of stage 22 whole embryo eDNA. Standard RT-PCR 
negative controls were carried out. Pod J appeared to be induced by activin A alone at 
10 and 20ng/ml, or with low levels of retinoic acid (1 x IO-6M) and 5ng/ml activin A. 
Expression was retained at 10-6 and 10-5 with 10 and 20ng/ml activin A (Fig. 7.12). 
7.3 Discussion 
Pod J expression was shown to be initiated at stage 13, the stage at which the main 
pronephric components are specified. This was also shown to be the same stage as 
other pronephric development genes were up-regulated, and may suggest that Pod J is 
involved in the early events of pronephric initiation. 
Pod 1 and WTl miss-expression 
The Pod J knock-down resulted in a complete reduction of WTJ expression in the 
glomus. Wax-sectioning revealed a lack of cells in the area of the glomus, which could 
be the cause of the missing mRNA expression. Injected animal caps showed that Pod J 
was able to induce the expression of WTl and WT1 was not able to up-regulate Pod I 
expression. This may suggest that WT 1 is in the same pathway and in fact downstream 
of Pod 1. This places Pod I firmly in an important position with regard to development 
of the pronephric glomus. 
The WT1 pronephric over-expression phenotype in Xenopus laevis was not identical to 
that of Pod I observed in Chapter 6. WT lover-expression results in reduced pronephric 
tubules and reduced Xlim1 expression in the pronephric anlagen (Wallingford, et al., 
1998). However, there are similarities in the mouse knock-out phenotypes of Pod I and 
WT J. Both show lack of the maturation of specified glomerulus cells, reduced tubules 
and reduced or absent ureteric bud branching, (Kreidberg, et aI., 1993, Quaggin, et at., 
1999, Moore, et al., 1999 and Cui, et al., 2003). The mouse WT J knock-out phenotypes 
were, however, more extreme than the null Pod I phenotypes. The loss of Pod 1 
resulted in the increase of metanephric condensing mesenchyme, but a failure to 
develop (Quaggin, et al., 1999 and Cui, et at., 2OG3), whereas the null WT J phenotype 
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Fig. 7.12 Pod 1 expression in animal caps treated with retinoic acid and activin. Animal caps were dissected from stage 9 embryos and were 
incubated in a range of concentrations of retinoic acid (M) and activin (nglml) until the equivalent of stage 22. RT-PCR was performed 
on mRNA extracted from the treated animal caps. EFla was used as a loading control and a linearity of doubling dilutions of whole 
embryo cDNA was performed. The negative controls are no RNA in the RT reaction (-RNA), no reverse transcriptase in the RT reaction (-
RT) and no cDNA in the PCR (-). Pod 1 appeared to be up-regulated in animal caps treated with activin A and down-regulated with 
retinoic acid. 
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results in apoptosis of the mesenchyme prior to condensation, (Kreidberg, et al., 1993). 
Interestingly, both Wfl knock-out and Pod 1 knock-out results in tubule abnormalities 
also found in this study with Xenopus laevis where the tubules were reduced with little 
branching morphology. 
Separate knock-out experiments in the mouse with Pod 1 and Wfl have both resulted in 
aspleenism due to apoptotic cell death (Lu, et al., 2000 and Herzer, 1999). The lack of 
glomus observed in this work bears a striking resemblance to the missing spleen tissue 
in these experiments. Further investigation with TUNEL analysis would indicate 
whether apoptosis was the cause of glomus absence. 
Gene regulation in the early pronephric anlagen 
As mentioned in the Introduction, the expression of Pax 8 and Xliml during 
development partially overlap, and over-expression of both Pax 8 and Xliml will 
synergistically form enlarged ectopic pronephroi. These data indicated a co-operation 
between Pax 8 and Xliml in the formation of the pronephric anlagen (Carroll and Vize, 
1999). However, it has also been hypothesised that Pax 8 and Xliml are induced by 
separate pathways due to the differences in partially overlapping expression patterns 
(Carroll and Vize, 1999). Interestingly, Pod 1 knock-down only effects Pax 8 
expression and no measurable difference was observed on Xliml expression. Pod 1 
may therefore be able to transcriptionally regulate Pax 8. Indeed, E box motifs are 
present in the Pax 8 promoter region (Murre, et al., 1989 and ENSEMBLE, Hubbard, et 
al., 2(05). In contradiction to this hypothesis. Pod lover-expression alone does not 
result in the induction of the Pax 8 over-expression phenotype of ectopic pronephroi 
(Chapter 6). This suggests one of two possibilities, either that although Pod 1 may be 
required for pronephric Pax 8 expression, it is not sufficient in itself to induce Pax 8 
expression; or that Pod 1 both induces Pax 8 expression and regulates Pax 8 expression 
levels. Animal cap assay analysis performed in this chapter has shown that Pod 1 alone 
can up-regulate Pax 8 expression, but Pax 8 cannot up-regulate Pod 1 expression, 
eliminating the first of the two possibilities. Pod 1 may therefore be regulating Pax 8 
expression either directly, as Pod 1 is known to have both activational and inhibitory 
transcription properties (Miyagishi, et al., 2(00), or indirectly through an intermediate 
transcription factor. The mouse Pod 1 knock-out phenotype cannot be completely 
explained by a loss in Pax 8 expression as mice lacking Pax 8 expression do not have 
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kidney phenotype (Mansouri, et al., 1998). Pod J therefore may be involved in a 
number of different pathways. This is perhaps supported by its identification in 
multiple roles during development. 
Pod 1 pathway analysis 
Pax 8 has been shown to induce wn expression (Dehbi and Pelletier, 1996), supporting 
the hypothesised pathway in this study of Pod J-+ Pax 8 -+ WfJ (Fig 7.13). As may 
be anticipated due to the role of Pod J in mouse podocyte development, Pod J was able 
to induce Podocalyxin I expression in the animal cap assay. Furthermore, Podocalyxin 
J transcription has been shown to be activated by WTl (palmer, et al., 2001). The 
pathway may therefore be extended; Pod J -+ Pax 8 -+ Wfl -+ Podocalyxin J (Fig 
7.13). Podocalyxin I knock-out studies in mice have shown severe kidney defects 
including the absence of foot processes (Doyonnas, et ai., 200 I). Although similar, the 
expression patterns and mouse knock-out phenotypes of the genes in the hypothetical 
pathway do not match exactly, suggesting that other factors are involved. 
One of these factors could be Pax 2, which was also induced by Pod J expression in 
animal caps. Wf J and Pax 2 are believed to be in a regulatory cycle, whereby WT J 
down regulates Pax 2 expression and Pax 2 induces WfJ expression (Ryan, et al., 1995 
and Dehbi, et al., 1996). Mouse knock-out analysis has show that WTJ expression was 
found to be required for Pax 2 expression in the condensing mesenchyme (Kreidberg, et 
al., 1993) and Pax 2 down regulation was found to be required for podocyte maturation, 
(Quaggin, 2002). In addition, Pax 8 and Pax 2 are believed to be redundant in 
pronephric development, through their ability to rescue knock-out phenotypes 
(Bouchard, et al., 2002). The hypothetical pathway could be further developed to 
include Pax 2, although further analysis is required to support this hypothesis (Fig 
7.13). 
In this study, the relationships of Pod I with Xliml and xlmxl b were also investigated. 
Neither Xliml nor xlmxlb up-regulated Pod I or were up-regulated by Pod I in the 
animal cap assays (Data not shown). Furthermore, in Pod J knock-down embryos, there 
was no measurable effect on Xliml expression. This indicates that Pod I and Xliml are 
on different genetic pathways in the development of the kidney. The phenotypic effect 
on xlmxlb expression observed in Pod I knock-down embryos could be due to the lack 
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search. \. ,,11 arrows indicate results from the animal cap analysis performed in this study. Black shaded arrows 
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(2001) and (d ) Jordan, et al., (1993), Ryan, et al., (1995) and Dehbi, et aI., (1996). ( ) Does not fit with the hypothesis 
that down-regulation of Pax 2 required for podocyte maturation (Quaggin, 2002). 
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of glomus tissue present, rather than a direct down-regulation of gene expressIon. 
Therefore xlmx 1 b also seems unlikely to be on the same gene pathway as Pod 1. 
Class A basic helix-loop-helix Pod 1 binding partners 
Pod I did not appear to associate with the class A basic helix-loop-helix transcription 
factors E12, E47, HEB and ITF2b. It is possible that Pod I forms heterodimers with a 
different class A basic helix-loop-helix transcription factor that has not yet been 
investigated. Although, the four transcription factors were chosen on the evidence from 
previous literature (Lu, et al., 1998, Miyagishi, et al., 2000a and Miyagishi, et al., 
2000b). However, it must be noted that the Xenopus homologues for E47. HER and 
lTF2b have not been identified or were unattainable, and the human E47, mouse HER 
and mouse ITF2b ESTs were used in this study (www.ncbi.nlm.nih.gov). Subtle 
differences in protein structure caused by differences in amino acid sequences could be 
the cause of the inactivity of these transcription factors in the Xenopus embryos. 
Indeed, the Xenopus E 12 indicated strong mesoderm inducing properties, the only class 
A basic helix-loop-helix transcription factor activity observed. It is possible that EI2 is 
binding to endogenous Pod I protein and inducing pronephric tissues. However, as 
class B basic helix-loop-helix transcription factors are typically the rate and tissue 
restricting factors, this model would appear unlikely. 
Heart development and Pod 1 
Pod 1 was up-regulated in animal caps treated with concentrations of retinoic acid and 
activin A similar to those required for an up-regulation of Cardiac actin (Brennan, et 
al., 1999). Pod 1 was found to be expressed in the proepicardium, which although does 
not form directly from the cardiac primordium, does develop to form part of the heart 
(Fransen and Lemanski, 1990). These conditions could therefore be forming heart 
tissue. Surprisingly, however, Pod 1 was not induced in animal caps treated in 
conditions known to produce glomus tissue, which are higher concentrations of retinoic 
acid and activin (Brennan, et al., 1999). The induction of Pod 1 expression by retinoic 
acid and activin A treatment was however, similar to that of Pax 8 (Heller and Brandli, 
1999), a known pronephric development gene (Introduction). 
Both Pod 1 and Wfl were found to be expressed in the epicardium and have been 
implicated by expression patterns in the epithelial/mesenchymal transition of 
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proepicardial cells, (Hidai, et af., 1998, Lu, et af., 1998, Robb, et af., 1998, Lu, et af., 
1999, Moore, et af., 1999, Quaggin, et af., 1999, Andersson, et af., 2001 and Munoz-
Chapuli, et af., 2002). The null wn mouse heart is severely disrupted and does not 
have many epicardial cells (Moore, et af., 1999). Unfortunately, the null Pod 1 mouse 
phenotype has not been analysed in detail, except for observed hemopericardium 
(Quaggin, et af., 1999). Pod 1 and WI 1 are both expressed during the terminal 
development of mouse podocytes in the kidney before they terminally differentiate from 
epithelial cells to partially mesenchymal cells during normal development (Moore, et 
af., 1999). Again, this implies a role for both genes in the epithelial/mesenchymal 
transition of specialised heart and kidney cells. 
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Part 2 Conclusion 
Pod J over-expre ion experiments from chapter 6 indicated that Pod J has a role in 
glomu and heart development. This role appears to be a conserved developmental 
function in the mouse. Further analysis in chapter 7 has shown that Pod J may have a 
regulatory role in early pronephric development and was required for normal glomus 
and pronephric tubule development. Wax-sectioning has further highlighted a possible 
role in glomus cell urvival. In addition, Pod J was expressed in animal caps treated 
with concentration of retinoic acid and activin A similar to that required to produce 
pronephric tissue. The animal cap assay also demonstrated that Pod I does not 
as ociate with class A ba ic helix-loop-helix transcription factors E12, E47, HEB and 
ITF-2 which have previously been implicated as potential binding partners, (Lu, et aI., 
1998, Miyagi hi, et at., 2000a, Miyagishi, et al., 2000b). 
Pod J network analysis has led to the following hypothetical Pod J pathway, although 
further analysis is required. 
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The Role of Darmin r in the Development 
of the Pronephros. 
Chapter 8 
Pronephric lineage targeted Darmin r over-expression disrupts pronephric tubule 
formation. 
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The Role of Darmin r in the Development of the Pronephros. 
Introduction 
This thesis aimed to elucidate the role of two chosen genes in the development of the 
pronephros. The second gene chosen for further investigation was Darmin r. 
Preliminary analysis of Darmin r suggested a role in pronephric tubule development 
(Chapter 5). In order to further elucidate the role of Darmin r in pronephric 
development, the following were investigated: 
Chapter 8 
• Comparison of amino acid sequences of Darmin r homologues to establish 
the degree of evolutionary conservation. 
• Clarify the spatial expression pattern within the pronephros by RT-PCR. 
• Investigate the effects of Retinoic acid and Activin A on Darmin r 
expression. 
• Carry out over-expression studies in developing embryos, using targeted 
micro-injected mRNA. 
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Pronephric lineage targeted Darmin r over-expression disrupts 
pronephric tubule formation. 
8.1 Introduction 
Darmin-related was identified by in a direct secretion screen (Pera, et al., 2003). 
Darmin r (EST BU993920) has 99% identity to Xenopus laevis cytosolic non-specific 
dipeptidase, UniGene cluster xl.l0218. Cytosolic non-specific dipeptidase is also 
known as tissue carnosinase and carnosine dipeptidase 1/ and is in the metallopeptidase 
family M20, specifically M20.oo5. Members of the metallopeptidase family M20.005 
are generally involved in the hydrolysis of dipeptides in the cytosol of mammalian cells 
(MEROPS: Rawlings, et al., 2006). 
Early analysis of Xenopus Darmin r by Pera and colleagues (2003) indicated expression 
in the glomus and the lens of stage 32 embryos. However in this study, expression was 
observed in the pronephric tubules, not the glomus by wholemount in situ hybridisation. 
In order to resolve this issue, a stage 42 pronephric dissection RT-PCR was performed 
and is detailed in this Chapter. The temporal expression of Darmin r detailed by Pera 
and colleagues (2003) was confirmed in this work by RT-PCR (Chapter 5) and 
indicated high levels of maternal expression followed by late tail bud zygotic 
expression. 
In this chapter, the evolutionary conservation of Darmin r was established by 
comparing the amino acid sequences of the human, mouse, fly, worm and yeast Darmin 
r homologues. The region of Darmin r expression within the pronephros was 
determined using RT-PCR with mRNA extracted from a dissected stage 42 pronephros. 
The Xenopus adult spatial expression was elucidated using RT-PCR of adult tissues. 
These data gave an indication of the role of Darmin r in adult tissues. The role of 
Darmin r in pronephric development was investigated using over-expression analysis. 
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8.2 Results 
8.2.1 Darmin r amino acid sequence is evolutionarily conserved 
The full length Xenopus Darmin rEST, BU993920 (Pera, et al., 2003), was obtained 
from the IMAGE consortium (http://image.llnl.gov, IMAGE No. 5512805) and fully 
sequenced in house. The open reading frame runs from 35bp to 1 459bp, encoding a 474 
amino acid protein that is approximately 56kDa when separated on a 10% SDS 
polyacrylamide gel (Fig. 8.5). The EST has recently been linked to the UniGene cluster 
x1.l0218, encoding Cytosolic nonspecific dipeptidase. 
The Xenopus Darmin r amino acid sequence was aligned with the H. sapiens Cytosolic 
nonspecific dipeptidase (NP _060705), M. musculus Cytosolic nonspecific dipeptidase 
(NP _075638), D. melanogaster CG 17337 protein (NP _610 181), C. elegans Glutamate 
carboxypeptidase-like protein 1 (NP _506610) and potential homologue S. cerevisiae 
Hypothetical protein (YFR044C) (Fig. 8.1 A). Percentage similarity values were 
obtained using the NCBI BLAST program (Basic Local Alignment Search Tool, 
Altschul et al., 1990). The alignment indicated a high percentage similarity of 
approximately 80% with the mouse and human homologues, across the whole protein 
(Fig. 8.1 B). Lower levels of percentage similarity were observed with D. melanogaster, 
C. elegans and S. cerevisiae, however, this was expected due to a greater evolutionary 
distance between these species. 
8.2.2 Darmin r is expressed in the pronephric tubules 
The pronephros and individual components, the glomus, pronephric tubules and duct, 
were dissected from a stage 42 Xenopus laevis embryo. The RT-PCR was performed as 
previously described in Chapter 7. 
Darmin r exhibits highest levels of expression within the pronephric tubules and lower 
expression in the glomus (Fig. 8.2). This is in agreement with the whole mount in situ 
hybridisation analysis performed in Chapter 5, where strong expression was observed in 
the pronephric tubules in stages 32 to 42. 
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C. elegans 55 53 53 57 - -
S. cerevisiae 51 48 48 45 47 -
Fig. 8.1 Alignment of homologous Darmin r amino acid equences. (A) Alignment of 
Dannin r amino acid equence (AAH56069), H. sapiens Cytosolic nonspecific 
dipeptida e (NP _060705), M. musculus Cyto olic nonspecific dipeptidase 
(NP _075638) , D. melanogaster CO 17337 protein (NP _610181) , C. elegans Glutamate 
carboxypeptida e-like protein 1 (NP _506610) and potential homologue S. cerevisiae 
Hypothetical protein (YFR044C). Uhll'k shadin • indicates identical amino acids in all 
sequence compared with a frequency greater than 50%, whereas the re' shadin 
pecifie the same amino acid family frequency greater than 50%. (B) Percentage 
identity (%). The table indicates paired percentage identity as given by BLAST (Basic 
Local Alignment Search Tool , Altschul et al., 1990). 
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Fig. 8.2 Spatial pronephric expression of Darmin r in stage 42 X. laevis. The pronephros 
from a Xenopus laevis stage 42 embryo was dissected into the glomus, tubules and duct 
tissues, and an RT-PCR using Darmin r primers was carried out. Equalisation was 
carried out using EFla, and linearity and negative controls carried out as described in 
the methods. A fine dissection of the pronephros of a stage 42 X. laevis tadpole reveals 
the spatial expression of Darmin r within the pronephros. Darmin r appears to be most 
expressed in the tubules, less in the glomus and weakest in the duct. 
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8.2.3 Darmin r is expressed ubiquitously in Xenopus adult tissues 
The Xenopus adult spatial expression of Darmin r was elucidated using RT-PCR 
analysis on mRNA isolated from adult tissues. The RT-PCR analysis might indicate 
whether Darmin r had a particular role in the adult organs. The input cDNA was 
approximately equalised using EF 10. and a linearity check using doubling dilutions of 
kidney cDNA was performed. Darmin r was shown to be ubiquitously expressed in all 
the tissues tested, although it appeared to be more highly expressed in the ovary and 
duodenal samples (Fig. 8.3). 
8.2.4 Retinoic acid and activin A do not have an effect on Darmin r expression 
in animal caps 
As detailed in Chapter 3, retinoic acid and activin A can induce different tissues in 
treated animal caps, including the pronephros (Taira, et al., 1994, Brennan, et al., 1999 
and Osafune, et al., 2(02). It may be hypothesised, therefore, that the expression of 
pronephric development genes could be affected by retinoic acid and activin A 
treatment in animal caps. To observe their effects on Darmin r expression, Xenopus 
animal caps were treated with different concentrations of retinoic acid and activin A. 
Animal caps were dissected from stage 8/9 embryos and incubated overnight in a range 
of 0 to I x IO-4M retinoic acid and 0 to 20ng/ml activin A, as previously described 
(Chapter 3). Following treatment, the animal caps were incubated in Barth X until the 
equivalent of stage 22 when the mRNA was extracted (animal cap treatment and mRNA 
extraction carried out by Dr Caroline Haldin). RT-PCR was then performed using 
EF 10. as a loading control. Darmin r was found to be expressed at a constant level in all 
the animal caps tested (Fig. 8.4). Retinoic acid and activin A did not appear to effect 
the expression of Darmin r in treated animal caps. 
8.2.5 Darmin r over-expression gives a pronephric phenotype 
Pera and colleagues (2003) observed that Darmin r over-expression did not indicate an 
endodermal phenotype, however, no specific analysis of pronephric structures was 
performed at this time. To further investigate the role of Darmin r in pronephric 
development, Darmin r over-expression was targeted to the pronephros and analysed 
using pronephric markers. 
196 
Darmin r 
EFla 
Darmin r 
EFla 
"0 
.S 0 
,.Q e 
CQ CQ 
Neg. 
contro Is 
E 
::3 
c 
~ 
"0 g 
Cl 
>. 
.!l ~ E ~ ... ~ u Q.) ::3 ~ C ~ :2 >. Q.) J,l ::3 
u:J ::r: 
-
~ ~ ...J :; 
---
Linearity 
"E 
~ 0 ..c u E u ~ C >. 
.... ::3 ~ ~ ~ .~ ~ g .... U c '5. J,l :;;: B cr. tI:l ~ 0.. ~ 0 (l.. C/l C/l C/l C/l 
--
Fig. 8.3. Expression pattern of Darmin r in the adult organs of X. laevis. RT-PCR was performed 
on mRNA isolated from the organs of an adult Xenopus laevis. The RT-PCR was equalised 
using EF 1 a and linearity and negative controls performed as described in the methods. 
Darmin r expression is seen in all adult X. laevis organs anaJysed, with a higher expression 
observed in the ovary and the duodenum. 
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Fig. 8.4 Darmin r expression in animal caps treated with retinoic acid and activin A. Animal caps taken from stage 9 embryos were incubated 
in a range of concentrations of retinoic acid (M) and activin A (ng/ml) until the equivalent of stage 22. RT-PCR was performed on 
mRNA extracted from the animal caps. EFJa was used as a loading control and a linearity of doubling dilutions was performed. The 
negative controls are no RNA in the RT reaction (-RNA), no reverse transcriptase in the RT reaction (-RT) and no cDNA in the peR (-). 
Darmin r was expressed in all the animal caps tested. Retinoic acid and activin do not appear to have an effect on Darmin r expression. 
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Targeted Darmin r over-expression was performed by injecting in vitro transcribed 
Darmin r mRNA into a V2 blastomere of an embryo at the 8 cell stage. Darmin r 
eDNA from the IMAGE clone (http://image.llnl.gov, IMAGE No. 4965475) was cloned 
into the pCS2+ plasmid using Eco RJ and Xba J (Appendix), and the mRNA was 
synthesised using the SP6 mMessage mMachine Kit (Ambion). 
The ability of Darmin r mRNA to translate was checked using in vivo translation in 
Xenopus oocytes. The Xenopus oocytes were injected with either Xenopus Darmin r 
mRNA or water and incubated in Barth X containing 35S methionine and cysteine. Any 
new proteins containing these amino acids synthesised after oocytes were injected, were 
therefore radioactively labelled. The mRNA-injected oocytes and the water-injected 
oocytes were compared. Darmin r mRNA was translated, giving a protein of 
approximately 56kDa (Fig. 8.5) consistent with Pera and colleagues (2003). 
Having established the ability of the mRNA to translate, over-expression experiments 
were carried out in Xenopus embryos. In these experiments the in vitro transcribed 
Darmin r mRNA is immediately available for translation in the embryo after injection, 
yielding higher levels of Darmin r expression at an earlier stage than that observed 
during endogenous expression. The V2 cell of an 8 cell embryo was injected to target 
the pronephric region. Darmin r mRNA was co-injected with GFP mRNA to facilitate 
lineage tracing and the embryos were sorted for pro nephric left or right fluorescence at 
stage 25-30 (Methods 2.10.3 Micro-injection). GFP mRNA was also injected alone as a 
negative control, which indicated the effect of injecting an embryo with a 
developmentally irrelevant mRNA. 
The size of the glomus, pronephric anlagen and length of embryo was measured as 
described in Methods 2.10.7 Measurement of tissue area. When analysing the glomus 
and the pronephric anlagen, the length of the embryo was measured to eliminate the 
factor of the overall size of the embryo on the size of the glomus/pronephric anlagen. 
Where the comparison was made between different sets of embryos, the ratio of 
glomus/pronephric anlagen area to embryo length of each set was used in the analysis. 
The statistical analysis of measurements involved a Kruskal Wallis test, and a Dunn's 
post test to indicate the significant differences between the groups of test subjects. All 
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Fig. 8.5 Oocyte translation of Darmin r mRNA. Oocytes were injected with Darmin r mRNA 
and incubated overnight in full strength Barth X containing 35S labelled methionine and 
cy teine. The protein from the oocytes was extracted and run on a 10% SDS PAGE gel 
and expo ed for autoradiography. Oocytes were injected and lanes were loaded as 
indicated. Protein product of the injected Darmin r mRNA transcripts are highlighted 
by the black arrow. As indicated, the size of the Xenopus Darmin r protein is 
approximately 56kDa. The lane labelled "No injected mRNA" is the negative control 
where no mRNA wa injected and no Darmin r over-expression is observed. 
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statistical analysis was performed using the InSTAT 3 programme, (GraphPad Software 
Inc). 
8.2.5.1 Darmin r over-expression disrupts tubule development 
One of the V2 blastomeres was injected in each 8 cell embryo with 0.5ng Darmin r 
mRNA and GFP mRNA or GFP mRNA alone. GFP fluorescence was used to indicate 
pronephric targeting of the left or right side of the embryo. 3G8 and 4A6 
immunohistochemistry was used to observe the pronephric tubule (3G8) and duct (4A6) 
phenotypes at stage 40. 
Similarly to Chapter 6, the pronephric tubule phenotype was determined using the 
Pronephric Index (PNI) (Wallingford, et al., 1998) (Methods 2.10.8 Pronephric Index) 
and subsequent statistical analysis. The significant difference of the Pronephric Index 
(PNI) between the different sides of the embryos were validated using either the paired 
t-test, if the data were normal, or the Wilcoxon paired test, if the data were not normal. 
The morphology of the pronephric duct was scored by eye and given a rating of 
reduced, normal or enlarged. 
Injecting the embryos with 0.5ng Darmin r mRNA and GFP mRNA disrupted tubule 
development, reducing the PNI on the injected side of the embryo (Fig. 8.6). Half of the 
0.5ng Darmin r mRNA and GFP mRNA injected embryos analysed gave a PNI 
left/right difference of 2 or more. The 0.5ng Darmin r mRNA and GFP mRNA injected 
embryos has a median PNI of 2 on the injected side and 4 on the not injected side (N = 
20). The data did not have a normal distribution, so the Wilcoxon paired test was used, 
which indicated a significant difference in PNI between the injected and the not injected 
sides, p < 0.000 1. 
The GFP mRNA alone injected embryos did not show any tubule phenotype and had a 
median PNI value of 5 on both the injected and not injected side (N = 43). The 
Wilcoxon paired test was used as the data was not normal, which did not show a 
significant difference in PNI, p = 0.4261 (Fig. 8.6). 
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Fig. 8.6 Darmin r over-expression disrupts tubule formation. Embryos were injected with 
either; Darmin r mRNA and GFP mRNA (A) or GFP mRNA alone (8). Injections 
were done at the 8 cell stage into one V2 cell to target the pronephros. Embryos were 
sorted using GFP fluorescence, checking for pronephric targeting. Not injected sides 
and injected sides of the same embryos are as indicated. Antibody staining was 
performed with 3G8 to highlight the tubules, on stage 39-41 embryos. (A) Darmin r 
over-expression disrupts tubule morphology. (8) GFP, used as an injected mRNA 
control, does not affect tubule development. 
203 
Chapter 8 
The pronephric duct appeared similar on the injected and not injected sides of the 
embryo of both the 0.5ng Darmin r mRNA and GFP mRNA injected embryos and the 
GFP mRNA alone injected embryos (Data not shown, Statistical analysis in Appendix). 
8.2.5.2 Darmin r over-expression does not effect the size of the glomus 
In ritro transcribed 0.5ng Darmin r mRNA and GFP mRNA or GFP mRNA alone was 
injected into one V2 cell of an 8 cell embryo as before. The pronephric left/right 
targeting was again, lineage traced using GFP fluorescence. However to observe the 
size of the glomus. whole mount in situ hybridisation using a WTI antisense DIG-
labelled RNA probe was perfonned on stage 33-35 embryos. The glomus area on each 
side of the embryo was measured (Methods 2.10.7 Measurement of tissue area). 
There was no observable difference in glomus area on the injected side of the embryo 
compared to the not injected side of the embryo of 0.5ng Darmin r mRNA and GFP 
mRNA or GFP mRNA alone injected embryos (Fig. 8.7). The mean areas of glomus 
were 0.020mm2 for the injected side and 0.022mm2 for the not injected side (N = 33) of 
O.5ng Darmin r mRNA and GFP mRNA injected embryos. The Wilcoxon paired test 
was used to analyse the non parametric data. This did not show a significant difference. 
p = 0.5477. 
The GFP mRNA alone injected embryos also did not indicate a significant difference in 
glomus area, giving a glomus mean area of 0.024mm2 for the injected side, 0.025mm2 
for the not injected side (N = 34) and a Wilcoxon paired test p value of 0.5958 (Fig. 
8.7). 
8.2.5.3 Darmin r over-expression may effect nephrostome distribution 
As previously, 0.5ng Darmin r mRNA and GFP mRNA or GFP mRNA alone was in 
vitro transcribed and injected into one V2 blastomere of an 8 cell embryo. GFP 
fluorescence was used for lineage tracing left/right pronephric targeting. The 
nephrostomes were identified by wholemount in situ hybridisation with a fJ-tubulin 
antisense DIG-labelled RNA probe on stage 34 embryos. 
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Fig. 8.7 Darmin r over-expression does not have an effect on the glomus. Embryos were 
injected with either; 0.48ng Darmin r mRNA and GFP mRNA (A) or GFP mRNA 
alone (B). Injection were done at the 8 cell stage into one V2 cell to target the 
pronephros. Embryo were orted u ing GFP fluorescence, checking for left or right 
pro nephric targeting. Not injected ide and injected sides of the same embryos are as 
indicated. Wholemount in situ hybridi ation with a Wfl DIG-labelled antisense RNA 
probe wa performed on stage 33-35 embryos. (A) Darmin r over-expression does not 
have an effect on the ize of the glomus as indicated by Wfl expression. (B) The 
GFP mRNA control injected embryos al 0 have a normal ized the glomus. 
205 
Chapter 8 
Darmin r over-expression appears to alter the positioning of the nephrostomes (Data not 
shown). The two anterior nephrostomes appear closer together and the dorsal most 
nephrostome is more dorsal. This phenotype was categorised by observing whether the 
nephrostome patterning of the injected side matched that of the not injected side for 
both the 0.5ng Darmin r mRNA and GFP mRNA injected embryos and the GFP 
mRNA alone injected embryos. The data was analysed using the Fisher's exact test 
rather than the more well known Chi Square test due to the table producing I degree of 
freedom, and the low values within the table (Appendix). 
32% of embryos injected with 0.5ng Darmin r mRNA and GFP mRNA have 
disorganised nephrostomes on the injected side compared to 9% of GFP mRNA alone 
injected embryos. The Fisher's exact test indicates that there was a significant 
association between the mRNA injected and organisation of nephrostome, p = 0.0091. 
However, this experiment was performed once and would need to be repeated in order 
to draw reliable conclusions. 
8.2.5.4 Darmin r over-expression may reduce the size of the pronephric anlagen 
The embryos were injected with mRNA as previously and the embryos were sorted and 
fixed at stage 20-25. The pronephric anlagen was identified using wholemount in situ 
hybridisation with a lim} antisense DIG-labelled RNA probe. The pronephric anlagen 
on each side of the embryo and the length of embryo was measured (Methods 2.10.7 
Measurement of tissue area). 
Exogenous Darmin r expression appears to reduce the area of the pronephric anlagen, as 
indicated by liml expression (Fig. 8.8). The mean area of the pronephric anlagen on the 
injected side was 0.032mm2 and the not injected side was 0.038mm2 of 0.5ng Darmin r 
mRNA and GFP mRNA injected embryos, and there was a significant difference with 
the Wilcoxon paired test, p = 0.0199 (N = 32). The mean area of GFP mRNA only 
injected side of the embryos was 0.031 mm2, and the not injected side of the embryo 
was 0.029mm2, with no significant difference after the Wilcoxon paired test, p = 0.3391 
(N = 36). 
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Fig. 8.8 Darmill r over-expression reduces the size of the pronephric anlagen. Embryos 
were injected with either; 0.5ng Darmin r mRNA and GFP mRNA (A) or GFP 
mRNA alone (B). Injections were done at the 8 cell stage into one V2 cell to target 
the pronephro. Embryos were sorted using GFP fluorescence, checking for left or 
right pronephric targeting. Not injected sides and injected sides of the same embryos 
are as indicated. Wholemount in situ hybridisation with a lim] DIG-labelled antisense 
RNA probe was performed on stage 20-25 embryos. (A) Darmin rover-expression 
reduces the size of the pronephric anlagen as indicated by lim] expression. (B) The 
GFP mRNA injected embryos have a normal sized the pronephric anlagen. 
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However, there was no significant difference observed when comparing ratios of 
pronephric anlagen to length of embryo of the experimental and control embryos. In 
addition to this, analysis of untargeted whole embryo experiments where the embryo 
was injected at the I cell stage, have been inconclusive (Data not shown). Further 
investigation is therefore required to elucidate the effect of Darmin r over-expression on 
the pronephric anlagen. 
8.2.6 Darmin r knock-down experiments 
A morpholino oligonucleotide was designed using the published Darmin r cDNA 
sequence (EST BU993920; Pera, et al., 2003) (Chapter 7). The Darmin r morpholino 
oligonucleotide was designed to bind across the translational start site by Gene Tools 
(www.gene-tools.com) (Fig. 8.9). In vitro translation of Darmin r and Pod 1 mRNA 
was performed using the Rabbit Reticulolysate system (Promega) and the proteins 
labelled with 35S methionine. An autoradiograph showed Darmin r translation 
knocked-down by Darmin r morpholino oligonucleotide and not by Pod 1 morpholino 
oligonucleotide. In addition, Pod 1 translation was not effected by the Darmin r 
morpholino oligonucleotide. This indicated that the Darmin r morpholino 
oligonucleotide should specifically knock-down Darmin r expression (Fig. 8.9). 
The authenticity of a morpholino oligonucleotide generated phenotype is typically 
tested using a rescue mRNA that will not bind to the morpholino oligonucleotide and 
will functionally replace the activity of the knocked-down gene (Chapter 7). For 
Darmin r knock-down experiments, the mouse homologue, Cytosolic nonspecific 
dipeptidase (BCOO5532) (Fig. 8.9), could be used. The Darmin r morpholino 
oligonucleotide should not bind to this mRNA. 
Unfortunately there was not enough time investigate Darmin r knock-down in Xenopus 
embryos, however with a relatively strong over-expression phenotype, Darmin r knock-
down analysis would be very interesting to investigate. 
8.3 Discussion 
The Xenopus Darmin r amino acid alignment with Cytosolic nonspecific dipeptidase 
homologues, indicated a high percentage similarity, 80%, with humans and mice and 
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Fig.8.9 In vitro Darmin r expression is knocked-down by a Darmin r morpholino 
oligonucleotide. (A) A morpholino oligonucleotide was designed using the Xenopus 
Darmin r sequence (EST BU993920, www.ncbi.nlm.nih.gov) to include the tranlational 
by Gene Tool (www.gene-tools.com). By annealing to Xenopus Darmin r 
mRNA, the morpholino oligonucleotide will inhibit translation and knock-down Darmin 
r protein expre sion. The Darmin r morpholino oligonucleotide (5' CAA ACA GGG 
CTG GCA GAA CAG ACA T 3 ') is shown in reverse to indicate binding region. To 
re cue the Darmin r knock-down, mouse Dat'min r (M. musculus Cytosolic nonspecific 
dipeptidase, BC005532) could be used as it will not anneal to the morpholino 
oligonucleotide. (B) Autoradiograph showing in vitro translation of Darmin r and Pod 
1 mRNA knocked-down by re pective morpholino oligonucleotides. Lanes and 
protein are labelled accordingly. Negative control does not contain any mRNA, and 
therefore no protein is ob erved. In vitro translation was performed using the Rabbit 
Reticulocyte ly ate y tern (Promega). 
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good percentage similarity with less related organisms, the fly, worm and yeast. This 
high degree of similarity across the phyla suggests a conserved biological role. 
The published Darmin r wholemount in situ hybridisation indicated expression in the 
glomus at stage 32. This is in conflict with the wholemount in situ hybridisation 
performed in this study, where expression was observed in the pronephric tubules at 
stage 32. At stage 32 the glomus and the pronephric tubules are difficult to distinguish, 
however, the transverse sections of embryos subjected to Darmin r wholemount in situ 
hybridisation within the published paper are more consistent with expression within the 
pronephric tubules. We conclude that the published interpretation of the spatial 
expression of Darmin r is incorrect. 
Consistent with adult human expression patterns (Teufel, et al., 2003 and Janssen, et al., 
2(05), Darmin r expression was observed ubiquitously in Xenopus adult tissues. The 
adult organ expression pattern is in keeping with Cytosolic nonspecific dipeptidase's 
role as a housekeeping enzyme involved the catabolism of dipeptidic substrates in adult 
tissues (Teufel, et ai., 2003). 
Darmin r was evenly expressed in all the retinoic acid and activin A treated animal 
caps. Darmin r expression was observed at high level at stage 9 by a temporal RT -PCR. 
This expression appears to be continued in dissected animal caps from this stage, as 
indicated by the untreated animal cap. Although retinoic acid and activin A treatment 
did not appear to have an effect on Darmin r expression. it is still possible that Darmin r 
is involved in pronephric development. The mRNA in this experiment was extracted 
from animal caps at stage 22, the stage at which the pronephric anlagen is elongating. 
However temporal RT -PCR did not show Darmin r expression at this stage. It is 
conceivable, that Darmin r has a role later in pronephric development; especially when 
considering the over-expression phenotype involved pronephric tubule structure, which 
is formed later than stage 22. 
Darmin r over-expression disrupts the organisation of the pronephric tubules, the region 
of highest pronephric expression. The pronephric duct and the glomus showed no or 
low endogenous expression and did not appear to be effected by Darmin r over-
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expression. The exogenous Darmin r pronephric tubules were larger and had less 
branches/components than the negative controls. 
The nephrostomes, ciliated funnels located at the origin of the tubules ( 1.1.1 
Introduction), were disorganised. This would be consistent with the tubule Darmin r 
over-expression phenotype, as nephrostomes are linked to the pronephric tubules. 
However, exogenous Darmin r expression had a reduced effect on the nephrostome 
positioning, compared to the highly disrupted pronephric tubule coiling. Nephrostome 
positioning may therefore be more dependant on the position of the coelom than the 
pronephric tubule structures. Concurrently, the nephrostomes are formed from the 
tubule primordium, before the coiled tubules develop (Jones, 2005). Furthermore, in 
zebrafish, transient nephrostomes are formed in the coelom before the tubules develop 
(Drummond, 1998). 
Darmin r over-expression reduced the area of the pronephric anlagen. The reduction of 
the pronephric anlagen suggests that either there was a reduced number of pronephric 
competent cells forming the pronephros, or a condensation of these cells to occupy a 
smaller area. Wholemount in situ hybridisation using a DIG-labelled Xliml antisense 
probe to highlight the cells of the pronephric anlagen and wax-sectioning of the Darmin 
r over-expressed embryos would resolve this issue. If, however, the cells were 
condensed, then other pronephric morphological differences may be expected. A 
reduction in pronephric competent cell number could explain the localised effect on the 
tubules. Considering the previously stated hypothesis, that pronephric anlagen may 
develop into the three component subunits sequentially, Darmin r over-expression could 
be reducing the available pronephric competent cells to form the pronephric tubules. 
Darmin r is endogenously expressed in the tubules, possibly as a factor of later tubule 
development. The presence of Darmin r could prematurely signal the end of pronephric 
tubule development, and so result in a disruption of tubule morphology. 
Darmin r is also identified as Cytosolic nonspecific dipeptidase which is involved in the 
breakdown of dipeptides. The kidney has been identified to have a major role in the 
removal of dipeptides from the blood (Lochs, et ai., 1988). Darmin r may therefore 
function as a general dipeptidase, hydrolysing dipeptides in the pronephric tubules for 
reabsorbtion or excretion. However, this does not explain why Darmin r is expressed 
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during development. Darmin r could be regulating biologically active dipeptides, such 
as carnosine which is associated with cellular oxidative resistance and functional 
exhaustion (Boldyrev, 2000), neurotransmission (Sassoe-Pognetto, et al., 1993), and 
ageing (Ferrari, 2004), or similar related dipeptides like carcinine, homocarnosine and 
ophidine (Pegova, 2000). 
Although C.rtosolic nonspecific dipeptidase may not traditionally be expected to have a 
developmental role, recent studies have shown that other metabolic or 'house keeping' 
enzymes do have a role in development. For example, Prolidase, has been implicated in 
fetal maturation, (Gurdol, et al., 1995), NTPDase has been found to have a critical role 
in eye development (Masse, et al., Submitted) and membrane-type matrix 
metalloproteinase I has been found to be involved in lung organogenesis (Irie, et al., 
2(05). 
Further investigation into the role of Darmin r during development could include the 
effect of Darmin r over-expression and knock-down on the expression of tubule 
development genes such as, Pax 2, Pax 8 (Carroll and Vize, 1999), and Annexin IV 
(Seville, et al., 2(02). In addition, knock-down analysis of the pronephric tubules, 
nephrostomes, glomus and duct have not been performed. The potential regulatory 
effect of Darmin r in pronephric development could be examined using animal cap 
assays in the same fashion that has been performed with Pod I (Chapter 7). This may 
further indicate whether Darmin r has a role in the development or function of the 
pronephros. 
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Darmin r is also identified as Cytosolic nonspecific dipeptidase which is involved in the 
breakdown of dipeptides. As expected of a housekeeping enzyme (Teufel, M., et at., 
2(03), the Xenopus adult organ expression pattern indicated expression throughout the 
tissues tested. In addition, the Xenopus Darmin r amino acid alignment with Cytosolic 
nonspecific dipeptidase homologues, indicated a high degree of similarity across the 
phyla suggesting a conserved biological role. 
Over-expression analysis disrupted the structure and branching of the pronephric 
tubules, the region of highest expression in the developing embryo. Unsurprisingly, the 
nephrostomes, ciliated funnels located at the origin of the tubules (Introduction), were 
also weakly disorganised. Darmin r over-expression was found to reduce the area of 
the pronephric anlagen indicating that the disruption of pronephric tubule morphology 
was due to a reduction in pronephric tubule fated cells. 
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Discussion 
9.1 Potential target gene identification 
This thesis had two main aims, the identification of a suitable target gene involved in 
the development of the pronephros and then to study its role in development. The first 
aim was addressed by examining the spatial and temporal expression patterns of genes 
identified from 3 different sources. The effectiveness of the sources of the studied 
genes is discussed. 
9.1.1 Screen of a stage 13 cDNA library with a subtractive hybridisation probe 
The formation of pronephric structures can be induced in animal caps with the 
combined treatment of activin A and retinoic acid, but not by the treatment of the 
factors alone (Taira, et al., 1994, Brennan, et al., 1999 and Osafune, et al., 2002). This 
phenomenon was used to create a subtractive hybridisation probe that potentially 
highlighted the genes involved pronephric organogenesis. The screen was performed 
on a stage 13 cDNA library, the stage of approximate pronephric initiation, to identify 
genes that are involved early in pronephric development (Brennan, et al., 1998). 
The screening methodology had two weaknesses. Firstly, the subtractive hybridisation 
probes could detect the down-regulation of a gene in the animal cap treatments as a 
false positive. Secondly, treatment of retinoic acid and activin A in animal caps can 
also induce anterior and posterior neural tissue, cardiac tissue and pancreatic tissues 
(Haldin, et al., 2003 and Moriya, et al., 2000). This combined with the screen being 
performed using a whole embryo stage 13 cDNA library, meant that not only pronephric 
development genes were highlighted in the screen. 
The screen resulted in the isolation of eight clones from the stage 13 cDNA library. 
Each of the eight clones were found to be expressed in the pronephros, although 
expression was not unique, nor enriched. The eight clones were not chosen for further 
analysis. However, during the course of this work the wholemount in situ hybridisation 
protocol was refined, and some clones now appear to be candidates for further 
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investigation. This screen was therefore successful in the identification of target genes. 
This screening methodology or similar screening methodologies, have previously been 
successful in the isolation of other pronephric genes, for example Annexin IV, XSMP-30 
and X-CypA (Seville, et al., 2002, Sato, et al., 2000 and Masse, et al., 2004). 
9.1.2 UniGene cluster genes 
The second source of potential target genes was from the preliminary analysis of a set of 
UniGene cluster genes that were previously found to be pronephros specific (Personnal 
correspondence Pollet, N). UniGene cluster genes are formed as part of the National 
Center for Biotechnology Information service and are in a public searchable database 
(www.ncbi.nlm.nih.gov). They are created by aligning EST sequences using 
statistically significant sequence similarity in the 3' UTR, the recognition of gene 
sequence characteristics and/or by the identification of possible homologous genes 
across organisms (Wheeler, et al .. 2005). 
The four UniGene cluster genes were found to be expressed the pronephros, although 
expression was not augmented in this region and the UniGene cluster genes were not 
investigated further. In hindsight, the spatial expression analysis could be improved 
with the enhanced wholemount in situ hybridisation protocol, however, the temporal 
expression data were not promising. 
9.1.3 Data mining 
The third source of target genes included data mining to identify Xenopus homologues 
of kidney development genes or newly established genes expressed in the pronephros. 
Pod I and Darmin r were selected for further study after consideration of the literature 
and the preliminary data obtained from the temporal and spatial expression analysis. 
Further investigation of these two potential pronephric development genes proved 
promising and some of the initial work on Pod I has been published (Simrick, et al., 
2(05). A further publication on the functional role of Pod 1 will be written after 
completion of this thesis. 
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9.2 Pod J 
Preliminary analysis of Pod 1, a basic-helix-loop-helix transcription factor, indicated an 
early glomus development gene. with enhanced expression in the pronephros. The 
expression patterns of Pod 1 strongly matched that of the mouse homologue, implying a 
conserved evolutionary role (Hidai, et al., 1998). Pod 1 was therefore chosen as an 
ideal target gene for further functional investigation. 
Functional analysis 
Pod 1 targeted over-expression resulted specifically in the reduction of glomus tissue 
with no alteration in pronephric tubule or duct morphology. The hypothesis was that 
the reduced glomus resulted from the promotion of later glomus differentiation events at 
the expense of glomus cell recruitment from the pronephric anlagen. This concurs with 
data from the mouse. whereby Pod 1 is involved in the terminal differentiation of 
specialised kidney cells (Quaggin, et al .• 1999 and Cui. et al., 2003), although no gain 
of function experiments have been published in the mouse. Further evidence could 
come from the higher order magnification analysis of glomus sections during the course 
of pronephric organogenesis. The developing glomus cells may have a more 
differentiated morphology. or express maturation genes such as podoca/yxin or nephrin 
(Schnabel. et al .• 1989 and Gerth. et al., 2(05). earlier in the presence of exogenous Pod 
1. 
Another hypothesis is that the boundary between the glomus and the pronephric tubules 
may be regulated by the dynamic relationship between wn and Pax 2. The expression 
patterns of Pax 2 and Wfl are exclusive at the glomus/pronephric tubule boundary 
(Carroll. et al .• 1999). WTl has been shown to inhibit Pax 2 expression and Pax 2 down 
regulation was found to be required for podocyte maturation (Ryan. et al .• 1995 and 
Quaggin.2(02). In addition, mouse knock-out analysis has shown that WTl expression 
was found to be required for Pax 2 expression in kidney development and Pax 2 can 
induce WTl expression (Kreidberg. et al., 1993 and Dehbi, et al .• 1996). In this work, 
Pod 1 has been shown to induce both Wf 1 and Pax 2 expression in injected animal 
caps. An over-expression of Pod 1 may therefore lead to an increased expression of 
these factors. resulting in a disruption of the glomus/pronephric tubule boundary. 
Inconsistent with this hypothesis. there does not appear to be a pronephric tubule 
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phenotype with Pod J over-expression. Observation of Pax 2 expression in targeted 
Pod J over-expression would indicate whether Pax 2 expression is increased. Also, the 
observation of another boundary marker, xWnt-4, may also prove interesting (Heller and 
Brandli, 1997). 
The targeted knock-down of Pod 1 resulted in the absence of cells in the glomus region. 
Further investigation with TUNEL analysis would show whether this was due to 
apoptosis. or a failure of cells to proliferate. As mentioned previously, Pod I can 
induce both xWTl and Pax 2 in injected animal caps. Interestingly, Pax 2 expression 
has been linked with protection against apoptosis in mouse kidneys (Porteous, et al., 
2000 and Dziarmaga, et al., 2(03) and wn was found to be required for Pax 2 
expression in mice (Kreidberg, et al., 1993). xWTl expression was found to be reduced 
in Pod J morpholino oligonucleotide injected embryos. The lack of both Pod 1 and 
XWT J may severely reduce Pax 2 expression, which may lead to increased apoptosis in 
Pod I knock-down pronephroi. To test this hypothesis, Pax 2 expression could be 
observed in Pod J knock-down embryos. Also the observation of whether Pax 2 or 
WTJ expression could rescue the ablation of cells in the glomus. However, experiments 
performed on chimeric null Pod 1 knock-out mice did not display an altered Pax 2 
expression pattern (Quaggin, et al., 1999). 
Pod 1 as a tumour suppressor gene 
The human Pod 1 homologue has been located to chromosome 6q23-24 (Smith. et al., 
2(06). This chromosomal region has been implicated in head and neck squamous cell 
carcinomas and non-small-cell lung cancer. By screening for methylation events in 
these types of carcinomas, a common methylation event was found to be located within 
the human Pod 1 gene (Smith, et al., 2006). Hypermethylation was shown to silence 
the human Pod 1 gene, and expression was absent in carcinoma cells, despite being 
present in surrounding epithelial tissues (Smith. et al., 2006). The study goes on to 
over-express Pod 1 in a lung cancer cell line, which reduces cell proliferation without 
visible cell death. The Pod lover-expressing cells also indicated a gain of contact 
inhibition. These data clearly place Pod J as a tumour suppressor gene and suggest that 
Pod 1 mis-expression in carcinoma cells may be due to methylation and not gene 
mutation. 
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Pod I and WTl 
Pod ] has similar properties to another tumour suppressor gene involved in kidney 
development, Wf]. Mutations in the Wf] gene are responsible for a number of renal 
conditions such as Denys-Drash syndrome and Frasier's syndrome (1.2.1 Introduction) 
(Denys, et al., 1967, Drash, et al., 1970 and Barbaux, et al., 1997). The dominant 
symptoms linked to these conditions are nephropathy and intersex. The nephropathy 
mainly effects the glomerulus, specifically the morphology of the podocytes and the 
glomerulus capillaries (Denys, et al., 1967, Drash, et al., 1970 Barbaux, et ai., 1997, 
Scharnhorst, et al., 2001 and Ito, et al., 2(03). Podocytes appear immature with 
reduced or fused foot processes and glomerulus capillaries are disturbed due to 
alterations in mesangial cell proliferation. Pod] knock-out experiments result in mice 
with comparable kidney phenotypes. Podocytes are similarly immature and lack foot 
processes, and the glomerulus capillary network is highly disorganised, although it is 
not clear whether the mesangial cells are responsible for this effect (Quaggin, et al., 
1999 and Cui, et al., 2(03). 
Wf] mutations also effect gonad development. Genetically male Denys-Drash 
syndrome and Frasier's syndrome patients often have female or ambiguous genitalia, 
streak gonads and develop gonadoblastoma (Little and Wells, 1997). This phenotype 
was also observed in Frasier's syndrome mice, where wn was shown to activate SF], a 
sex organogenesis gene (Wilhelm and Englert, 2002). Interestingly, null Pod] male 
mice are also externally female and have immature gonads (Cui, et al., 2004). 
However, contrary to Wf], Pod] has been shown to repress SF] expression (Tamura, 
et al., 200 I and Cui, et al., 2004). 
From these data, a clear link between Pod] and Wf] may be established. Indeed, in 
this work, Pod] has been shown to induce Wf] expression in Xenopus animal caps. A 
potential study would be to analyse Pod 1 expression in Denys-Drash syndrome and 
Frasier's syndrome mouse models. In humans, expression analysis could prove more 
fruitful than sequencing, especially regarding the study of Pod 1 methylation (Smith, et 
al., 2(06). 
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9.3 Darmin r 
Preliminary analysis of Darmin r, a cytosolic non-specific dipeptidase, indicated a role 
later in pronephric tubule development. Targeted over-expression experiments 
disrupted tubule morphology and reduced the size of the pronephric anlagen. 
Hypothetically, the over-expression of Darmin r could be prematurely signalling the 
terminal differentiation of pronephric tubule cells, and so reduce the number of 
pronephric tubule cells recruited via the pronephric anlagen. Observation of the number 
of cells within the pronephric anlagen contributing to the pronephric tubules by double 
wholemount in situ hybridisation, or analysis of the pronephric anlagen using a second 
marker, xPax 8, could add to the hypothesis. Also, the Darmin r knock-down analysis 
by morpholino oligonucleotide may further elucidate the role of Darmin r. 
Diabetic nephropathy has been linked to human chromosome 18q and is suggested to be 
the result of a dominant acting mutation in this locus (Janssen, et al., 2(05). Analysis of 
diabetic patients with and without nephropathy indicated a significant association with 
mutations in the CNDPJ gene and 5' of the human Darmin r homologue, CNDP2. 
These two genes are positioned at chromosome 18q22.3. The significance of the human 
Darmin r homologue association with diabetic nephropathy is unclear. Darmin r may 
degrade peptide carnosine, which has been shown to protect against oxidative stress and 
inhibit the renin-angiotensin system. Inhibition of the renin-angiotensin system can 
delay disease progression in patients with diabetic nephropathy. However, there is no 
direct evidence of the involvement of Darmin r in these processes. 
9.4 Future work 
As well as testing the discussed hypothesises arisen in the thesis, future work could also 
include analysis of the various clones highlighted in the search for target genes. These 
clones were previously overlooked due to inferior wholemount in situ hybridisation 
methodology, for example screen clones 18Bl and ~f6, or strict selection procedures, 
for example ~c7. These clones may yet prove important in the development of the 
pronephros. 
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9.5 Conclusion 
The data obtained in this study with the evidence discussed in this thesis, show a 
conserved developmental role of genes, not only between the 3 successive kidney 
forms, but also between species, such as the frog, mouse and even human. It is hoped, 
that by the functional analysis of developmental genes in lower organisms, steps 
towards understanding human congenital conditions may be made. 
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X"flOPU\ and m u Pod J bo\\ tb arne o\ er-e"pression phenotype demonstrated by WTJ ill 
\iJu indi alin Ibe iz or tbe glomu . 
o ta from F 65A+8 
InJechon 
Expenmental Control 
Glomus measurements Length of Glomus measurements 
Injected I Not II1j8C1ed embryo InJected 
1 0020 0.020 5490 0.030 
2 0020 0.020 5.255 0.020 
3 0020 0.030 5100 0.030 
• 0020 0030 5.325 0.030 5 0020 0020 5200 0.020 
6 0.010 0010 5.070 0.030 
7 0020 0030 5305 0.040 
8 0020 0040 5245 0.030 
9 0020 0020 5235 0.030 
10 0020 0030 5340 0.030 
11 0.020 0.030 5150 0.030 
12 0.010 0030 4.925 0.030 
13 0030 0030 5.335 0.030 
14 0030 0.030 5.180 0.030 
15 0020 0040 4880 0.020 
16 0020 0020 4.520 0.040 
17 0020 0040 4.635 0.040 
18 0000 0000 4385 0.040 
19 0020 0020 5.1 50 0.030 
20 0020 0030 5.155 0.030 
21 0040 0040 5.245 0.030 
22 0020 0030 5.505 0.050 
23 0020 0030 5135 0020 
24 0010 0020 5315 0.020 
25 0020 0020 5010 0.040 
26 0020 0030 4.340 0.020 
27 0020 0.040 5.230 0.040 
28 0020 0.020 5.250 0.020 
29 0002 0.020 4585 0.020 
3D 0030 0.044 5215 0.020 
31 0011 0.020 4945 0.030 
32 0016 0.020 5080 0.040 
33 0031 0030 5410 0.040 
J4 0008 0030 5.130 0.020 
J5 0026 0.033 5265 0.030 
J6 0020 0.030 5155 0.020 
37 0030 0030 4995 
38 0.030 0.030 4860 
Mean 0020 0.027 5093 0.030 
Ex 'menta I tiOI'I • 0 6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control injectlon • GFP mRNA 
Giomus measuremenl. in (3d p) mm' 
Not injected 
0.030 
0.030 
0.040 
0.020 
0.030 
0.020 
0.020 
0.030 
0.030 
0.030 
0.040 
0.040 
0.030 
0.020 
0.030 
0.040 
0.030 
0.020 
0.050 
0.010 
0.030 
0.040 
0.030 
0.030 
0.020 
0.030 
0.020 
0.040 
0.020 
0.020 
0.020 
0.020 
0.030 
0.030 
0.030 
0.030 
0.029 
Lenglh of 
embryo 
5.550 
5.600 
5.205 
5.880 
5.120 
5.570 
5.425 
5.275 
5.490 
5.630 
5.065 
5.810 
5.850 
6.095 
5.570 
5.040 
5.335 
5.520 
5.570 
4.700 
5.755 
5.505 
5.805 
5.555 
5.665 
5.420 
5.750 
5.650 
5.625 
5.595 
5.605 
5.510 
5.580 
5.625 
5.375 
5.490 
5.523 
LengItI of embryo mea urad on each side. Mean value of Sides for each embryo shown in (3.d.p) mm. 
Koimogorov-SmlfTlOV I 1 for norma ,ty: All failed 
W,Ico.onma ,pu'S nad0(8nks lesl : Expenmental 
Control 
P < 0.0001 
P = 0.4348 
n u LUCIA G versIOn 4 .81 for NIKON ltd Laboratory Imaging, www.lim.cz 
by Gl'lphPad InStat versIOn 3.06 for Windows, GraphPad Software, San Diego California 
phpadoom 
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XI!nOP"S and mou e Pod I shol' the arne oHr-expression phenotype demonstrated by WTI ill 
situ indicating the ize of the glomu . 
Data from Figure 6.5MB 
Injection 
Expenmenlal ratios Control ratios 
Injected Not Injected Injected Not injected 
1 0.004 0.004 0.005 0.005 
2 0.004 0004 0004 0.005 
3 0.004 0006 0.006 0.008 
4 0.004 0.006 0.005 0.003 
5 0.004 0004 0.004 0.006 
6 0.002 0.002 0.005 0.004 
7 0.004 0006 0007 0.004 
8 0.004 0008 0006 0.006 
9 0.004 0004 0.005 0.005 
10 0004 0006 0005 0.005 
11 0.004 0006 0.006 0.008 
12 0002 0.006 0.005 0.007 
13 0.006 0.006 0.005 0.005 
14 0.006 0.006 0.005 0.003 
15 0.004 0.008 0004 0.005 
16 0.004 0.004 0008 0.008 
17 0.004 0.009 0.007 0.006 
18 0.000 0.000 0.007 0 .004 
19 0.004 0.004 0.005 0.009 
20 0.004 0.006 0.006 0.002 
21 0008 0.008 0.005 0.005 
22 0.004 0.005 0.009 0.007 
23 0.004 0.006 0.003 0.005 
24 0002 0.004 0.004 0.005 
25 0.004 0004 0.007 0.004 
26 0.005 0.007 0.004 0.006 
27 0.004 0.008 0 .007 0.003 
28 0004 0.004 0.004 0.007 
29 0.000 0004 0.004 0.004 
30 0006 0.008 0.004 0.004 
31 0002 0004 0.005 0.004 
32 0.003 0.004 0.007 0.004 
33 0006 0006 0.007 0.005 
34 0.002 0.006 0.004 0.005 
35 0.005 0.006 0.006 0.006 
36 0.004 0.006 0.004 0.005 
37 0006 0006 
38 0.006 0006 
Mean 0.004 0.005 0 .005 0.005 
Expenmental inJecbon = 06ng Xenopus Pod 1 mRNA and GFP mRNA 
Control InJeclion = GFP mRNA 
Rallo of Glomus measurement diVIded by Length of Embryo shown in (3.d.p) mm'/mm 
Kolmogorov-Smlmov test for normality: 
KruskaJ Walhs test 
Dunn's post test 
(P values) 
I 
P = 0.0002 
Control 
All failed 
I InJected 
INot Injected 
Experimental 
Injected I Not injected 
<0.01 I > 0.05 
<0.05 L >0.05 
SlalistJcs calculated by GraphPad InS tat version 3.06 for Windows, GraphPad Software, San Diego California 
USA. wwwgraphpad.com 
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X(moplI and mou e Pod I ho\\ the arne over-expression phenotype demonstrated by WT/ ;/1 
;/11 indi sting tbe lze of the glomu _ 
Data from Figure 6.5C+O 
Injection 
Expenmental Control 
Glomus measurements Length of Glomus measurements 
Injected Not Injected embryo Injected 
1 0.010 0.020 4.775 0.030 
2 0.010 0020 4.565 0.020 
3 0.008 0.014 4.235 0.020 
4 0.032 0.027 4750 0.040 
5 0.021 0028 4.980 0.030 
6 0024 0.037 5.055 0.020 
7 0.015 0018 4.960 0.020 
8 0015 0.028 4.145 0.030 
9 0.016 0.027 4.195 0.020 
10 0.025 0.032 4.205 0.030 
11 0000 0.010 4.440 0.020 
12 0.020 0.020 4700 0.020 
13 0.020 0.040 4.235 0.020 
14 0020 0.030 4.780 0.020 
15 0.020 0.020 4.600 0.020 
16 0.020 0.020 4.600 0.020 
17 0.020 0.020 4.750 0.020 
18 0020 0.010 4.410 0.020 
19 0020 0020 4.645 0.040 
20 0.020 0.020 4.545 0.030 
21 0.010 0.030 4.390 0.020 
22 0017 0.020 4.635 0.030 
23 0.022 0.020 4.665 
24 0043 0023 4.500 
25 0020 0.022 4.750 
26 0013 0029 4.530 
27 0023 0.017 4.045 
28 0029 0.028 4.405 
29 0.020 0.020 4.385 
30 0.020 0.020 4.685 
31 0.010 0.020 4285 
Mean 0.019 0.023 4543 0.025 
Expermental,nj8Cbon = 0 6ng mouse Pod 1 mRNA and GFP mRNA 
Control Inj8Cbon = GFP mRNA 
Glomus measurements In (3d p) mm' 
Not injected 
0.030 
0.020 
0.020 
0.030 
0.030 
0.020 
0.020 
0.030 
0.020 
0.040 
0.020 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.020 
0.027 
Length of 
embryo 
4.515 
5.035 
4.320 
4.700 
4.785 
4.535 
3.755 
3.810 
3.540 
4.465 
4.450 
4.495 
4.315 
4.415 
4.455 
4.510 
4.540 
4.120 
4.425 
4.485 
4.580 
3.360 
4.346 
Length of embryo measured on each Side. Mean value of sides for each embryo shown in (3.d.p) mm. 
KoImogorov-SrTlImov test for normaloty. All failed 
Wilcoxon matched-palrs signed-ranks test Expenmental 
Control 
P = 0.0083 
P = 0.1294 
Measurements taken USing LUCIA G version 4.81 for NIKON Ltd. Laboratory Imaging, www.lim.cz 
StalJslJcs calculated by GraphPad InStat versIOn 3.06 for Windows, GraphPad Software, San Diego California 
USA, www graphpad.com 
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Xl!flOPII and mou Pod I ho\\ the ame over-expression phenotype demonstrated by WTI in 
\;(11 indie ting the ize of th glomu. 
Data from Figure 6 5C+D 
Injecllon 
Expenmental ratios Control ratios 
Injected Not 100ected 100ected Not Inlected 
1 0.002 0.004 0.007 0.007 
2 0.002 0.004 0.004 0.004 
3 0002 0003 0.005 0.005 
4 0 .007 0.006 0.009 0.006 
5 0.004 0006 0.006 0.006 
6 0.005 0.007 0.004 0.004 
7 0003 0.004 0.005 0.005 
8 0004 0.007 0.008 0.008 
9 0.004 0.006 0006 0.006 
10 0.006 0.008 0.007 0.009 
11 0000 0.002 0.004 0.004 
12 0 .004 0.004 0.004 0.007 
13 0005 0.009 0.005 0.007 
14 0.004 0.006 0.005 0.007 
15 0004 0.004 0.004 0.007 
16 0004 0.004 0.004 0.007 
17 0004 0004 0.004 0.007 
18 0.005 0002 0.005 0.007 
19 0.004 0.004 0009 0.007 
20 0004 0 .004 0.007 0.007 
21 0002 0007 0.004 0.007 
22 0004 0004 0.009 0.006 
23 0005 0.004 
24 0 .010 0005 
25 0004 0.005 
26 0003 0006 
27 0006 0004 
28 0.007 0.006 
29 0005 0.005 
30 0.004 0004 
31 0.002 0.005 
Mean 0.004 0.005 0.006 0.006 
ExpenmentallnjoctJon = 0 609 mouse Pod 1 mRNA and GFP mRNA 
Control lntecbon .. GFP mRNA 
RallO of Glomus measurement divided by Length of Embryo shown in (3.d.p) mm 2/mm 
Kolmogorov-SmtrTlOV test for normality: 
Kruskal Wallis test 
Dunn's post test 
(P values) 
I 
P < 0.0001 
Control 
All failed 
Iiniected 
INot Injected 
Experimental 
Injected I Not iniected 
< 0.05 I > 0.05 
< 0.001 I < 0.05* 
• Probably due to differences in embryo length 
Sta lies calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA. WNW graphpad.com 
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, mopu Pod I 0\ er-e\pr ion glomus pbenotype confirmed by xllllx lb expression analys is. 
Data from Figure 6.7 
Iniection 
Experimental Control 
GlOmus measurements Length of Glomus measurements 
Inteded Not inlected embryo Iniected 
, 0.010 0.010 3.365 0.020 
2 0008 0010 4.255 0.020 
3 0.011 0.012 4.750 0.020 
4 0.010 0.012 4.325 0.020 
5 0.015 0.010 4.040 0.040 
6 0.018 0.013 2.605 0.020 
7 0.015 0 .016 3.855 0.010 
8 0.009 0.010 4.565 0.020 
9 0.010 0.010 4.490 0.020 
10 0.008 0.010 4.225 0.010 
11 0.010 0.012 4.145 0.010 
12 0.005 0.009 3.840 0.020 
13 0.016 0.016 4.175 0.020 
14 0010 0 .012 3.945 0.010 
15 0 .010 0.018 4.345 
16 0.015 0.018 3.950 
17 0.015 0 .010 4.270 
18 0.013 0 .014 4.415 
19 0004 0.010 3.005 
20 0.015 0.014 3.155 
21 0.012 0.003 2.925 
22 0000 0.013 3.525 
23 0.007 0.014 3.280 
24 0.000 0.009 2.785 
25 0000 0 .014 3.535 
2S 0.000 0.012 3.030 
27 0012 0013 3.480 
28 0018 0 .013 3.930 
M n 0.010 0.012 3.793 0.019 
Expenmentallnj8CllOn = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
ControllnjeclJon = GFP mRNA 
GlOmus measurements 10 (3.d.p) mm' 
Not infected 
0.020 
0.030 
0.010 
0.010 
0.020 
0.020 
0.010 
0 .020 
0.020 
0.010 
0.020 
0.020 
0 .010 
0.020 
0.017 
Length of 
embryo 
4.085 
3.775 
3.820 
4.455 
4.055 
4.400 
2.485 
4.115 
3.650 
4.090 
3.855 
4.365 
3.825 
4.855 
3.988 
Length of embfyo measured on each Side. Mean value of sides for each embryo shown in (3 .d.p) mm. 
Kolmogorov-Smlmov tasl for normality: All failed 
Wllco)(on matched-pairS stgned-ranks test: Experimental 
Control 
P = 0.0393 
P = 0.5781 
M asurements ta en uSing LUCtA G version 4.81 for NIKON Ltd. Laboratory Imaging, www.lim.cz 
Stabsbcs calculat by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA. WNW graphpadcom 
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XellopliS Pod / over-expression glomus phenotype confirmed by x/lllx/b expression analysis. 
Data from Figure 6.7 
Iniection 
Experimental ratios Control ratios 
Injected Not injected Injected Not injected 
1 0.003 0.003 0.005 0.005 
2 0.002 0.002 0.005 0.008 
3 0.002 0.003 0.005 0.003 
4 0.002 0.003 0.004 0.002 
5 0.004 0.002 0.010 0.005 
6 0.007 0.005 0.005 0.005 
7 0.004 0.004 0.004 0.004 
8 0.002 0.002 0.005 0.005 
9 0.002 0.002 0.005 0.005 
10 0.002 0.002 0.002 0.002 
11 0.002 0.003 0.003 0.005 
12 0.001 0.002 0.005 0.005 
13 0.004 0.004 0.005 0.003 
14 0.003 0.003 0.002 0.004 
15 0.002 0.004 
16 0.004 0.005 
17 0.004 0.002 
18 0.003 0.003 
19 0.001 0.003 
20 0.005 0.004 
21 0.004 0.001 
22 0.000 0.004 
23 0.002 0.004 
24 0.000 0.003 
25 0.000 0.004 
26 0.000 0.004 
27 0.003 0.004 
28 0.005 0.003 
Mean 0.003 0.003 0.005 0.004 
Experimental injection = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control injection = GFP mRNA 
Ratio of Glomus measurement divided by Length of Embryo shown in (3.d.p) mm'/mm 
Kolmogorov-Smimov test for normality: 
Kruskal Wallis test 
Dunn's post test: 
(P values) 
I 
P = 0.0002 
Control 
All failed 
I Injected 
INot Iniected 
Experimental 
Iniected I Not injected 
<0.01 I < 0.05-
<0.01 I > 0.05 
- Probably due to differences in embryo length 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
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Histochemical analysis orthe Xenopus Pod J over expression phenotype showed 11 0 observable 
effect on either pronep hric tubule or duct. 
PNI data from Figure 6.8 
Injection 
Experimental Control 
Injected Not injected Injected Not Injected 
1 2 3 4 4 
2 5 4 5 4 
3 4 4 5 5 
4 4 4 4 5 
5 4 5 4 4 
6 3 4 3 4 
7 3 4 4 4 
8 4 5 5 4 
g 4 5 3 5 
10 4 4 5 5 
11 5 4 4 5 
12 5 4 5 4 
13 2 4 3 4 
14 4 4 5 5 
15 4 4 5 4 
16 3 4 5 4 
17 4 5 5 5 
18 3 3 4 5 
19 4 4 3 3 
20 2 3 4 5 
21 5 4 5 5 
22 5 5 
23 1 2 
Median 4 4 4 4 
Experimental injection = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control Injection = GFP mRNA 
Kolmogorov-Smirnov test for normality: 
Wilcoxon paired test: Experimental 
Control 
Experimental 
Control 
P = 0.0946 
P = 0.5186 
Failed 
Failed 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
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Histochemical analysis of the Xenopus Pod lover expression phenotype showed no observable 
effect on either pronephric tubule or duct. 
Duct morphology observations from Figure 6.8 
Injection 
Experimental Control 
Injected I Not injected Injected I Not Injected 
I Altered 6 I 2 3 
I Normal 17 I 21 18 
Experimental injection = 0.6n9 Xenopus Pod 1 mRNA and GFP mRNA 
Control injection = GFP mRNA 
Fisher's exact test: 
Experimental 
Control 
P = 0.2427 
P = 1 
I 4 
I 17 
244 
XenoPlls Pod J over-expression analysis with Ii", J does not indicate a pronephric anlagen 
phenotype. 
Data from Figure 6.9 
Injection 
Experimental Control 
Glomus measurements Length of Glomus measurements 
Injected Not iniected embryo Iniected 
1 0.060 0.050 4.045 0.030 
2 0.010 0.040 3.775 0.050 
3 0.020 0.040 3.135 0.050 
4 0.030 0.010 3.450 0.070 
5 0.060 0.040 3.1BO 0.060 
6 0.060 0.050 3.745 0.060 
7 0.040 0.050 3.265 O.OBO 
8 0.040 0.060 3.595 0.070 
9 0.040 0.050 3.720 0.060 
10 0.040 0.030 3.020 0.070 
11 0.040 0.020 3.930 0.050 
12 0.070 0.030 3.330 0.060 
13 0.030 0.030 4.140 0.100 
14 0.040 0.040 3.500 0.050 
15 0.030 0.030 3.760 0.090 
16 0.040 0.060 3.700 0.050 
17 0.050 0.070 4.095 O.OBO 
1B 0.030 0.050 2.765 0.050 
19 0.070 0.080 3.560 
20 0.040 0.050 3.905 
21 0.030 0.030 3.495 
22 0.050 0.060 3.095 
23 0.040 0.070 2.905 
24 0.070 0.040 3.680 
25 0.040 0.030 3.245 
26 0.030 0.020 3.340 
27 0.060 0.030 3.695 
2B 0.060 0.060 3.780 
Mean 0.044 0.044 3.530 0.063 
Experimental injection = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control injection = GFP mRNA 
Pronephric anlagen measurements in (3.d.p) mm ' 
Not injected 
0.050 
O.OBO 
0.130 
O.OBO 
0.030 
0.090 
0.110 
0.050 
0.070 
0.070 
0.060 
0.040 
0.060 
0.070 
0.090 
0.050 
0.040 
0.070 
0.069 
Length of 
embryo 
3.635 
4.300 
4.160 
3.340 
3.170 
3.B95 
3.B70 
4.015 
2.545 
3.425 
3.565 
3.705 
2.650 
3.B75 
4.190 
2.B70 
3.395 
3.500 
3.561 
Length of embryo measured on each side. Mean value of sides for each embryo shown in (3.d.p) mm. 
Kolmogorov-Smirnov test for normality: 
Wilcoxon matched·pairs signed-ranks test: 
Two tailed paired t-test: 
Experimental injected 
Experimental not injected 
Control injected 
Control not injected 
Experimental 
Control 
P = 0.799B 
P = 0.3922 
Failed 
Passed 
Passed 
Passed 
Measurements taken using LUCIA G version 4.B1 for NIKON Ltd. Laboratory Imaging. www.lim.cz 
Statistics calculated by GraphPad InStat version 3.06 for Windows. GraphPad Software. San Diego California 
USA. www.graphpad.com 
245 
XenoPlls Pod J over expression does not have an effect on the henrt, as indicated wit h Ilrt/ill L' 
troponin I expression, 
Data from Figure 6.11 
Injection 
Experimental Control 
Heart measurements Length of Heart measurements 
Left RiQht embryo Left 
1 0.030 0.020 4.170 0.030 
2 0.030 0.040 3.790 0.040 
3 0.030 0.040 3.825 0.020 
4 0.030 0.050 3.785 0.020 
5 0.040 0.010 4.125 0.040 
6 0.010 0.020 4.340 0.030 
7 0.020 0.010 3.965 0.030 
8 0.020 0.020 4.470 0.050 
9 0.020 0.030 4.205 0.030 
10 0.020 0.030 3.845 0.030 
11 0.020 0.020 4.330 0.040 
12 0.020 0.030 4.240 0.030 
13 0.020 0.020 4.200 0.100 
14 0.020 0.020 4.430 0.020 
15 0.020 0.030 4.275 0.050 
16 0.030 0.030 3.995 0.040 
17 0.030 0.020 4.310 0.030 
18 0.020 0.030 4.025 0.020 
19 0.020 0.020 4.115 0.030 
20 0.010 0.020 3.605 0.020 
21 0.030 0.030 3.830 0.000 
22 0.030 0.020 3.780 0.060 
23 0.030 0.020 3.445 0.050 
24 0.030 0.010 4.070 0.030 
25 0.000 0.000 3.435 0.040 
26 0.030 0.020 4.230 0.000 
27 0.020 0.020 2.200 0.060 
28 0.010 0.040 2.320 0.050 
29 0.030 0.030 3.385 0.030 
30 0.030 0.030 3.760 0.009 
31 0.030 0.060 2.450 
32 0.030 0.008 3.135 
33 0.000 0.000 2.705 
34 0.010 0.024 2.520 
35 0.060 0.068 1.470 
Mean 0.024 0.025 3.679 0.034 
Experimental injection = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control Injection = GFP mRNA 
Heart measurements in (3.d.p) mm 2 
RiQht 
0.030 
0.020 
0.020 
0.010 
0.020 
0.030 
0.020 
0.040 
0.020 
0.030 
0.020 
0.030 
0.007 
0.015 
0.027 
0.033 
0.035 
0.037 
0.000 
0.030 
0.000 
0.030 
0.050 
0.030 
0.000 
0.000 
0.038 
0.017 
0.037 
0.034 
0.024 
Len9th of 
embryo 
4.190 
4.060 
4.005 
4.130 
3.920 
4.090 
3.890 
3.875 
4.200 
4.310 
3.970 
4.245 
3.480 
3.965 
3.580 
4.010 
4.140 
3.435 
2.835 
4.275 
3.610 
3.070 
3.645 
3.260 
2.910 
3.385 
3.105 
3.730 
4.235 
3.330 
3.763 
Length of embryo measured on each side. Mean value of sides for each embryo shown In (3.d.p) mm. 
Measurements taken using LUCIA G version 4.61 for NIKON Ltd . Laboratory Imaging , www.lim.cz 
246 
Xellopus Pod lover expression docs not havc pn effect on the heart, ps Indlcnted with Curdiu£' 
tropollill I cxpression, 
Data from Figure 6.11 
Injection 
Experimental Control 
Ratio Ratio 
Left Right Left Right 
1 0.007 0.005 0.007 0.007 
2 0.008 0.011 0.010 0.005 
3 0.008 0.010 0.005 0.005 
4 0.008 0.013 0.005 0.002 
5 0.010 0.002 0.010 0.005 
6 0.002 0.005 0.007 0.007 
7 0.005 0.003 0.008 0.005 
8 0.004 0.004 0.013 0.010 
9 0.005 0.007 0.007 0.005 
10 0.005 0.008 0.007 0.007 
11 0.005 0.005 0.010 0.005 
12 0.005 0.007 0.007 0.007 
13 0.005 0.005 0.029 0.002 
14 0.005 0.005 0.005 0.004 
15 0.005 0.007 0.014 0.008 
16 0.008 0.008 0.010 0.008 
17 0.007 0.005 0.007 0.008 
18 0.005 0.007 0.006 0.011 
19 0.005 0.005 0.011 0.000 
20 0.003 0.006 0.005 0.007 
21 0.008 0.008 0.000 0.000 
22 0.008 0.005 0.020 0.010 
23 0.009 0.006 0.014 0.014 
24 0.007 0.002 0.009 0.009 
25 0.000 0.000 0.014 0.000 
26 0.007 0.005 0.000 0.000 
27 0.009 0.009 0.019 0.012 
28 0.004 0.017 0.013 0.005 
29 0.009 0.009 0.007 0.009 
30 0.008 0.008 0.003 0.010 
31 0.012 0.024 
32 0.010 0.003 
33 0.000 0.000 
34 0.004 0.010 
35 0.054 0.046 
Mean 0.007 0.008 0.009 0.006 
Experimental injection = 0.6ng Xenopus Pod 1 mRNA and GFP mRNA 
Control injection = GFP mRNA 
Ratio of Heart measurement divided by Length of Embryo shown in (3.d.p) mm ' /mm 
Kolmogorov·Smirnov test for normality: 
Kruskal Wallis test P = 0.0965 
Dunn's post test not performed 
Experimental 
Control 
Left = Fall Right = Fall 
Left = Fall Right = Pass 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
247 
Xenop"s Pod I expression is required for glomus development as indicated by WTI expression 
Data from Figure 7.3 
40ng PMO 
Injected I Nol injected 
~ 
40ng PMO: 
I No gtomus present 
I Gtomus present 
400g Pod 1 morphohno + GFP mRNA 
40ng PMO + RESCUE: 
13 1 0 
9 22 
In'action 
40ng PMO + RESCUE 
Injected Nolin 'ected 
7 1 
30 I 36 
40ng Pod 1 morphotino + 0.6ng mPod 1 mRNA + GFP mRNA 
4OogCMO: 
40ng Control morphohno + GFP mRNA 
Fishe(s exact test 
4OngPMO: P < 0.0001 
40ng PMO + RESCUE: P = 0.0557 
4OngCMO: P=1 
40ng PMO injected vs. 40ng PMO + RESCUE 
injected 
400g PMO injected vs. 40ng CMO injected 
400g PMO + RESCUE injected vs. 40ng 
CMO injected 
P = 0.0037 
P < 0.0001 
P = 0.0602 
40ngCMO 
Injected Not inected 
1 0 
31 I 32 
Statistics calculated by GraphPad InStat version 3.06 for Windows. GraphPad Software. San Diego California USA. 
www.graphpad.com 
248 
Confirmation that Xenopu .• Pod / expression Is required for glomus development, Indicated h~ x/nI"-/" 
expression 
Data from Figure 7 ,4 
40no PMO 
Injected , Not injected 
Columns 
40ng PMO: 
'No gtomus present 
, Glomus present 
11 
11 
40ng Pod 1 morpholino + GFP mRNA 
40ng PMO + RESCUE: 
, 0 
, 22 
Inection 
40no PMO + RESCUE 
Injected , Not injected 
5 , 1 
15 , 19 
40ng Pod 1 morpholino + 0.6ng mPod 1 mRNA + GFP mRNA 
40ng CMO: 
40ng Control morpholino + GFP mRNA 
Fishers exact test 
40ng PMO: P = 0,0002 
40ng PMO + RESCUE: P E 0,1818 
40ngCMO: P=l 
40ng PMO injected vs. 40ng PMO + 
RESCUE injected 
40ng PMO injected VB. 40ng CMO injected 
40ng PMO + RESCUE Injected VS. 40ng 
CMO injected 
P = 0,0372 
P = 0,0006 
P = 0,0814 
40na CMO 
Injected , Not injected 
1 I 0 
22 , 23 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California USA, 
www.graphpad.com 
249 
Pod J knock-down disrupts tubule morphology 
PNI data from Figure 7.6 
Injection 
40nQ PMO 40nQ PMO + RESCUE 40n9 CMO 
Injected 
1 2 
2 1 
3 1 
4 1 
5 4 
6 5 
7 3 
8 4 
9 2 
10 1 
11 1 
12 2 
13 4 
14 1 
15 2 
16 2 
17 1 
18 
19 
20 
21 
22 
23 
24 
Median 2 
Columns 
40ng PMO: 
Not injected 
4 
5 
4 
4 
5 
5 
4 
2 
5 
3 
3 
4 
5 
4 
5 
5 
4 
4 
40ng PMO + RESCUE: 
40ng CMO: 
Injected Not injected Injected 
4 5 5 
4 4 5 
5 5 3 
2 3 4 
4 4 5 
3 5 4 
5 4 3 
1 4 3 
5 5 4 
4 4 3 
4 4 5 
5 4 3 
3 4 5 
2 3 4 
4 5 5 
4 5 5 
5 4 5 
4 4 5 
4 3 4 
4 4 4 
3 4 5 
2 3 3 
3 4 3 
3 
4 4 4 
40ng Pod 1 morpholino + GFP mRNA 
40ng Pod 1 
40ng Control morpholino + GFP mRNA 
Kolmogorov-Smirnov test for normality: 40ng PMO 
Wilcoxon paired test: 
40ng PMO + RESCUE 
40ng CMO 
40ng PMO 
40ng PMO + RESCUE 
40ng CMO 
P = 0.0004 
P = 0.0730 
P = 0.0897 
Not injected 
5 
5 
5 
4 
5 
5 
5 
4 
4 
3 
5 
5 
5 
4 
5 
5 
5 
5 
4 
3 
5 
4 
2 
3 
5 
Injected Not injected 
Passed Failed 
Failed Failed 
Failed Failed 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego 
California USA, www.graphpad .com 
250 
Pod I knock-down does not have an effect on earlyXlim I expression 
Data from Figure 7.7 
40n9 PMO 
Glomus measurements 
Injected 
1 0.030 
2 0.030 
3 0.040 
4 0.030 
5 0.040 
6 0.030 
7 0.030 
8 0.040 
9 0.030 
10 0.030 
11 0.050 
12 0.050 
13 0.060 
14 0.060 
15 0.020 
16 0.060 
17 0.050 
18 0.040 
19 0.040 
20 0.040 
21 0.020 
22 0.040 
23 0.030 
24 0.040 
25 0.030 
26 0.040 
27 0.020 
28 0.030 
29 0.040 
30 0.050 
31 0.038 
Mean 0.038 
~ 
40ng PMO: 
Not injected 
0.040 
0.020 
0.020 
0.040 
0.050 
0.030 
0.030 
0.020 
0.040 
0.050 
0.040 
0.040 
0.030 
0.040 
0.020 
0.040 
0.040 
0.060 
0.020 
0.020 
0.030 
0.050 
0.020 
0.020 
0.030 
0.030 
0.040 
0.040 
0.030 
0.030 
0.034 
0.034 
40ng PMO + RESCUE: 
40ng CMO: 
Length of 
embryo 
2.360 
2.020 
2.315 
2.225 
2.265 
2.210 
2.385 
2.190 
2.245 
2.130 
2.075 
2.325 
1.860 
2.090 
2.255 
1.990 
2.285 
2.265 
2.415 
2.300 
2.175 
2.615 
2.145 
2.285 
2.065 
2.270 
2.680 
2.620 
2.410 
2.570 
2.220 
2.266 
Glomus measurements in (3.d.p) mm' 
Inlectlon 
40ng PMO + RESCUE 
Glomus measurements Length of 
Injected Not injecled embryo 
0.030 0.010 2.440 
0.040 0.032 2.480 
0.020 0.019 2.060 
0.050 0.050 2.535 
0.020 0.040 2.540 
0.040 0.010 2.570 
0.030 0.040 2.425 
0.030 0.020 2.525 
0.010 0.020 2.510 
0.010 0.040 2.330 
0.030 0.040 2.755 
0.020 0.020 2.330 
0.020 0.006 2.370 
0.040 0.020 2.505 
0.020 0.030 2.605 
0.040 0.030 2.485 
0.040 0.060 2.585 
0.040 0.020 2.290 
0.030 0.020 2.425 
0.020 0.040 2.580 
0.030 0.030 2.425 
0.030 0.020 2.525 
0.040 0.040 2.530 
0.050 0.030 2.285 
0.030 0.050 2.380 
0.030 0.030 2.815 
0.030 0.030 2.473 
40ng Pod 1 morpholino + GFP mRNA 
40ng Pod 1 
40ng Control morpholino + GFP mRNA 
40ng C MO 
Glomus measurements 
Injected Not Injocted 
0.070 0.040 
0.010 0040 
0.020 0.020 
0.050 0.070 
0.040 0.030 
0.040 0.070 
0.040 0.050 
0.030 0.030 
0.040 0040 
0.060 0.060 
0.070 0.060 
0.060 0.050 
0.020 0.040 
0.050 0010 
0.050 0.040 
0.030 0.040 
0.050 0.040 
0.050 0.070 
0.040 0.040 
0.050 0.040 
0.040 0.030 
0.040 0.050 
0.050 0.040 
0.030 0.030 
0.050 0.040 
0.050 0.070 
0.050 0.040 
0.030 0.060 
0.043 0.044 
Length of embryo measured on each side. Mean value of sides for each embryo shown In (3.d.p) mm. 
Kolmogorov-Smirnov test for normality: 
Wilcoxon matched-pairs signed-ranks test: 
All failed 
40ng PMO 
40ng PMO + RESCUE 
40ng CMO 
P = 0.1042 
P = 08117 
P = 0.6556 
Length of 
embryo 
2.290 
2.075 
2.530 
2670 
2.650 
2.420 
2.500 
1.985 
2.530 
2.510 
2.565 
2.555 
2.060 
1.975 
2.570 
2.725 
2.035 
2.61 5 
2.685 
2.610 
2.745 
2.645 
2.460 
2. 700 
2.555 
2.820 
2. 220 
2.630 
2.476 
Measurements taken using LUCIA G version 4.81 for NIKON Ltd. Laboratory Imaging. www llm.cz 
Statistics calculated by GraphPad InS tat version 3.06 for Windows. GraphPad Software. San Diego California USA. 
www.graphpad.com 
25 1 
Pod I expression is required for Pax 8 expression. 
Data from Figure 7.8 
40ng PMO 
Injected Not injected 
Pax 8 expression 
absent 
Pax 8 expression 
present 
~ 
40ng PMO: 
12 
13 
40ng Pod 1 morpholino + GFP mRNA 
40ng PMO + RESCUE: 
0 
25 
Injection 
40ng PMO + RESCUE 
Injected Not injected 
5 1 
16 20 
40ng Pod 1 morpholino + 0.6ng mPod 1 mRNA + GFP mRNA 
40ng CMO: 
40ng Control morpholino + GFP mRNA 
Fisher's exact test 
40ng PMO: P '" 0.0001 
40ng PMO + RESCUE: P=0.1836 
40ng CMO: P=l 
40ng PMO injected vs. 40ng PMO + RESCUE 
injected 
40n9 PMO injected vs. 40n9 CMO injected 
40ng PMO + RESCUE injected vs. 40ng CMO 
injected 
P = 0.1283 
P = 0.0022 
P = 0.1836 
40ng CMO 
Injected Not injected 
1 0 
19 20 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego 
Califomia USA, www.graphpad.com 
252 
Dorm;" r over-expression disrupts tubule forma tion. 
PNI data from Figure 8.6 
Injection 
Experimental Control 
Injected Not injected Injected Not injected 
1 4 5 5 5 
2 5 4 5 4 
3 3 4 5 4 
4 2 3 5 5 
5 1 5 5 5 
6 2 4 4 5 
7 1 4 4 5 
8 3 4 4 5 
9 3 5 5 4 
10 4 5 5 4 
11 1 3 5 5 
12 5 5 5 5 
13 1 3 5 5 
14 2 4 4 4 
15 3 5 5 5 
16 2 3 5 5 
17 2 4 4 5 
18 4 4 5 5 
19 2 3 4 5 
20 1 3 5 4 
21 4 4 
22 5 5 
23 5 4 
24 5 5 
25 5 4 
26 4 5 
27 5 5 
28 5 4 
29 4 4 
30 4 5 
31 4 5 
32 5 4 
33 4 5 
34 3 5 
35 3 5 
36 4 5 
37 4 4 
38 4 5 
39 4 4 
40 5 4 
41 5 4 
42 5 5 
43 4 5 
2 4 5 5 
Experimental injection = 0.5ng Darmin r mRNA and GFP mRNA 
Control injection = GFP mRNA 
Kolmogorov-Smirnov test for normality: 
Wilcoxon paired test: Experimental 
Control 
All failed 
P < 0.0001 
P= 0.4261 
Statistics calcu lated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
253 
Darmill r over-expression does not have an effect on the glomus. 
Data from Figure 8.7 
Injection 
Experimental Control 
Glomus measurements Length of Glomus measurements 
Injected Not injected embryo Injected 
1 0.040 0.020 4.300 0.030 
2 0.020 0.030 4.345 0.030 
3 0.020 0.020 4.180 0.020 
4 0.020 0.030 4.225 0.020 
5 0.030 0.010 3.430 0.020 
6 0.020 0.030 4.325 0.020 
7 0.030 0.020 3.860 0.020 
8 0.020 0.020 4.425 0.030 
9 0.020 0.020 4.105 0.030 
10 0.020 0.030 4.235 0.030 
11 0.020 0.020 4.695 0.010 
12 0.020 0.020 4.475 0.030 
13 0.020 0.020 4.380 0.020 
14 0.020 0.020 4.215 0.030 
15 0.020 0.020 4.300 0.030 
16 0.010 0.030 4.365 0.030 
17 0.030 0.020 4.300 0.020 
18 0.020 0.020 4.270 0.040 
19 0.020 0.020 4.205 0.020 
20 0.020 0.020 4.285 0.020 
21 0.020 0.020 4.250 0.020 
22 0.030 0.020 4.195 0.020 
23 0.020 0.020 4.090 0.030 
24 0.020 0.020 4.100 0.030 
25 0.003 0.010 4.405 0.010 
26 0.025 0.010 4.320 0.020 
27 0.008 0.030 4.300 0.010 
28 0.008 0.020 4.000 0.010 
29 0.009 0.030 4.750 0.030 
30 0.030 0.030 4.180 0.030 
31 0.018 0.020 4.240 0.030 
32 0.020 0.020 4.160 0.040 
33 0.024 0.020 4.215 0.020 
34 0.030 
Mean 0.020 0.022 4.246 0.024 
Experimental injection = 0.5ng Dannin r mRNA and GFP mRNA 
Control injection = GFP mRNA 
Glomus measurements in (3.d.p) mm 2 
Not Injected 
0.040 
0.050 
0.020 
0.020 
0.030 
0.030 
0.020 
0.020 
0.020 
0.030 
0.030 
0.030 
0.030 
0.030 
0.030 
0.020 
0.020 
0.020 
0.020 
0.010 
0.020 
0.020 
0.030 
0.020 
0.020 
0.030 
0.020 
0.020 
0.020 
0.020 
0.040 
0.030 
0.020 
0.030 
0.025 
Length of 
embryo 
4.440 
4.525 
4.455 
4.545 
4.545 
4485 
4.335 
4.615 
4.490 
4.495 
4.405 
4.250 
4.400 
4.400 
4.535 
4.640 
4.375 
4.330 
4.240 
4.330 
4.560 
4.545 
4.495 
4.155 
4365 
4.360 
4.290 
4.505 
4.505 
4.355 
4.420 
4.395 
4.555 
4.395 
4.433 
Length of embryo measured on each side. Mean value of sides for each embryo shown In (3.d p) mm 
Kolmogorov-Smirnov test for normality: All Failed 
Wilcoxon matched-pairs signed-ranks test: Experimental 
Control 
P = 0.5477 
P = 0.5958 
Measurements taken using LUCIA G version 4.81 for NIKON Ltd. Laboratory Imaging, www.lim.cz 
Statistics calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
254 
Dorm;', r over-expression reduces the size of the proneph rlc anlagen. 
Data from Figure 8.8 
In'ection 
Experimental Control 
Glomus measurements Length of Glomus measurements 
Injected Not injected embryo Injected 
1 0.030 0.030 2.290 0.040 
2 0040 0,030 2075 0,049 
3 0.020 0,030 2,530 0,010 
4 0,020 0,040 2,670 0,032 
5 0,040 0,030 2,650 0,039 
6 0,050 0,040 2,420 0,050 
7 0,030 0,030 2,500 0,040 
8 0,030 0,030 1,985 0,030 
9 0020 0,040 2,530 0,040 
10 0,040 0,030 2,510 0,020 
11 0,050 0,030 2,565 0,020 
12 0,040 0,050 2,555 0,040 
13 0,040 0,050 2,060 0,040 
14 0,030 0,060 1,975 0,020 
15 0,040 0,060 2,570 0,026 
16 0,020 0,020 2,725 0,020 
17 0,040 0,060 2,035 0 ,030 
18 0,040 0,050 2,615 0 .030 
19 0,020 0,040 2,685 0,060 
20 0,020 0,040 2,610 0,020 
21 0020 0.040 2,745 0,020 
22 0,030 0,020 2,645 0,040 
23 0,050 0,040 2.460 0,030 
24 0,020 0,030 2,700 0,020 
25 0,020 0,040 2,555 0,040 
26 0,030 0,030 2,820 0,030 
27 0,030 0,040 2,220 0,050 
28 0.040 0,020 2.630 0.030 
29 0.040 0,030 2,365 0.045 
30 0,030 0,040 2,720 0.025 
31 0.030 0,050 2,525 0.030 
32 0,020 0050 2.390 0.045 
33 0,040 
34 0,020 
35 0.030 
36 0.040 
Mean 0,032 0038 2.479 0 .033 
Experimental injection = 0,5ng Darmin r mRNA and GFP mRNA 
Control injection = GFP mRNA 
Prone ph ric anlagen measurements in (3.d p) mm' 
Not injected 
0.040 
0 .040 
0 ,030 
0 ,040 
0 ,020 
0 ,050 
0 ,050 
0 .040 
0 ,030 
0,030 
0 ,050 
0 ,040 
0 ,030 
0 ,020 
0 ,020 
0 ,040 
0 ,020 
0 ,040 
0,040 
0 ,040 
0 ,030 
0 ,020 
0 ,030 
0 ,030 
0 ,040 
0,050 
0 ,030 
0 .030 
0 ,040 
0 .050 
0 ,040 
0 ,050 
0 .040 
0 .020 
0020 
0040 
0035 
Length of 
embryo 
2,505 
2125 
2440 
2.480 
2,060 
2,535 
2.540 
2,570 
2.425 
2,525 
2.510 
2,330 
2,755 
2,330 
2,370 
2505 
2605 
2485 
2585 
2290 
2.425 
2,580 
2.425 
2,525 
2,530 
2,285 
2.380 
2,815 
2.265 
2275 
2,350 
2.295 
2.495 
2290 
2470 
2450 
2440 
Length of embryo measured on each side. Mean value of Sides for each embryo shown In (3 d.p) mm 
Kolmogorov-Smimov test for normality: All failed 
Wilcoxon matched-pairs signed-ranks test. Experimental 
Control 
P = 00199 
P = 0.3319 
Measurements taken using LUCIA G version 4,81 for NIKON Ltd Laboratory Imaging, www IIm.cz 
Statistics catculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
255 
Darmill r over-expression reduces the size of the pronephric anlagen. 
Data from Figure 8 .8 
Injection 
Experimental ratios Control ratios 
Injected Not injected Injected Not injected 
1 0.013 0.013 0.016 0.016 
2 0.019 0.014 0.023 0.019 
3 0.008 0.012 0.004 0.012 
4 0.007 0.Q15 0.013 0016 
5 0.015 0.011 0.019 0.010 
6 0.021 0.017 0.020 0.020 
7 0.012 0.012 0.016 0.020 
8 0.015 0.Q15 0.012 0.016 
9 0.008 0.Q16 0.016 0.012 
10 0.016 0.012 0.008 0.012 
11 0.019 0.012 0.008 0.020 
12 0.016 0.020 0.017 0.017 
13 0.019 0.024 0.015 0.011 
14 0.015 0.030 0.009 0.009 
15 0.016 0023 0.011 0.008 
16 0.007 0.007 0.008 0.016 
17 0.020 0.029 0.012 0.008 
18 0.015 0.019 0.012 0.016 
19 0.007 0.Q15 0.023 0.Q15 
20 0.008 0.Q15 0.009 0.017 
21 0.007 0.015 0.008 0.012 
22 0.011 0.008 0.016 0.008 
23 0.020 0.016 0.012 0.012 
24 0.007 0.011 0.008 0.012 
25 0.008 0.016 0.016 0.016 
26 0.011 0.011 0.013 0.022 
27 0.014 0.018 0.021 0013 
28 0.015 0.008 0.011 0011 
29 0.017 0.013 0.020 0018 
30 0.011 0.015 0.011 0022 
31 0.012 0.020 0.013 0017 
32 0.008 0.021 0.020 0.022 
33 0.016 0.016 
34 0.009 0.009 
35 0012 0.008 
36 0.016 0.016 
Mean 0.013 0.016 0.014 0.015 
Experimental Injection = 0.5ng Darmin r mRNA and GFP mRNA 
Con trot Injection = GFP mRNA 
Ratio of Pronephrlc anlagen measurement divided by length of Embryo shown In (3 d p) mm'/mm 
Koimogorov-Smirnov test for normality: 
Experimental Injected = Failed 
Experimental not Injected = Failed 
Kruskal Wallis test P = 0.2307 
Dunn's post test not performed 
Control Injected · Passed 
Control not Injected = Failed 
StatistiCS calculated by GraphPad InStat version 3.06 for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com 
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Duct morphology observations from Darmin rover-expression 
Injection 
Experimental Control 
Injected I Not injected Injected I Not injected 
I Altered 5 I 8 4 
I Normal 29 I 26 27 
Experimental injection = 0.5ng Darmin r mRNA and GFP mRNA 
Control injection = GFP mRNA 
Fisher's exact test: 
Experimental 
Control 
P = 0.5387 
P=1 
I 3 
I 28 
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Nephrostome morphology observations fromDarmin rover-expression 
Nephrostomes Disrupted Nephrostomes Matching 
I Darmin r inj 14 30 
I GFP inj 5 48 
Experimental injection = 0.5ng Darmin r mRNA and GFP mRNA 
Control injection = GFP mRNA 
Fisher's exact test: P = 0.0091 
Number of embryos 
44 
53 
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Pia mid maps 
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Plasmid maps 
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Plasmid maps 
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